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Abstract 
The Synthesis of Tryptophan Derivatives, 2- and/or 3-Substituted Indoles, Progress 
Toward Dilemmaones A-C, and Synthetic Studies Towards Fistulosin via Palladium-
Catalyzed Reductive N-Heteroannulation 
 
Christopher Andrew Dacko 
 Palladium-catalyzed carbon monoxide-mediated reductive N-heteroannulation of 
o-nitrostyrenes has emerged as a very powerful method for constructing the 
corresponding indole core.  The Söderberg variety of this methodology has been utilized 
to synthesize several asymmetric tryptophan derivatives along with a collection of 2- 
and/or 3-substituted indoles.  The same protocol has also been employed to make 
synthetic progress toward the construction of the marine indole alkaloids Dilemmaones 
A-C.  Finally, this versatile cyclization was implemented in studies designed to determine 
the true structure of the compound isolated by Tomita et. al. and given the name 
“fistulosin”. 
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1.1 Indole Background and Notable Indoles 
 Indole (1) is the commonly used name for the benzopyrrole in which the benzene 
ring is fused to the 2- and 3-positions of the pyrrole ring.1  Its name is an acronym from 
indigo, the natural dye it originated from, and oleum, which is used for the isolation.2  
Numbering of the atoms in indole begins with the nitrogen atom and proceeds 
counterclockwise around the nucleus (Figure 1). 
Figure 1: Structure and Numbering of Indole 
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Indole is a planar heteroaromatic molecule.  The ten-electron π-system is formed 
by a pair of electrons from the nitrogen atom and eight electrons from the eight carbon 
atoms.2  Indoles are highly reactive toward electrophilic reagents, including acids and 
certain oxidants, with the 3-position being the most reactive site for substitution.  The 
high reactivity of the 3-position can be predicted on the basis of π-electron density, 
localization energy, or frontier electron density information obtained from molecular 
orbital calculations.2  The N-H group of indoles is relatively acidic (pKa = 17) and forms 
the anion in the presence of strong bases.1  Although the electron pair of this anion is 
orthogonal to the π-system, it nevertheless increases reactivity at C-3 toward 
electrophiles.1  As a consequence, the indolyl anion has ambident properties in alkylation 
and acylation reactions.1 
The synthesis and reactivity of indole derivatives has been a topic of research 
interest for well over a century.3  As previously mentioned, the development of indole 
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chemistry began with extensive research on the dye indigo (2).1  In 1841, indigo was 
oxidized to isatin (3) using nitric acid (Scheme 1).4 
Scheme 1: Indigo Oxidation to Isatin 
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In 1866, Baeyer and Knop successfully converted isatin (3) to oxindole (5).  This 
transformation was achieved by the reduction of isatin (3) with sodium amalgam in water 
to dioxindole (4), which, without isolation, could be further reduced to oxindole (5) with 
the same reagent in aqueous acidic medium (Scheme 2).5 
Scheme 2: Conversion of Isatin to Oxindole 
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Later in 1866 Baeyer prepared indole (1) by zinc dust pyrolysis of oxindole (5) 
(Scheme 3).6 In 1869, he proposed the formula of indole that is accepted today.7 
Scheme 3: Synthesis of Indole from Oxindole 
    
N
H
O Zn dust
N
H  
            5                                              1 
Indole chemistry continued to be important in the dyestuff industry until the 
beginning of the twentieth century when newer dyes overtook the indoles.1  This caused a 
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brief decline in indole research, but interest was quickly renewed in the 1930’s when it 
was discovered that many useful alkaloids contained the indole nucleus.1  This interest is 
even greater in modern times, considering that reports of several thousand individual 
indole derivatives appear annually in the chemical literature.3  In fact, the indole ring 
system is probably the most frequently found heterocycle in nature.8  The main reason for 
this sustained attraction is the wide range of biological activity found among indoles.3  
There are several indoles involved in processes in the human body.  L-Tryptophan (6),9 is 
one of the 20 standard amino acids, as well as an essential amino acid in the human diet.  
In addition, tryptophan functions as a biochemical precursor for serotonin (7),10 a 
neurotransmitter synthesized via tryptophan hydroxylase.11  Serotonin can be further 
converted to melatonin (8), a neurohormone, via N-acetyltransferase and 5-
hydroxyindole-O-methyltransferase activities.12  A  pharmaceutically relevant indole 
containing the same basic structural skeleton is sumatriptan (9), which is used in the 
treatment of migraine headaches (Figure 2).13   
Figure 2: Structures of L-Tryptophan, Serotonin, Melatonin, and Sumatriptan 
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Ergoline (10) is an indole derivative whose structural skeleton is contained in a 
diverse range of alkaloids used for vasoconstriction and treatment of Parkinson’s 
disease14  The ergoline core is also seen in a few psychedelic drugs.  For example, 
lysergic acid diethylamide (11), commonly called LSD, is a famous hallucinogen.  
 5
Lisuride (12) is an anti-Parkinson’s drug also used to lower prolactin, a peptide hormone 
associated with lactation (Figure 3).15 
Figure 3: Structures of Ergoline, LSD, and Lisuride 
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In addition, yohimbine (13),16 has been shown in human studies to be effective in 
the treatment of male impotence.  Ellipticine (14) has received a tremendous amount of 
attention from the synthetic community due to its potent antitumor activity.17  Strychnine 
(15) is a very toxic indole alkaloid used as a pesticide to kill small birds and rodents 
(Figure 4).18 
Figure 4: Structures of Yohimbine, Ellipticine, and Strychnine 
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Marine organisms produce an unprecedented molecular diversity by the 
incorporation of elements like bromine that are not readily available to terrestrial 
species.19  Marine indole alkaloids are often produced and are of great importance due to 
the significant activity that they have elicited in cancer and cytotoxicity assays.19  
Eudistomin L (16) contains a novel oxathiazepine ring and shows antiviral activity by 
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inhibiting HSV-1 growth. 20  Dragmacidin (17), a bisindole alkaloid isolated from a deep 
water marine sponge, has shown cytotoxicity against P-388 cell lines and activity against 
human lung and colon cancer cell lines.21  Dihydroflustramine C (18), isolated from the  
marine bryozoan F. foliacea, exhibits a wide antibacterial spectrum including activity 
against E. coli (Figure 5).22 
Figure 5: Structures of Eudistomin L, Dragmacidin, and Dihydroflustramine C 
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This wealth of biologically active indole derivatives found in nature has sparked 
organic researchers past and present to develop numerous synthetic strategies to produce 
the indole core.   Some of these methods, involving extremely diverse starting materials 
and reaction conditions, are discussed in the next section. 
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1.2 Classic Routes to the Indole Core 
  For well over 100 years, the synthesis and functionalization of indoles has been a 
major area of focus for synthetic organic chemists.8  This interest is mostly due to the 
remarkable range of biological and medicinal properties displayed by indole-containing 
molecules.23  Substituted indoles have been referred to as “privileged structures” since 
they are capable of binding to many receptors with high affinity.24  The principal 
commercial source of indole (1) is extraction from coal tar, although the feasibility of 
industrial synthesis from starting materials such as aniline and ethylene glycol, N-
ethylaniline, or 2-ethylaniline has been demonstrated.3  Highly substituted indoles, such 
as the many that appear in biologically active natural and unnatural compounds, are not 
as easily harvested from natural sources.  These indoles, most often, must be produced 
synthetically using one of the numerous methods that have been developed for the 
preparation of the indole core.  Key factors, including starting material availability and 
functional group tolerance, often dictate which particular indole synthesis will be 
suitable.8   
1.2.1 Fischer Indole Synthesis 
The Fischer indole synthesis25, 26 has remained an extremely useful method for the 
synthesis of a variety of indole intermediates and biologically active compounds.27  Even 
though it was developed in 1883, it is still probably the most widely used of all the indole 
syntheses.  The Fischer reaction provides a simple method for the transformation of 
enolizable N-arylhydrazones into indoles.  The cyclization is usually carried out with a 
protic acid or Lewis acid (mainly ZnCl2) which functions both to facilitate the formation 
of the enehydrazine by tautomerization and also to assist the N-N bond cleavage.3, 27  
 8
Watson et. al.28 recently developed a large-scale preparation of MDL 103371 (23), an N-
methyl-D-aspartate (NMDA)-type glycine receptor antagonist for the potential treatment 
of stroke, based on Fischer indolization chemistry.  Starting from commercially available 
3,5-dichlorophenylhydrazine (19), treatment with ethyl pyruvate in ethanol gave the 
hydrazone 20 as an E/Z mixture.  Fischer cyclization using polyphosphoric acid (PPA) 
provided the indole 21 in excellent yield.  Next, a Vilsmeier-Haack formylation gave 
aldehyde 22, which was then converted to MDL 103371 (23) in six steps and 49% overall 
yield (Scheme 4).28 
Scheme 4: Synthesis of MDL 103371 Utilizing Fischer Indole Synthesis  
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The mechanism of the reaction (Scheme 5), which is supported by spectroscopic 
observation of intermediates29 and by isolation of examples of intermediates in 
specialized structures30, is thought to begin with the tautomerization of hydrazone 20 to 
the ene-hydrazine 24.  Tautomer 24 then undergoes a [3,3]-sigmatropic rearrangement to 
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form bis iminobenzylketone 25.  Heteroannulation and aromatization gives indoline 26 
which then loses ammonia to provide the indole product 21. 
Scheme 5: Mechanism of the Fischer Indole Synthesis 
Cl
Cl N
H
N
CO2Et
H
Cl
Cl N
H
H+
N
CO2Et
H
H
Cl
Cl NH
NH2
CO2Et
H
 
               20               24           25 
H+
Cl
Cl N
H
CO2Et
NH3
Cl
Cl N
H
CO2Et
H
-NH3
 
           26          21 
Advantages of the Fischer reaction include the acceptance of a wide range of 
compatible functional groups around the aromatic ring and lack of a requirement for a 
functional group to form the new C-C and C-N bonds8, while one major limitation is the 
availability of certain substituted aryl hydrazine or hydrazone intermediates.  Buchwald 
and co-workers have narrowed this limitation31 by implementing a palladium-catalyzed 
coupling of hydrazones with aryl bromides as an entry to N-arylhydrazones for use in the 
Fischer indolization.8,32  For example, commercially available and inexpensive 
benzophenone hydrazone 27 was coupled to 1-bromo-4-chlorobenzene using palladium 
diacetate to give hydrazone 28, which then gave indole 29 upon treatment with acid in the 
presence of cyclohexanone (Scheme 6). 
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Scheme 6: Buchwald Modification of the Fischer Indole Synthesis 
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1.2.2 Madelung Indole Synthesis 
 The Madelung synthesis produces the indole core by the intramolecular 
cyclization of N-phenylamides using a strong base at high temperatures.33  Specifically, 
the original conditions for preparing 2-methylindole (31) involve heating o-
methylacetanilide (30) with sodium amide at 250oC (Scheme 7).34 
Scheme 7: Madelung Indole Synthesis of 2-Methylindole 
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 These conditions are so harsh that they are applicable only to indoles with the 
most inert substituents.3  The Houlihan modification35 of the Madelung synthesis, 
however, utilizes n-butyllithium (n-BuLi) or lithium diisopropylamide (LDA) as bases 
under much milder conditions.  Employing these improved conditions, the formation of 
5-chloro-2-phenylindole (34) could be effected in excellent yield by treating N-(4-chloro-
2-methylphenyl)benzamide (32)  with two equivalents of n-BuLi in tetrahydrofuran 
(THF) at -20oC, producing dilithiated intermediate 3336,  and then allowing the reaction 
mixture to gradually warm to room temperature (Scheme 8). 35 
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Scheme 8: Madelung-Houlihan Indole Synthesis of 5-Chloro-2-phenylindole      
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1.2.3 Bartoli Indole Synthesis 
 The Bartoli indole synthesis37,38 involves the reaction of ortho-substituted 
nitroarenes with three equivalents of a vinyl Grignard reagent to form highly-substituted 
indoles.  It is particularly suitable for producing indoles that are substituted on both the 6- 
and 5-membered rings.  The reaction is also a good method for synthesizing 7-substituted 
indoles.  The presence of a group ortho to the nitro group is critical for the success of the 
reaction, but Dobbs has shown39 that bromine can be used in that position and then 
removed under radical conditions using azobisisobutyronitrile (AIBN) and tributyltin 
hydride after formation of the indole.  Blechert et. al. performed the Bartoli reaction with 
1-bromo-4-ethyl-2-nitrobenzene (35)  and vinylmagnesium bromide in THF to yield 7-
bromo-4-ethylindole (36), which was subsequently converted to the marine natural 
product (±)-cis-trikentrin A (37) in seven steps (Scheme 9).40 
Scheme 9: Bartoli Indole Synthesis of 7-Bromo-4-ethylindole 
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 The mechanism of the Bartoli indole synthesis41 begins with the addition of 
vinylmagnesium bromide to the nitroarene 35 to form intermediate 38.  Intermediate 38 
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then decomposes to form nitrosoarene 39.  The second equivalent of Grignard reagent 
then reacts with nitrosoarene 39 to give intermediate 40.  Next, a [3,3]-sigmatropic 
rearrangement occurs to give aldehyde 41.  Cyclization and tautomerization of 41 gives 
indoline 43, which reacts with a third equivalent of vinylmagnesium bromide to give 
dimagnesium salt 44.  Finally, reaction work-up eliminates water and gives the desired 
indole 36 (Scheme 10). 
Scheme 10: Mechanism of the Bartoli Indole Synthesis 
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1.2.4 Gassman Indole Synthesis 
 The Gassman indole synthesis42 is a one-pot procedure used to synthesize 
substituted indoles from anilines.  Under typical reaction conditions, 4-chloroaniline (45) 
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is first exposed to tert-butyl hypochlorite, giving N-chloroaniline 46.  Addition of the 
sulfide provided sulfonium ion 47, which was deprotonated using triethylamine to give 
ylide 48.  Ylide 48 then undergoes a [2,3]-sigmatropic rearrangement to give ketone 49.  
Cyclization, followed by loss of water, produces 5-chloro-2-methyl-3-(methylthio)-1H-
indole (50) in 72% yield.  If desired, the thiomethyl group can be removed using Raney-
nickel to give 5-chloro-2-methyl-1H-indole (51) (Scheme 11).3 
Scheme 11: Gassman Indole Synthesis 
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1.2.5 Leimgruber-Batcho Indole Synthesis 
 The Leimgruber-Batcho indole synthesis43 is one of the most important and 
commonly used methods for preparing 2,3-unsubstituted indoles.  This two-step method 
first involves the condensation of an appropriately substituted o-nitrotoluene with N,N-
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dimethylformamide dimethylacetal (DMFDMA) to give an intermediate β-
(dimethylamino)-2-nitrostyrene.8  The reaction depends on the nitro group both to acidify 
the toluene methyl group and to stabilize the enamine product.  In the original version, 
the reaction was driven to completion by distillation of methanol.3  However, an 
improvement that  has been widely adopted is the inclusion of pyrrolidine in the reaction 
mixture.44  Under these conditions, the reaction is accelerated and the pyrrolidine is 
exchanged into the enamine product.3  The second step of the reaction involves reductive 
cyclization, which leads to substituted indoles.  A number of reducing agents have been 
used, with the choice being dictated by the nature of the carbocyclic substituents.3  The 
two most common choices, however, are palladium on carbon/H2 and Raney 
nickel/hydrazine.  The reaction has been used extensively for the construction of key 
intermediates in pharmaceutically important compounds.  Simig and co-workers45 have 
demonstrated a new and practical synthesis of 5-formylindole (56), an intermediate in the 
synthesis of the antimigraine drug naratriptan (57).  According to the authors, the 49% 
overall yield represents the most efficient synthetic route currently available for the 
preparation of 5-formylindole.  The synthesis began with the conversion of 3-methyl-4-
nitrobenzaldehyde (52) to acetal 53 using ethylene glycol and catalytic TsOH.  
Leimgruber-Batcho reaction of 53 using DMFDMA in DMF and subsequent 
hydrogenation of the nitro group with Pd/C gave indole 55 in good yield.  Hydrolysis of 
acetal 55 with aqueous HCl provided 5-formylindole (56) in 91% yield (Scheme 12). 
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Scheme 12: Leimgruber-Batcho Indole Synthesis of 5-Formylindole 
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1.2.6 Nenitzescu Indole Synthesis 
 The Nenitzescu indole synthesis46 involves the condensation of p-benzoquinones 
with β-aminocrotonic esters and is a highly regioselective method for the formation of 
1,2,3-trisubstituted-5-hydroxyindoles.8  Kasai and co-workers47 have recently reported 
the large-scale preparation of methyl 5-hydroxy-2-(methoxymethyl)-1H-indole-3-
carboxylate (59), a key indole intermediate in the synthesis of the antitumor agent EO9 
(60).  Reaction of ester 58 with 3 equivalents of p-benzoquinone and 3.5 equivalents of 
AcOH, followed by the addition of Na2S2O4 and adjustment of the pH using aqueous 
NaOH, gave indole 59 in 49% yield after recrystallization.  Indole 59 was then converted 
to EO9 (60) in 10 additional steps (Scheme 13). 
Scheme 13: Nenitzescu Indole Synthesis  
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Low yields in the Nenitzescu reaction are often attributed to its mechanism, which 
provides several possibilities for side reactions.8 The most accepted mechanism48 
(Scheme 14) begins with a Michael addition of enamine 58 to the protonated 
benzoquinone 61, which, after proton transfer, provides imine 63.  Imine 63 undergoes 
the loss of a proton to induce heteroannulation and give indole precursor 64.  Finally, loss 
of water provides rearomatization, producing indole 59. 
Scheme 14: Mechanism of the Nenitzescu Indole Synthesis 
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The classical syntheses discussed in this chapter have been around for many 
years, but are still commonly used in the construction of indoles today.  In addition to 
these syntheses, however, new methods have emerged including the fairly recent use of 
palladium to compose the indole core.  These important indole-forming reactions are 
discussed in Chapter 2. 
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2.1 Introduction 
 In addition to the well-established classical methods of indole synthesis, 
palladium-catalyzed N-heteroannulation reactions have emerged as very powerful 
methods for producing the indole core.  Since the discovery of the Wacker process49 in 
the late 1950’s, an ever-increasing number of organic transformations have been based on 
palladium catalysis.  Transformations involving palladium are generally tolerant of a 
wide range of functionalities.  In addition, they are dependent on a number of factors 
(ligands, bases, additives, solvents, temperature), making these types of reactions very 
flexible.50  Also, since palladium processes are almost always catalytic, target molecules 
can be reached in fewer steps and with less waste then classical methods.50   
Heterocyclic chemistry has been greatly influenced by the discovery of palladium 
catalysis.51  Indole synthesis has been no exception to this trend.  Numerous palladium-
catalyzed approaches to substituted indoles have been developed, employing a wide 
variety of starting materials.  N-heteroannulation routes to indoles utilizing palladium 
usually involve the assembly of the functionalized pyrrole nucleus on a benzenoid 
scaffold.  This is most commonly done by using nitrogen atoms (anilides, anilines, 
nitrenes, etc.) as nucleophiles to attack alkene and alkyne moieties.  In addition, other less 
frequently applied strategies for the construction of the functionalized pyrrole nucleus 
have been described that are based on the Buchwald/Hartwig N-arylation process.52   
2.2 Indole Formation via o-Alkynylanilides and o-Alkynylanilines 
 A large part of the studies dedicated to the development of new sequences in the 
bond-making process leading to the construction of the indole pyrrole ring is based on the 
utilization, as precursors, of compounds containing nitrogen nucleophiles and carbon-
 19
carbon triple bonds.50  These alkyne based procedures provide a wide range of 
possibilities for indole formation.  The first example of palladium-catalyzed cyclization 
of o-alkynylanilides to indoles was by Taylor and McKillop53 around 1985.  Their 
procedure, however, is rarely used today due to the toxicity of the o-thallated anilides 
used as starting materials.  More modern protocols, such as that reported by Kundu et. 
al.54, are much more feasible routes to indoles (Scheme 15).  In Kundu’s example, the 
cyclization of o-[(3-hydroxy-3,3-dimethyl)prop-1-yl]trifluoroacetanilide (65) was 
effected using palladium(II) acetate to give 2-(prop-1-en-2-yl)-1H-indole (66) in 
excellent yield after hydrolysis of the amide bond and dehydration of the tertiary alcohol. 
Scheme 15: Palladium-Catalyzed Synthesis of Indoles from o-Alkynylanilides 
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 The nitrogen atom of free anilines can also be used as a nucleophile to attack 
alkynes in palladium-catalyzed processes.  Cacchi and co-workers55 developed an 
approach to 2-substituted indoles using a common acetylenic building block: o-
ethynylaniline (67).  The synthesis of o-ethynylaniline is easily accomplished by 
performing a Sonogashira coupling56 of o-iodoaniline with ethynyltrimethylsilane 
followed by desilylation.  Once this o-alkynylaniline is in hand, palladium-catalyzed 
couplings with vinyl and aryl triflates or halides can be carried out followed by 
subsequent palladium-catalyzed N-heteroannulations to give 2-substituted indoles.  This 
coupling/cyclization approach can also be conducted as a one-pot process omitting the 
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isolation of the coupling intermediate.  In a typical procedure, o-ethynylaniline (67) was 
coupled to 4-phenylcyclohex-1-enyl trifluoromethanesulfonate (68) in the presence of 
tetrakis(triphenylphosphine)palladium(0) (Pd(PPh3)4), giving the intermediate o-
alkynylaniline 69, which was then cyclized without isolation to give indole 70 in 98% 
yield (Scheme 16).32, 57 
Scheme 16: Palladium-Catalyzed Synthesis of Indoles from o-Alkynylanilines 
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2.3 Indole Formation via Intermolecular Cycloaddition with Alkynes 
 The palladium-catalyzed reaction between o-iodoaniline derivatives and internal 
alkynes for the preparation of 2,3-disubstituted indoles is referred to as the Larock 
heteroannulation.58  The reaction is an extremely attractive synthesis since both starting 
materials (i.e. o-iodoaniline and internal alkyne) can possess considerable functionality, 
giving highly substituted indoles as products.8  The heteroannulation is regioselective and 
almost always gives 2,3-disubstituted indoles, where the more sterically hindered group 
of the alkyne occupies the 2-position of the indole ring.  In most of the reactions studied, 
the more hindered acetylenic termini were silyl groups, which can either serve as 
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versatile intermediates for the synthesis of other indole derivatives or can be desilylated 
to the corresponding 3-substituted indoles.58  In addition, substituents on the aniline 
nitrogen are also tolerated, leading to N-substituted indoles.  Gathergood and 
Scammells59 utilized the Larock heteroannulation in the preparation of N,N-dimethyl 
tryptamine 73 via the intermolecular cycloaddition of iodoaniline 71 and TMS-alkyne 72 
in the presence of palladium(II) acetate.  Indole 73 was used as an intermediate in a 
practical and versatile synthesis of the natural product psilocin (74) (Scheme 17). 
Scheme 17: Synthesis of Psilocin via the Larock Heteroannulation  
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2.4 Indole Formation via o-Allylanilines 
 Hegedus et. al.60,61 first reported the synthesis of 2-alkylindoles via the palladium-
assisted cyclization of o-allylanilines, although Mori62 and Heck63 each discovered this 
transformation independently around the same time.  The reaction proceeds by a 
nucleophilic attack of the aromatic amine across the palladium-coordinated olefin, 
resulting in a σ-alkylpalladium complex, which after β-hydride elimination and 
spontaneous isomerization, gives the indole moiety.61  Originally, the reaction involved 
using stoichiometric amounts of palladium; however, improvements were made by 
adding benzoquinone in order to reoxidize Pd(0) to Pd(II), thereby allowing the reaction 
to be catalytic in palladium.  One of the original examples is shown in Scheme 18.  
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Allylic aniline 75 was converted to 2-ethylindole (76) using PdCl2(MeCN)2 in good 
yield. 
Scheme 18: Palladium-Catalyzed Heteroannulation of o-Allylanilines 
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2.5 Indole Formation via o-Vinylanilines 
 In the same paper describing the cyclization of o-allylanilines to give indoles61, 
Hegedus and co-workers reported the successful palladium-catalyzed preparation of 
indole (1) from o-vinylaniline (77), again using PdCl2(MeCN)2 (Scheme 19).  To their 
surprise, no cyclization occurred under stoichiometric palladium conditions.  This 
methodology was also applied to several N-substituted substrates (o-vinylacetanilides64, 
o-vinyl-N-alkylanilines65, etc.), giving N-substituted indoles in good yield.  Despite the 
potential of this chemistry, it has remained essentially unexplored due to difficulty in 
synthesizing the starting materials (o-vinylanilines). 
Scheme 19: Palladium-Catalyzed Heteroannulation of o-Vinylanilines 
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2.6 Indole Formation via Buchwald/Hartwig N-Arylation Processes 
 Buchwald’s aryl amination technique66, which involves a palladium-catalyzed C-
N bond forming reaction between aryl halides or triflates and amines, amides, and 
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carbamates, has been parlayed into a simple and versatile indoline synthesis.67  In the 
recent total syntheses of the marine alkaloids makaluvamine C and damirones A and B, 
key indole intermediate 80 was assembled using the Buchwald strategy.68  Aryl iodide 78 
underwent an palladium-catalyzed intramolecular amination to give indoline 79, which 
was subsequently oxidized using Pd/C to give indole 80 (Scheme 20). 
Scheme 20: The Buchwald/Hartwig N-Arylation Route to Indoles 
MeO
OMe
I
N
NHBn
Pd2(dba)3, P(o-tolyl)3
NaOtBu, PhMe, 80oC
72%
Pd/C, HCO2NH4
MeOH, reflux
80%
MeO
OMe
N
N
Bn
MeO
OMe
N
N
Bn
        
              78                                   79                 80 
 Willis and co-workers have very recently implemented a Buchwald-type 
amination to produce N-substituted indoles.23  They describe a sequential inter- and 
intramolecular palladium-catalyzed animation reaction used to prepare indoles bearing 
sterically demanding N-substituents.  This strategy avoids having to functionalize the 
indole N-H, which can sometimes be problematic due to the low nucleophilicity of the 
indole nitrogen atom.  In a typical procedure, a mixture of cis- and trans-1-bromo-2-(2-
chlorovinyl)benzene (81) was reacted with 2-methylbut-3-en-2-amine (82) in the 
presence of Pd(OAc)2, giving N-prenylated indole 83 in good yield.  Indole 83 was 
subsequently transformed into Demethylasterriquinone A1 (84) in 5 steps (Scheme 21). 
 
 
 
 
 
 24
Scheme 21: Willis Route to N-Substituted Indoles 
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2.7 Indole Formation via Nitrenes 
 Nitrenes are neutral, reactive intermediates containing six electrons in their outer 
shell, two bonded and four nonbonded.69  Nitrenes are believed to exist in two different 
forms, singlet nitrenes and triplet nitrenes.  A typical singlet nitrene 85 has its nonbonded 
electrons arranged as two lone electron pairs, and is considered to be the lower energy 
state.  A typical triplet nitrene 86 has its nonbonded electrons arranged as a lone pair and 
an unpaired biradical, and is considered to be the higher energy state (Figure 6). 
Figure 6: Typical Singlet and Triplet Nitrenes 
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Probably the first reported generation of a nitrene intermediate in a heterocyclic 
synthesis was by Smith and Brown70 in 1951.  They reported the synthesis of carbazole 
(88) from the thermal decomposition of 2-azidobiphenyl (87) in kerosene at 180oC 
(Scheme 22). 
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Scheme 22: First Nitrene in the Synthesis of Nitrogen Containing Heterocycles  
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 Mechanistically, the reaction is believed to proceed via the thermally induced loss 
of nitrogen from azide 87 to produce nitrene 89.  Nitrene 89 then rapidly undergoes 
cyclization to give tricycle 90, which, after a [1,5]-sigmatropic rearrangement, restores 
aromaticity and affords carbazole (88) (Scheme 23). 
Scheme 23: Mechanism of Carbazole Formation via Azide Decomposition  
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 Nitrogen loss from azide 87 can also be initiated photochemically, which has led 
to studies of the reactive intermediates involved in the formation of carbazole (88) by 
chemical trapping71, matrix spectroscopy72, and flash photolysis73.  Swenton, Ikeler, and 
Williams74 demonstrated that carbazole (88) is derived from the reaction of a singlet state 
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species, presumably singlet nitrene 89, whereas triplet nitrene 91 dimerizes to form azo 
compound 92 (Scheme 24). 
Scheme 24: Singlet Nitrene vs. Triplet Nitrene in the Formation of Carbazole 
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 The Sundberg indole synthesis75 involves the thermolysis of o-azidostyrenes and 
cyclization of the resulting nitrene to form indoles.  Mechanistically, it is almost identical 
to the protocol used by Smith and Brown in their formation of functionalized carbazoles.  
Molina and co-workers employed this reaction to prepare 2-(2-azidoethyl)indole (94) via 
the thermolysis of arylazide 93.  The less reactive aliphatic azido group remained intact 
(Scheme 25). 
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Scheme 25: Sundberg Indole Synthesis 
                      
N3
N3 160oC, toluene
sealed tube, 61% N N3
H  
                                    93                                                                94 
 The Cadogan-Sundberg indole synthesis,76, 77 an extension of the Sundberg indole 
synthesis, yields indoles by the deoxygenation of o-nitrostyrenes with trivalent 
phosphorus compounds (typically triethyl phosphite) and subsequent cyclization of the 
resulting nitrene.  Although other reactive intermediates have been suggested to result 
from this nitro group deoxygenation, the products derived from the Cadogan-Sundberg 
reaction are overwhelmingly similar to the products obtained from thermal and 
photochemical reactions of azides.69  This observation suggests that a reactive, electron 
deficient nitrogen atom, most likely a nitrene, develops during the deoxygenation of 
nitroaromatics.  While this reaction is very broad in scope, the extreme reaction 
conditions (>150oC), formation of both N-hydroxy- and N-ethoxyindole byproducts, and 
generation of large amounts of phosphorus waste all contribute to detract from this 
approach.8  Palmisano et. al.78 utilized the Cadogan-Sundberg reaction to synthesize 2-
(pyridin-2-yl)indole (96) by exposing 2-(2-nitrostyryl)pyridine (95) to boiling triethyl 
phosphite (Scheme 26). 
Scheme 26: Cadogan-Sundberg Indole Synthesis 
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Mechanistically, the formation of nitrene intermediate 104 most likely occurs 
through a process involving the sequential removal of the nitro group oxygen atoms.  
Addition of triethyl phosphite to nitroarene 95, followed by the loss of triethyl phosphate 
provides nitroso compound 100.  A similar addition-elimination process could occur a 
second time to give the nitrene 104 (Scheme 27).   
Scheme 27: Mechanism of Cadogan-Sundberg Indole Synthesis 
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 Another pathway to the indole core can also be envisioned.  Although the first 
deoxygenation step is generally accepted, a second immediate deoxygenation to arrive at 
the nitrene is questionable.  It has been shown that direct cyclization of o-nitrosostyrene 
100 can occur to form N-hydroxyindole 105 after isomerization and protonation.  
Hydroxyindole 105 can then be readily deoxygenated using an equivalent of triethyl 
phosphite to give indole 96.  Evidence for this mechanistic route is provided by the 
frequent isolation of N-hydroxy- and N-ethoxyindoles from the reaction mixture (Scheme 
28).69 
Scheme 28: Alternate Cadogan-Sundberg Reaction Pathway 
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 Transition metal promoted deoxygenation of nitroaromatics to give heterocycles 
was first realized by Waterman and Vivian79 in the 1940’s using stoichiometric iron 
oxalate at 215oC.  Nitroarene 106 was converted to carbazole (88) in 63% yield (Scheme 
29). 
Scheme 29: First Transition Metal Promoted Deoxygenation of Nitroaromatics 
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 The direct involvement of o-nitrostyrenes as substrates in the palladium-catalyzed 
synthesis of indoles was first observed by Kasahara et. al.80 in 1989.  In an attempt to 
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prepare o-nitrostyrene (108) via a Heck reaction of o-bromonitrobenzene (107) and 
ethylene in the presence of palladium acetate, Kasahara isolated 43% of the desired 
alkene along with an unexpected 22% of indole (1) (Scheme 30).  The authors suggested 
a mechanism consisting of the reduction of o-nitrostyrene (108) (formed via Heck 
reaction) to o-vinylaniline (77) by a palladium hydride species (generated in the Heck 
reaction as well), followed by a more conventional Pd(II)-catalyzed cyclization to 
produce indole (1). 
Scheme 30: Kasahara Heck Reaction/Indole Synthesis 
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 The transition metal catalyzed reductive cyclization of o-nitrostyrenes employing 
carbon monoxide (CO) as the stoichiometric reductant has emerged in recent years as a 
highly versatile method for the construction of indoles.8  Several different metals, 
including ruthenium81, for example,  have been examined as catalysts in this 
transformation and have been deemed synthetically impractical due to numerous factors 
including moderate yields, high carbon monoxide pressures, high reaction temperatures, 
and high catalyst loadings.  Palladium-based systems have subsequently been identified 
as very efficient catalysts for this transformation.  These palladium-catalyzed reductive 
N-heteroannulations are thought to resemble reactions such as the Sundberg and 
Cadogan-Sundberg indole syntheses in that they too involve a reactive intermediate that 
is nitreneoid in character.  Evidence of this type of intermediate arises from similarities 
between products obtained using palladium/CO protocols and products obtained starting 
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from more conventional sources of nitrenes. Mechanistically, the palladium-catalyzed 
carbon monoxide-mediated reductive N-heteroannulation does not proceed by an initial 
reduction of the nitro group to an amine followed by an amino-palladation/β-hydride 
elimination sequence.  This Hegedus-type mechanism would require a palladium(II) 
species, which has to be regenerated by an added oxidant.69  The previously mentioned 
palladium-catalyzed N-heteroannulation conditions not only lack an oxidant, but are 
highly reductive in nature.  The proposed reaction mechanism involves (a) the 
deoxygenation of the nitro group of the nitroarene by carbon monoxide, (b) the attack of 
the resultant active transition metal nitrene intermediate to the olefinic carbon, and (c) the 
hydrogen transfer via [1,5]-sigmatropic rearrangement to yield the indole core.50  This 
rationalization is primarily supported, again, by the product distribution from reactions of 
aromatic nitro compounds and their analogous azides. 
 Watanabe82 and co-workers were some of the first researchers to describe the 
preparation of indoles from 2-ethenyl-1-nitrobenzenes via reductive N-heteroannulation 
in the presence of carbon monoxide, catalytic amounts of PdCl2(PPh3)2, and an excess of 
SnCl2 (Sn/Pd = 10:1).  In the simplest example, o-nitrostyrene (108) was converted to 
indole (1) in good yield, albeit under a high carbon monoxide pressure (Scheme 31). 
Scheme 31: Watanabe Pd-Catalyzed Reductive N-Heteroannulation 
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 Cenini83 et. al. also used high carbon monoxide pressures to help pioneer indole 
formation utilizing palladium-catalyzed reductive N-heteroannulation.  For example, 
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indole 96 was synthesized in good yield from 2-(2-nitrostyryl)pyridine (95) in the 
presence of 5 mol % Pd(TMB)2 (TMB=2,5-dimethyl-2,5-diisocyanohexane) and 
TMPhen (TMPhen=3,4,7,8-tetramethyl-1,10-phenanthroline), under 20 atm of carbon 
monoxide pressure (Scheme 32). 
Scheme 32: Cenini Pd-Catalyzed Reductive N-Heteroannulation 
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 Kuethe and Davies84 recently developed a palladium-catalyzed reduction of o-
nitrostyrenes to afford indoles in good to excellent yield.  Their cyclization occurs under 
much milder conditions (1 atm CO, 80oC) and at lower catalyst loadings (0.1 mol % Pd) 
than those previously reported by Watanabe and Cenini.  The Kuethe group recently 
described the preparation of the highly functionalized indole 110, which was 
subsequently deprotected to give the potent and selective KDR kinase inhibitor 111.  
Under their optimized reaction conditions which employed 0.1 mol % Pd(TFA)2 
(TFA=trifluoroacetate), 0.7 mol % TMPhen in DMF, at 80oC, and 15 psi of CO, o-
nitrostyrene 109  produced indole 110 as the only product in 95% isolated yield (Scheme 
33).85 
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Scheme 33: Kuethe and Davies Pd-Catalyzed Reductive N-Heteroannulation 
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 Dong and co-workers86 have very recently reported a new synthesis of indoles via 
reductive cyclization of conjugated nitroalkenes in the presence of carbon monoxide.  
This method differs from those previously mentioned which involved indole formation 
by reductive cyclization of nitroarenes.  Under mild conditions87, the amination of both 
electron-rich and electron-deficient aromatic sp2 C-H bonds was shown to occur.  This 
methodology is limited, however, in that the starting diaryl nitroalkenes can only be 
derived from the corresponding ketones.  In a typical procedure, 2,2-di(4-chlorophenyl)-
1-nitroethylene (112) was converted to 6-chloro-3-(4-chlorophenyl)indole (113) in almost 
quantitative yield employing a palladium(II) acetate/1,10-phenanthroline catalyst system 
(Scheme 34). 
Scheme 34: Dong Transformation of Conjugated Nitroalkenes into Indoles 
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 Similar to the conditions used by Davies, Söderberg et. al. have developed a mild 
palladium-catalyzed, carbon monoxide-mediated reductive N-heteroannulation route to 
indoles starting from the corresponding o-nitrostyrenes.88  The discovery of these 
conditions came rather unexpectedly during an attempted palladium-catalyzed 
methoxycarbonylation reaction.  In an effort to synthesize methyl 3-nitro-2-vinylbenzoate 
(115), which was required as a precursor in another study involving Fischer chromium 
carbene conversions to indoles, it was observed that none of the desired product was 
obtained using 1-bromo-3-nitro-2-vinylbenzene (114) as the starting aryl bromide.  
Instead, 4-bromoindole (116) was isolated as the sole product in 63% yield (Scheme 
35).88 
Scheme 35: Söderberg Attempted Methoxycarbonylation/Indole Synthesis 
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 After substantial optimization studies, the highest yields were obtained under 
slightly modified reaction conditions: 6 mol % Pd(OAc)2, 24 mol % PPh3, CO (60 psi), 
MeCN, 70oC.  These conditions were subsequently used to synthesize a variety of 
indoles88,89,90 possessing functional groups on both the carbocyclic and pyrrole rings.  For 
example, 4-methoxy-2-nitro-1-(prop-1-en-2-yl)benzene (117) was exposed to these 
adjusted conditions to yield 6-methoxy-3-methylindole (118) in excellent yield (Scheme 
36). 
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Scheme 36: Optimized Söderberg N-Heteroannulation Conditions 
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 In addition, Söderberg and co-workers have extensively used another palladium-
catalyzed reductive N-heteroannulation protocol to cyclize o-nitrostyrenes that are 
resistant to the previously mentioned conditions.  These alternate, slightly more harsh 
conditions consist of  6 mol % Pd(dba)2 (dba=dibenzylideneacetone), 6 mol % dppp (1,3-
bis(diphenylphosphino)propane), 12 mol %  1,10-phen (1,10-phenanthroline), and CO (6 
atm) in DMF at 120oC.  Various types of indole cores have been synthesized utilizing this 
procedure including 3-alkoxysubstituted indoles91 and tetrahydrocarbazoleones92.  
Natural products have been formed in this manner as well, namely the pyrano[3,2-
b]indole koniamborine (120), which was constructed via cyclization from o-nitrostyrene 
119 in good yield (Scheme 37).93 
Scheme 37: Synthesis of Koniamborine Using Alternate Söderberg Conditions 
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 The Söderberg cyclization conditions are fairly mild, proceeding at a substantially 
lower temperature and pressure than those of Watanabe82 and Cenini83.  Also, unlike 
Watanabe’s protocol, no Lewis acid is required.  Compared to previously mentioned 
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palladium-catalyzed routes to indoles employing aniline derivatives, the Söderberg 
annulations are more attractive because (a) nitrobenzenes are usually precursors to aniline 
derivatives, consequentially eliminating a synthetic step, and (b) palladium re-oxidants 
are not required.88  In general, the reaction appears to be independent of the substituents 
on the aromatic ring.  o-Nitrostyrenes containing either electron-withdrawing or electron-
donating substituents give indoles in good to excellent yields.  Also, since the only 
stoichiometric byproduct of the reaction is CO2, the reductive cyclization offers 
significant economic and environmental advantages.   In addition, the stereochemistry of 
the alkene moiety does not effect the reaction outcome.  Cyclization of pure trans-2-
nitrostilbene (121) gave 2-phenylindole (122) in quantitative yield, while cyclization of 
an equal mixture of cis- and trans-2-nitrostilbene (123) produced the desired indole in 
91% yield (Scheme 38).88 
Scheme 38: Effect of Söderberg N-Heteroannulation on Isomeric Mixtures 
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 Interestingly, exposing trans-4-nitrostilbene (124) to typical Söderberg 
cyclization conditions left the starting material unchanged; no alteration of the nitro 
group was observed (Scheme 39).88  It appears that the close proximity of the olefin 
moiety to the nitro group is critical for any reaction to occur.  It has been hypothesized 
that palladium coordination to the double bond may assist in the reduction of the nitro 
group.88 
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Scheme 39:  Possible Palladium-Olefin Coordination in N-Heteroannulation 
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 A definite, concrete mechanism explaining the Söderberg N-heteroannulation, and 
others like it, remains elusive.  While the exact details of the reaction continue to be 
mysterious, these transition metal catalyzed reductive cyclizations can be considered 
formally nitreneoid in character, although this is most likely an oversimplification of very 
complex reactions.  However, combined efforts in this field, along with several 
mechanistic investigations have led to three plausible mechanistic routes (Scheme 40).91  
To initiate any of the three routes, Pd(0) must first react with nitroarene 108 to give 
intermediate 125.  Intermediate 125 can then undergo an insertion of carbon monoxide to 
give 5-membered palladacycle 126, which loses a molecule of carbon dioxide to yield 
palladium-bound nitrosoarene 127.  Two mechanistic pathways are possible from 
intermediate 127.  Path A84 proceeds by reductive elimination of Pd(0) to give the free o-
nitrosostyrene 128, which can now undergo a 6π-electron 5 atom electrocyclic reaction, 
giving nitronate 129.  Subsequent [1,5]-hydrogen shift and isomerization 
(129Æ130Æ131) affords N-hydroxyindole (131), which is then reduced by a second 
equivalent of CO to give indole (1).  Path B begins with a second carbon monoxide 
insertion into the palladium-bound nitrosoarene 127.  Loss of carbon dioxide from 132 
would produce palladium-bound nitrene 133 that via a 6π-electron cyclization could give 
palladacyle 134.  Reductive elimination to regenerate the palladium(0) catalyst would 
afford intermediate 135. Isomerization via a [1,5]-hydrogen shift would then furnish 
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indole (1).  Finally, path C arises from reductive elimination of Pd(0) from 133 to give 
the free nitrene 136.  An electrocyclization of 136 would produce 135, which after a 
[1,5]-hydrogen shift could also yield indole (1). 
Scheme 40: Proposed Mechanistic Pathway(s) of Reductive N-Heteroannulation 
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 Mechanistic studies involving the [1,5]-hydride shift proposed to be involved in 
pathways A, B, and C above have been performed by Watanabe.82  He and co-workers 
utilized deuterium labeling experiments to further investigate the details of the reductive 
N-heteroannulation.  Reaction of 2-(2,2-dideutereo-1-methylvinyl)nitrobenzene (137) 
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afforded 3-methylindole 139 with deuterium located at the 1- and 2-positions.  This result 
indicates that the deuterium at the β-position of the starting o-nitrostyrene 137 may be 
directly abstracted by the nitrogen atom (probably of a nitrene intermediate) in the 
construction of the indole skeleton.  This deuterium labeling experiment also suggests 
evidence of a hydrogen (or in this case, deuterium) transfer via a [1,5]-sigmatropic 
rearrangement of intermediate 138 to afford indole 139 (Scheme 41). 
Scheme 41: Watanabe N-Heteroannulation of Deuterated Nitro-olefin              
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 Watanabe et. al.82 also investigated the reductive N-heteroannulation of β,β-
disubstituted 2-nitrostyrenes, concluding that these compounds conform to a similar 
mechanism.  For example, (2-nitrobenzylidene)cyclopentane (140) was transformed into 
1,2,3,4-tetrahydrocarbazole (142) via alkyl rearrangement.  In this case, results suggest 
that spirocyclic intermediate 141 must be produced, and then undergo a [1,5]-alkyl shift, 
causing ring expansion and furnishing tetrahydrocarbazole 142 after the necessary 
hydrogen migration (Scheme 42). 
Scheme 42: Mechanistic [1,5]-Alkyl Shift in Reductive N-Heteroannulation.                     
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 Having a solid understanding of the mechanism of palladium-catalyzed, carbon 
monoxide-mediated reductive N-heteroannulation has provided researchers with the 
necessary knowledge to expand and develop this methodology to its fullest potential.  
Several examples of advancements in this field are presented in chapters hereafter. 
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3.1 Introduction to Tryptophan/Tryptophan Skeleton in Natural Products 
 Tryptophan, abbreviated Trp or W, is one of the twenty standard amino acids 
found in proteins and coded for in the standard genetic code as the codon UGG.94,95  The 
standard amino acids are also referred to as proteinogenic, or protein building amino 
acids.94  These amino acids are assembled into a polypeptide, a protein subunit, through a 
process known as translation, the second stage of protein biosynthesis.94  For humans, 
tryptophan is an essential amino acid, meaning that we cannot synthesize it and therefore 
must make it part of out diet.  Also, as mentioned in chapter 1, tryptophan functions as a 
biochemical precursor for important compounds in the body such as serotonin (7) and 
melatonin (8) (see Figure 2).  Only L-tryptophan (6) is used in structural or enzyme 
proteins, but D-tryptophan (143)96 is occasionally found in naturally produced peptides 
(Figure 7). 
Figure 7:  Structures of L-Tryptophan and D-Tryptophan 
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 By virtue of its ubiquitous distribution in plant and animal proteins, tryptophan 
may justifiably be regarded as the most important of the naturally occurring indoles.1  Its 
skeleton can be seen in a variety of natural products, including diketopiperazines like 
brevicompanine C (144) and fiscalin B (145) (Figure 8).  Diketopiperazines are 
widespread microbial products commonly found in nutrient rich cultures of both 
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terrestrial and marine fungi.97  These compounds are of high interest because of their 
activity in various pharmacological assay systems.98 
Figure 8: Structures of Brevicompanine C and Fiscalin B  
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 In addition, a number of ring-A (the six-membered carbocyclic ring) substituted 
tryptophan-based alkaloids appear in nature as well.  Examples include echinulan (146), 
along with methoxylated alkaloids99 like fuchsiaefoline (147) and alstophylline (148), 
which both contain an enantiopure L-tryptophan moiety (Figure 9).  L-Tryptophan 
derivatives, including N-methyl-L-tryptophan, have proven to be most potent competitive 
IDO (indoleamine 2,3-dioxygenase) inhibitors.100  Indoleamine 2,3-dioxygenase is a 
heme-containing enzyme that causes depletion of tryptophan which can lead to halted 
growth of microbes as well as T cells.99 
Figure 9: Structures of Echinulan, Fuchsiaefoline, and Alstophylline 
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 It is important to note that almost all tryptophan derivatives and natural products 
that are of biological use tend to possess high enantiomeric enrichment; racemates are 
rarely, if ever observed in this context.  For this reason, several procedures have been 
developed to synthesize optically active substituted tryptophans, along with chiral amino 
acids in general. 
3.2 Previous Enantioselective Syntheses of α-Amino Acid Derivatives 
 Numerous methods have been reported for the asymmetric synthesis of α-amino 
acids.  Dellaria and co-workers101 developed a synthesis of amino acid derivatives via the 
stereoselective alkylation of a homochiral glycine enolate synthon.  When the glycine 
derivative 149 was added in dry THF to sodium bis(trimethylsilyl)amide (NaHMDS) in 
THF at -78oC and subsequently alkylated with benzyl bromide, the corresponding 
alkylation adduct 150 was obtained in good yield and excellent diastereoselectivity 
(>200:1).  Exposure of 150 to excess refluxing ethanolic HCl provided alcohol 151, 
which was then converted to the chiral amino ester 152 via palladium-catalyzed 
hydrogenolysis (Scheme 43).  
Scheme 43: Dellaria Alkylation of Homochiral Glycine Enolate Synthon 
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 Leanna et. al.102 have reported the synthesis of optically active unnatural amino 
acids via a tandem biocatalytic kinetic resolution of a racemic amino ester.  Racemic 
ester 153 was treated with Subtilisin Carlsberg, an enzyme, to afford a mixture of ester 
154 and carboxylic acid 155.  The now enantiopure D-ester 154 was extracted with 
CH2Cl2 after the reaction had consumed 48.5% of racemic ester 153, as judged by C-18 
HPLC.  The aqueous solution containing N-acetyl-L-acid 155 was then treated with 
Porcine Kidney Acylase I to remove the acetyl group and give optically pure L-amino 
acid 156 in 75% over the two steps (Scheme 44). 
Scheme 44: Leanna Biocatalytic Kinetic Resolution of a Racemic Amino Ester 
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 Myers and co-workers103 developed a practical method for the synthesis of D- or 
L-α-amino acids by the direct alkylation of (+)- or (–)-pseudoephedrine glycinamide 
hydrate.  In a typical procedure, the enolate dianion of (R,R)-(–)-pseudoephedrine 
glycinamide (157) was reacted with benzyl bromide to give the asymmetric alkylation 
product 158 in 93% diastereomeric excess.  Compound 158 was then hydrolyzed to the 
L-amino acid (159) after exposure to refluxing water (Scheme 45).  It should be noted 
that (R,R)-(–)-157 produces L-amino acid derivatives while the pseudoephedrine 
glycinamide enantiomer produces D-amino acid derivatives. 
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Scheme 45: Myers Direct Alkylation of Pseudoephedrine Glycinamide Hydrate 
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 Several asymmetric syntheses have been developed specifically to produce 
enantiopure derivatives of both D- and L-tryptophan.  These methods involve a wide 
variety of starting materials and reaction conditions.  Hruby and co-workers104 have 
reported a protocol for the asymmetric synthesis of both D- and L-aromatic substituted 
tryptophan derivatives under mild reaction conditions.  The general strategy involves the 
asymmetric hydrogenation of α-enamides to generate functional amino acids in high 
optical purity (>96% ee) which serve as common intermediates from which a variety of 
substituted amino acid derivatives may be readily obtained through Suzuki-type 
couplings.  α-Enamide 160, obtained from a Horner-Emmons olefination with a 
commercially available indole-3-carboxaldehyde, underwent asymmetric hydrogenation 
using 1,2-bis ((2S,5S-2,5-diethylphospholano)benzene(cyclooctadiene rhodium (I) 
trifluoromethane sulfonate ((S,S)-[Et-DuPHOS-Rh] OTf) to give L-amino acid derivative 
161 in quantitative yield (Scheme 46).  Using the enantiomer of the rhodium catalyst 
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gave the D-amino acid derivative 163 in excellent yield.  5-Bromotryptophan derivative 
161 was then subjected to Suzuki cross couplings with a variety of boronic acids to give 
aryl-substituted chiral tryptophans with the general structure 162.  This overall method is 
limited in the number of commercially available indole starting materials.  Carlier et. al. 
have also reported a similar method in constructing protected tryptophan regioisomers.105 
Scheme 46: Hruby Asymmetric Hydrogenation of α-Enamides 
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 Gellerman and co-workers106 have developed an approach for the asymmetric 
synthesis of ring-A disubstituted tryptophans based on modification and extension of the 
simple Fischer-indole reaction between 2,4- or 2,3-disubstituted phenylhydrazine 
hydrochlorides and optically active N,N-diprotected glutamic acid γ-aldehydes.  These 
glutamic acid derivatives needed to be diprotected to prevent undesired intramolecular 
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lactamization, which would result in racemization of the asymmetric carbon.  In a typical 
reaction, 2,4-dimethylphenylhydrazine (164) was refluxed with N,N-di-Boc protected L-
glutamic acid t-butyl ester 165 in isopropanol to give the expected tryptophan core.  
However, the second unstable Boc group was partially cleaved in the presence of HCl 
during the Fischer indole reaction, affording a mixture of the mono-Boc tryptophan ester 
166 and di-Boc tryptophan ester 167 in 27% and 50% yield, respectively (Scheme 47).  
This partial deprotection proved to be non-significant as the mixture was further treated 
with trifluoroacetic acid (TFA), leading to a common unprotected amino acid.   
Scheme 47: Gellerman Tryptophan Synthesis via Fischer-Indole Reaction 
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 Probably the most commonly employed tool in the field of asymmetric tryptophan 
synthesis is the Schöllkopf bis-lactim ether chiral auxiliary.107  This method is a practical 
and versatile technique for the preparation of both D- and L-α-amino acids in high 
enantiomeric excess.  The synthesis of this chiral auxiliary, developed by Chen et. al.,108 
is outlined in scheme 48.  The source of chirality, L-valine (168), was first converted to 
N-Boc-L-valine (169) in excellent yield.  Next, carboxylic acid 169 was treated with 
isobutyl chloroformate and triethylamine (NEt3) to give an intermediate mixed anhydride, 
which was then converted to amide 170 upon treatment with glycine methyl ester 
hydrochloride.  Heating amide 170 in 1,2-dichlorobenzene induced removal of the Boc 
group and subsequent cyclization to give 3,6-piperazinedione 171 in moderate yield.  
Finally, cyclic diamide 171 was treated with trimethyloxonium tetrafluoroborate to 
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produce Schöllkopf’s bis-lactim ether chiral auxiliary, (5S)-2,5-dihydro-3,6-dimethoxy-5-
isopropylpyrazine (172) in good yield.  A similar, but less attractive Schöllkopf auxiliary 
synthesis has been reported by Davies and co-workers.109  It should be noted that (5R)-
2,5-dihydro-3,6-dimethoxy-5-isopropylpyrazine, the enantiomer of  172, can be 
synthesized by starting the synthesis with D-valine. 
Scheme 48: Chen Synthesis of the Schöllkopf Chiral Auxiliary 
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 Bis-lactim ether 172 can be metalated regiospecifically in the glycine moiety by 
butyllithium.  The lithium compound 173 reacts with alkyl halides with, in part, >95% 
diastereoselectivity to give adducts with the general structure 174 (Scheme 49).  The 
alkyl residue enters trans to the isopropyl group on C-5, i.e. the (R)-configuration is 
induced at C-2.107 
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Scheme 49: Lithiation/Alkylation of Schöllkopf’s Chiral Auxiliary 
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 The alkylated pyrazine 174 can then be hydrolyzed with TFA or a dilute HCl 
solution to liberate the (R)-amino acid methyl ester 175.  Saponification of ester 175 with 
NaOH provides the free amino acid 176 (Scheme 50).107 
Scheme 50: Hydrolysis/Saponification of Alkylated Pyrazine 
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 Sakagami et al.110 utilized the Schöllkopf method in their synthetic studies on 
peptides containing geranyltryptophans.  Metallation of Schöllkopf chiral auxiliary 178 
with n-BuLi in THF was followed by alkylation of chloride 177 in the presence of 
tetramethylethylenediamine (TMEDA) to provide geranyltryptophan derivative 179 in 
78% yield (Scheme 51).  The addition of TMEDA improved the diastereomeric ratio up 
to 30:1 (trans:cis) as detected by 1H-NMR.  Cook and co-workers111 have also reported a 
similar tryptophan synthesis. Potential drawbacks to these methods are the availability of 
substituted indole electrophiles and the need to protect the indole nitrogen. 
 
 
 
 51
Scheme 51: Sakagami Tryptophan Synthesis  
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 Cook has also developed a novel and concise synthesis of optically active 
tryptophan derivatives99,112 via a Larock heteroannulation58 (see section 2.3) of 
substituted o-iodoanilines with an internal alkyne.  The required internal alkyne 182 was 
prepared in greater than 96% diastereomeric excess (de) via alkylation of Schöllkopf 
chiral auxiliary 180 with diphenyl (triethylsilyl)propargyl phosphate (181).  Larock 
reaction of alkyne 182 with 2-iodo-5-methoxyaniline (183) in the presence of 
palladium(II) acetate furnished TES-tryptophan derivative 184.  Desilylation, along with 
hydrolysis of the chiral auxiliary, provided amino ester 185 (Scheme 52).  Some 
biologically important tryptophan analogs99 were also synthesized by Cook utilizing this 
method, including L-isotryptophan, L-homotryptophan, and L-benz[f]tryptophan.  
Although this protocol is very versatile, it has a few disadvantages, including the 
formation of regioisomers in some cases (2-alkyl-3-silyltryptophan derivatives).  Another 
major limitation is that the reaction fails to give tryptophan products in useful yields 
when 2-bromo- or 2-chloroanilines are employed and requires the use of iodoanilines 
which are often more expensive and less commercially available.8  Recently, however, 
Lu and Senanayake113 have reported a solution to this problem. 
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Scheme 52: Cook Tryptophan Synthesis 
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 Castle and co-workers114 have improved upon Cook’s heteroannulation strategy 
by employing a chiral phase-transfer-catalyzed alkylation of a glycinate Schiff base in 
place of the diastereoselective alkylation of a stoichiometric amount of the Schöllkopf 
chiral auxiliary.  Chiral phase transfer catalyst 188, containing a trifluorobenzyl moiety, 
promoted the alkylation of glycine derivative 186 with propargyl bromide 187 in good 
yield and excellent enantiomeric excess (ee).  The resulting propargyl glycine 189 was 
converted to 192, the central tryptophan residue of Celogentin C115, in three steps, with 
the Pd-catalyzed heteroannulation as the key transformation (Scheme 53).  In addition, 
this process is quite economical and attractive for large-scale synthesis since the phase-
transfer catalyst can be recovered from the reaction mixture. 
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Scheme 53: Castle Tryptophan Synthesis 
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3.3  Tryptophan Derivatives via Palladium-Catalyzed N-Heteroannulation 
 In an effort to improve upon the current syntheses of enantiopure tryptophan 
derivatives, a route was envisioned that employed the Söderberg palladium-catalyzed, 
carbon monoxide-mediated reductive N-heteroannulation reaction.116  The 1-(2-
nitrophenyl)-1-alkene cyclization precursors are derived from Schöllkopf’s chiral 
auxiliary.  These asymmetric tryptophans have the general structure of 193, with R being 
various electron-withdrawing and electron-donating substituents.   
Figure 10: General Structure of Tryptophan Target Molecules 
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3.3.1  Retrosynthetic Analysis 
 The proposed retrosynthetic route is outlined in scheme 54.  Functionalized 
tryptophan derivative 194 can be constructed from the aforementioned palladium-
catalyzed N-heteroannulation of o-nitrostyrene 195.  This cyclization precursor 195 can 
be formed from a Kosugi-Migita-Stille cross coupling between aryl iodide 197 and vinyl 
stannane 196.  Tin compound 196 can be envisioned from a palladium-catalyzed 
stannylation of the corresponding vinyl bromide 198.  Finally, trans-pyrazine 198 results 
from the diastereoselective alkylation of Schöllkopf’s chiral auxiliary 172 with 2,3-
dibromopropene (199). 
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Scheme 54: Proposed Retrosynthetic Outline to Tryptophan Derivatives 
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3.3.2  Results and Discussion 
 The synthetic endeavor began with the diastereoselective alkylation of the 
commercially available (R)-Schöllkopf auxiliary 200 with commercially available 2,3-
dibromopropene 199 to give trans-pyrazine 201117 in good yield and excellent de (96%) 
(Scheme 55). 
Scheme 55: Alkylation of Schöllkopf Auxiliary 
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Conversion of the vinylic bromide in 201 to the corresponding vinylic tributyltin 
moiety 202 was examined next.  By performing this transformation, a more practical 
coupling partner would be created for use in upcoming Kosugi-Migita-Stille reactions 
with commercially available aryl halides.  A variety of conditions were attempted ranging 
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from palladium-catalyzed protocols to procedures involving sonication; however, all 
failed to furnish the target stannane 202 (Table 1). 
Table 1: Attempts to Convert to the Vinyl Stannane 
                 
N
N OMe
MeO
Bu3Sn
N
N OMe
MeO
Br
X
 
                     201                  202  
________________________________________________________________________ 
Entry Conditions Solvent Time (hrs) Temp (oC) 
1 (SnBu3)2, Pd(dba)2, PPh3 Toluene 72 115 
2 (SnBu3)2, PdCl2(PPh3)2 Dioxane 19 105 
3 Mg, PbBr2, Bu3SnCl THF 69 25 
4 Mg, 1,2-dibromoethane, Bu3SnCl, ))) THF 0.5 25 
________________________________________________________________________ 
 
 An alternate route to stannane 202 was envisioned utilizing a multi-step procedure 
(Scheme 56).  A hydrostannylation was performed on methyl propiolate (203) via a 
palladium-catalyzed procedure employing tributyltin hydride to give geminal alkene 204.  
Ester 204 was reduced to the corresponding primary alcohol 205118 with 
diisobutylaluminum hydride (DIBAL-H), followed by exposure to acetic anhydride to 
yield allylic acetate 206.  It should be noted that acetate 206 was pursued only after 
failing to synthesize both the corresponding allylic chloride119 and bromide120 from 
alcohol 205.  Allylic acetate 206 was then exposed to lithiated Schöllkopf reagent 200 in 
hopes of assembling allylic pyrazine 202.  Unfortunately, free alcohol 205 was recovered 
as the sole reaction product owing to acetate ester cleavage. 
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Scheme 56: Alternate route to the Vinyl Stannane 
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 Assembly of a vinyl boronate ester as the amino acid-containing coupling partner 
was also examined.121  Regrettably, palladium-catalyzed reaction of vinyl bromide 201 
with bis(pinacolato)diboron failed to give boronate ester 207 (Scheme 57). 
Scheme 57: Attempted Synthesis of the Vinyl Boronate Ester 
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 After examining several options for the conversion of vinyl bromide 201 to a 
more versatile vinylic moiety, the decision was made to utilize 201 itself to construct the 
crucial o-nitrostyrene precursors.  Kosugi-Migita-Stille cross-coupling of 201 and aryl 
stannane 208 using bis(acetonitrile)palladium dichloride (5 mol %), triphenylarsine, (10 
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mol %), and copper iodide (10 mol %) in N-methylpyrrolidinone (NMP) at 80oC gave the 
expected trans-coupling product 209.  However, a considerable amount of isomerization 
of the chiral center at C-2 of the pyrazine ring was observed (4:1-10:1), providing 
diastereomer 210 as well (Scheme 58).  Evidence of this isomerization emerged as a 
second set of doublets in the 1H NMR spectrum, corresponding to the isopropyl methyl 
groups.122 
Scheme 58: Isomerization in Kosugi-Migita-Stille Cross-Coupling 
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 Despite significant epimerization of the key chiral center, the isomeric mixture 
was subjected to the alternate Söderberg cyclization conditions (see scheme 37) in order 
to determine if N-heteroannulation would occur with this type of substrate.  Thus, a 
mixture of compounds 209 and 210 was subjected to the aforementioned protocol.  As 
expected, a mixture of indole isomers 211 and 212 was obtained in a similar ratio to that 
of the starting mixture; no additional racemization of the asymmetric center was observed 
(Scheme 59).  It should be noted that cyclization did not occur by exposing a mixture of 
209 and 210 to the original, milder Söderberg cyclization protocol (see scheme 36).   
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Scheme 59: Söderberg N-Heteroannulation on the Isomeric Mixture 
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 With knowledge that the reaction sequence was viable, an effort was made to 
reduce, or ideally, eliminate the amount of isomerization obtained in the Kosugi-Migita-
Stille coupling step.  Several different variants of the reaction were attempted by altering 
the catalyst, ligands, solvent, etc.  Unfortunately, the reaction either did not proceed or 
occurred in low yield with significant isomerization.  The results are summarized in 
Table 2. 
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Table 2: Attempted Couplings with Pyrazine Moiety 
 
SnBu3
NO2 NO2 N
N OMe
MeO
N
N OMe
MeO
Br
+
R1
R1
R2
R2
 
                201                                   213                                                     214 
________________________________________________________________________ 
Entry R1 R2 Catalyst Ligand Adda Solv Tempb Time Yieldc 
1 H H PdCl2(PhCN)2 AsPh3 CuI NMP 80 72 h 46% 
2 H H Pd(dba)2 PPh3 - PhMe 110 120 h 0% 
3 OMe H PdCl2(PhCN)2 AsPh3 CuI NMP 80 19 h 30% 
4 OMe H PdCl2(PhCN)2 AsPh3 CuI NMP 100 22 h 25% 
5 OMe H PdCl2(PhCN)2 AsPh3 CuI PhMe 110 23 h 0% 
6 H OMe Pd(dba)2 AsPh3 CuI THF 50  27 h 0% 
7 H OMe Pd(dba)2 AsPh3 - PhMe 110  19 h 0% 
8 H OMe Pd(dba)2 AsPh3 CuI NMP 80  72 h 20% 
________________________________________________________________________ 
a Indicates CuI as an additive (8-20%) 
b Temperature in oC 
c Yields, if any, include significant amounts of isomerization 
 
 
 The mechanism of this isomerization is unclear.  However, it was found later to 
be thermally induced since heating a 12:1 trans/cis mixture of o-nitrostyrene 215 in DMF 
at 120oC for 20 hours resulted in additional racemization to a 5:1 trans/cis ratio.  
Furthermore, exposing indole 216 to identical conditions resulted in a similar 
isomerization (Scheme 60).  
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Scheme 60: Thermally Induced Isomerizations 
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  Cook et. al. encountered a similar isomerization in their attempt to 
synthesize enantiopure isotryptophan (Scheme 61).99  Organocopper compounds, such as 
218, can become quite basic when the temperature is raised.  Hence, indolylcopper 
intermediate 218 could abstract a proton from the chiral center in the pyrazine group 
under the high reaction temperatures (80-90oC) to provide intermediate 219.  The 
reprotonation of the stabilized anion that results could occur from either face to furnish 
epimerized pyrazine 220.  Regeneration of CuI would give isomerized isotryptophan 221.  
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Scheme 61: Cook’s Isotryptophan Isomerization 
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 Utilization of a coupling partner containing a protected amino ester was also 
investigated.  After alkylation, the Schöllkopf auxiliary can be easily hydrolyzed with  
0.1 N HCl or 0.1 N TFA, then subsequently protected as the carbamate with di-tert-butyl 
dicarbonate (Boc2O) to furnish the corresponding Boc-protected amino ester.117,123  This 
reaction sequence was performed on pyrazine 201.  Hydrolysis of 201 with aqueous TFA 
gave much higher yields of amino ester 222 than did a dilute HCl solution.  Protection of 
the resulting free amine in 222 with Boc2O furnished vinyl bromide 223 in 68% over two 
steps (Scheme 62). 
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Scheme 62: Hydrolysis/Boc-Protection of Alkylated Schöllkopf Auxiliary 
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 With vinyl bromide 223 in hand, some Kosugi-Migita-Stille couplings were 
attempted with tributyl(4-methoxy-2-nitrophenyl)stannane (224) while varying the 
reaction conditions.  Again, no evidence of coupling product 225 was observed (Table 3). 
Table 3: Attempted Couplings with Amino Ester Moiety 
Br CO2Me
NHBoc MeO
SnBu3
NO2
+ CO2Me
NHBoc
MeO
NO2
X
 
            223                                    224                                                    225 
________________________________________________________________________ 
Entry Catalyst Ligand Additive Solvent Temp (oC) Time (h) 
1 Pd(dba)2 PPh3 - Toluene 110 42 
2 PdCl2(PhCN)2 AsPh3 CuI NMP 80 25 
3 Pd(OAc)2 PPh3 K2CO3 CH3CN 50 71 
________________________________________________________________________ 
 
 
 An aryl boronic ester was next examined as a possible coupling piece. Boronic 
acid pinacol ester 228 was synthesized in moderate yield from 1-iodo-2-nitrobenzene 
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(226) in the presence of Pd(dba)2 and bis(pinacolato)diboron (227).124  Palladium-
catalyzed coupling of 228 with vinyl bromide 201 afforded only 13% of a mixture of 
diastereomers (3:1, trans:cis) of pyrazine 215 (Scheme 63).  
Scheme 63: Suzuki-Type Coupling of Aryl Boranate Ester 
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 The synthesis of o-nitrostyrene 209 was also attempted via a lengthier procedure 
involving key methyl acrylate derivative 231 (Scheme 64).  Two synthetic routes were 
envisioned in constructing 231.  The first route starts with conversion of commercially 
available carboxylic acid 229 to the corresponding methyl ester 230.125  Ester 230 is then 
condensed with formaldehyde and subsequently dehydrated to produce α,β-unsaturated 
methyl ester 231.  Route two begins with the palladium-catalyzed conversion of alkyne 
203 to stannane 204 in the presence of tributyltin hydride.  Palladium cross-coupling of 
stannane 204 with 1-iodo-2-nitrobenzene (226) using 75 mol % CuI at ambient 
temperature in DMF gave the target o-nitrostyrene 231 in excellent yield.126 
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Scheme 64: Synthetic Routes to Methyl 2-(2-nitrophenyl)acrylate 
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 Reduction of methyl ester 231 to the corresponding alcohol 232, followed by 
reaction with bromine and triphenylphosphine gave allylic bromide 233.  
Disappointingly, alkylation of lithiated pyrazine 200 employing allylic bromide 233 as 
the electrophile failed to generate the desired 2-nitrostyrene 209 (Scheme 65). 
Scheme 65: Attempted Alkylation Route to Cyclization Precursor 
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 Recognizing that Levin’s room-temperature coupling protocol126 worked so 
efficiently in combining 204 and 226, it was decided to implement the same conditions in 
the presence of amino ester 223 and aryl stannane 208.  Surprisingly, these conditions 
provided cyclization precursor 234 in high yield (Scheme 66).  It should be noted that 
coupling partner 223, resulting from hydrolysis/protection of the pyrazine moiety, was 
used in this case only due to its availability at the current time. 
Scheme 66: Utilization of Levin’s Cross-Coupling Conditions 
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 Exposing nitrostyrene 234 to the Söderberg annulation conditions (6 mol % 
Pd(dba)2, 6 mol % dppp, 12 mol % 1,10-phen, and CO (6 atm) in DMF at 120oC) 
afforded indole 235 in 70% yield (Scheme 67).   
Scheme 67: Successful Cyclization of Amino Ester Nitrostyrene 
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 With an effective coupling/cyclization strategy in hand, reaction of pyrazine 
moiety 201 and stannane 208 was investigated.  Using the pyrazine moiety for this 
transformation would save synthetic steps needed to arrive at amino ester 223.  As 
expected, nitrostyrene 209 was obtained as a single stereoisomer in good yield.  
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Palladium-catalyzed N-heteroannulation of 209 provided tryptophan derivative 211 
(Scheme 68). 
Scheme 68: Successful Coupling/Cyclization with Pyrazine Moiety 
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 After an exhaustive literature search, a procedure reported by De Kimpe et. al. 
was discovered describing the palladium-catalyzed conversion of a vinylic bromide to the 
corresponding vinylic trimethylstannyl derivative using hexamethylditin.127  Specifically, 
N,N-dibenzyl-N-(2-bromo-2-propenyl)amine (236) was transformed into N,N-dibenzyl-
N-(2-trimethylstannyl-2-propenyl)amine (237) by reaction with hexamethylditin in the 
presence of 20 mol % of Hünig’s base and 5 mol % 
tetrakis(triphenylphosphine)palladium(0) in benzene at 80oC for 15 h (Scheme 69). 
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Scheme 69: De Kimpe Palladium-Catalyzed Trimethylstannylation 
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 Fortunately, very similar conditions were effective in converting bromide 198 to 
vinyl trimethyltin derivative 238 (Scheme 70).  Note that 198 is the enantiomer of 201 
and that this (2R,5S)-stereochemistry will be seen in all examples hereafter.  Compound 
198 was furnished from (5S)-2,5-dihydro-3,6-dimethoxy-5-isopropylpyrazine using the 
alkylation protocol reported in scheme 55. 
Scheme 70: Conversion to Amino Acid-Containing Tin Derivative 
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 With the key stannane and an efficient coupling protocol both in hand, a number 
of annulation precursors were prepared via coupling of 238 with various halonitroarenes 
using a slightly modified version of Levin’s room temperature coupling conditions.  The 
results of these reactions are summarized in table 4.  No epimerization was apparent in 
any of the coupling products.  Thus, methoxy-, fluoro-, carbomethoxy-, and nitro-
functionalized substrates, in addition to a pyridine derivative, were obtained in 58-82% 
yield.  Yields of isolated products appear in parentheses.   
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Table 4: Results of Kosugi-Migita-Stille Cross-Couplings 
Pd(dba)2, PPh3, 
CuI (75%), DMF, r.t.,
N
N OMe
MeO
Me3Sn
o-Halonitroarene + o-Nitrostyrene
 
                    238 
________________________________________________________________________ 
          Entry                   o-Halonitroarene                                       o-Nitrostyrene 
             
I
NO2 NO2 N
N OMe
MeO
1
                               
                                                    226                                                        239 (58%) 
 
 
             
I
NO2 NO2 N
N OMe
MeO
2
MeO
MeO
 
                                                  240                                                        241 (68%) 
  
 
             
I
NO2 NO2 N
N OMe
MeO
3
MeO
OMe
 
                                                  242                                                         243 (69%) 
 
  
             
I
NO2 NO2 N
N OMe
MeO
4
F
F
 
                                                  244                                                         245 (61%) 
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Table 4: Results of Kosugi-Migita-Stille Cross-Couplings (cont.) 
 
         Entry                  o-Halonitroarene                                       o-Nitrostyrene 
 
            
I
NO2 NO2 N
N OMe
MeO
5
MeO2C
MeO2C
 
                                                246                                                         247 (62%) 
   
 
            
Br
NO2 NO2 N
N OMe
MeO
6
O2N
O2N
 
                                                 248                                                        249 (82%) 
 
 
            
N Cl
NO2
N
NO2 N
N OMe
MeO
7
 
                                               250                                                         251 (60%) 
________________________________________________________________________ 
 
  
 The coupling of 6-methoxy-2-nitro-1-iodobenzene (253) with stannane 238 was 
also investigated.  Since 253 was not commercially available, it was synthesized starting 
from 2-amino-3-nitrophenol (252) (Scheme 71).  Conversion of the amino group in 252 
to the corresponding iodide using Sandmeyer-type conditions, followed by methylation 
of the phenolic alcohol gave 253 in 51% yield over three steps.  Unexpectedly, exposure 
of 253 to the conditions described in table 4 gave only homocoupling dimer 254123 and 
recovered aryl iodide.   
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Scheme 71: Homocoupling in the Reaction of 6-Methoxy-2-nitro-1-iodobenzene 
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 To solve this problem, the iodide 253 was transformed into the corresponding 
trimethyl tin compound 255 using a related procedure as for the preparation of 238 
(Scheme 72).  Coupling of 255 with vinyl bromide 198 under previously used Kosugi-
Migita-Stille conditions gave o-nitrostyrene 256 in moderate yield. 
Scheme 72: Successful Coupling Using Corresponding 6-Methoxy-1-stannane 
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 A similar dilemma was encountered after attempting to couple 3-methoxy-2-nitro-
1-iodobenzene with 238.  Again, the starting material was not available for purchase and 
had to be synthesized (Scheme 73).  Commercially available carboxlyic acid 257 was 
transformed to the corresponding amine 259 upon treatment with diphenylphosphoryl 
azide (258) and tert-butanol, followed by removal of the resulting Boc group with 6N 
HCl.128  A Sandmeyer-like protocol then provided iodide 260.  Almost identical to the 
behavior of 253, attempted coupling of 260 with stannane 238 gave dimer 254 as the sole 
product in low yield. 
Scheme 73: Homocoupling in the Reaction of 3-Methoxy-2-nitro-1-iodobenzene 
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 An identical remedy to that illustrated in scheme 72 was applied to this situation.  
Iodide 260 was first converted to the corresponding tin derivative 261 using a palladium-
catalyzed procedure employing hexamethylditin.  Stannane 261 was then coupled with 
pyrazine 198 using the Pd(dba)2-PPh3-CuI conditions at ambient temperature to furnish 
3-methoxy-2-nitrostyrene 262 in good yield (Scheme 74). 
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Scheme 74: Successful Coupling Using Corresponding 3-Methoxy-1-stannane 
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 With a selection of substrates having both electron-withdrawing and electron 
donating substituents in hand, the palladium-catalyzed N-heteroannulation was examined 
next (Table 5).  All cyclizations went to 100% completion and ranged in yield from 12-
88%.  Depending on the functional group on the aromatic ring, a varying degree of 
isomerization was observed for all substrates to give diastereomeric ratios ranging from 
4.5:1Æ30:1.  Characteristic of the minor cis-isomers are the significant upfield shifts of 
one of their isopropyl methyl group resonances (0.02-0.38 ppm) compared to the 
chemical shifts of their trans-counterparts (0.61-0.66 ppm).  This upfield shift can be 
explained by a conformation wherein the isopropyl group is shielded by the aromatic ring 
of the indole nucleus.129  It is interesting to note that the most hindered methoxy-
substituted substrate 262 gave a significantly lower yield (47%) and lower 
diastereromeric ratio (6:1) than the other three methoxy compounds (241, 243, 256), most 
likely due to steric hinderence.  Electron-withdrawing groups (-F, -CO2Me, -NO2) were 
also tolerated, although the fluoro-substituted compound 245 gave 266 with the highest 
amount of isomerization (dr=4.5:1), albeit in excellent yield (84%).  Pyridine-derived 
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substrate 251 cleanly produced aza-tryptophan compound 269 in 79% yield.  The lowest 
yield by far (12%) was obtained from cyclization of nitrobenzene 249; however, the 
starting material was completely consumed and no additional products were isolated. 
Table 5: Results of Palladium-Catalyzed N-Heteroannulations 
 
 
               
Pd(dba)2, dppp, 1,10 phen
CO, DMF, 120oC
o-Nitrostyrene Tryptophan Derivative
 
________________________________________________________________________ 
      Entry                        o-Nitrostyrene                                   Tryptophan Derivativea 
         
NO2 N
N OMe
MeO N
N
N
OMe
MeO
H
1
 
                                                  239                                                   263 (85%, dr=15:1) 
 
         
NO2 N
N OMe
MeO N
N
N
OMe
MeO
H
2
MeO
MeO
 
                                                 241                                                  264 (70%, dr=12:1) 
 
         
NO2 N
N OMe
MeO N
N
N
OMe
MeO
H
3
OMe
MeO
 
                                                  243                                                265 (85%, dr=22:1) 
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Table 5: Results of Palladium-Catalyzed N-Heteroannulations (cont.) 
      Entry                       o-Nitrostyrene                                   Tryptophan Derivativea 
 
         
NO2 N
N OMe
MeO N
N
N
OMe
MeO
H
4
F
F
 
                                                245                                                   266 (84%, dr=4.5:1) 
 
         
NO2 N
N OMe
MeO N
N
N
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MeO
H
5
MeO2C
MeO2C
 
                                               247                                                 267 (73%, dr=10:1) 
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N OMe
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N
N
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MeO
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                                                249                                                  268 (12%, dr>30:1) 
 
         
N
NO2 N
N OMe
MeO
N
N
N
N
OMe
MeO
H
7
 
                                                  251                                                   269 (79%, dr=11:1) 
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Table 5: Results of Palladium-Catalyzed N-Heteroannulations (cont.) 
      Entry                       o-Nitrostyrene                                    Tryptophan Derivativea 
  
         
NO2 N
N OMe
MeO N
N
N
OMe
MeO
H
8
OMe
OMe
 
                                                  256                                                   270 (88%, dr>30:1) 
 
         
NO2 N
N OMe
MeO N
N
N
OMe
MeO
H
9 MeO
OMe  
                                              262                                                         271 (47%, dr=6:1) 
________________________________________________________________________ 
 a  Yield of isolated product and diastereomeric ratio (dr) in parentheses 
  
 In addition to the tryptophan derivatives assembled in table 5, two other important 
tryptophan analogues were pursued via a similar cross-coupling/N-heteroannulation 
strategy: D-homotryptophan and D-isotryptophan.  Multistep syntheses of the racemic 
form of these two tryptophan analogues have been reported previously;130 however, Cook 
et. al.99 have reported the only enantioselective preparation of these compounds.  The 
synthesis of D-homotryptophan, the one carbon homolog of 263, began with exposure of 
commercially available 3-bromobut-3-en-1-ol (272) to methanesulfonyl chloride (MsCl) 
to provide mesylate 273 in excellent yield (Scheme 75).  Finkelstein-like reaction of 273 
with sodium iodide in acetone gave homoallylic iodide 274.  Successsful alkylation of the 
lithio derivative of Schöllkopf reagent 172 with iodide 274 required the presence of two 
equivalents of N,N-dimethylethyleneurea (DMEU) to furnish trans-pyrazine 275 in low 
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yield.131  It should be noted that alkylation did not proceed at all employing the 
corresponding homoallylic mesylate 273 or bromide.  Room temperature palladium-
catalyzed coupling of vinyl bromide 275 with aryl stannane 208 gave cyclization 
precursor 276 as a single stereoisomer in good yield.  Finally, N-heteroannulation of o-
nitrostyrene 276 afforded D-homotryptophan derivative 277 in 72% isolated yield and 
16:1 diastereomeric ratio. 
Scheme 75: Synthesis of D-Homotryptophan 
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 Preparation of D-isotryptophan via the Söderberg N-heteroannulation 
methodology began with the alkylation of lithiated Schöllkopf reagent 172 with a 
commercially available cis/trans mixture of 1,3-dibromopropene (278), yielding an equal 
cis/trans mixture of  279 (Scheme 76).  Bromide 279 was then coupled to tributyl(2-
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nitrophenyl)stannane (208) using the previously mentioned Pd(dba)2-PPh3-CuI conditions 
to give cis/trans alkene 280 in good yield.  Annulation of 280 gave the isotryptophan 
derivative 281 in low yield with almost complete isomerization (dr=1.2:1).  Also, an 
incomplete reduction forming N-hydroxyindole 282 was observed as a minor product.132  
Given the high degree of isomerization for the indole product 281, the 
diastereoselectivity for hydroxyindole 282 was surprisingly high (>30:1). 
Scheme 76: Attempted Synthesis of D-Isotryptophan  
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                                                    282 (11%, dr>30:1)                   281 (35%, dr=1.2:1)     
 79
3.3.3  Conclusions 
 A novel route to tryptophan derivatives using two sequential palladium-catalyzed 
reactions, a Kosugi–Migita–Stille cross-coupling and a carbon monoxide-mediated 
reductive N-heteroannulation, has been developed.  This reaction sequence may be useful 
for the preparation of novel amino acids related to tryptophan having either D- or L-
configuration. 
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4.1 Attempted Synthesis of 3-Silylindoles 
 Vinylsilanes are very useful intermediates in organic synthesis, particularly for 
palladium-catalyzed cross-coupling reactions.133  They are commonly used in the 
construction of natural products, especially due to their low toxicity.  The most common 
method of preparing vinylsilanes is by hydrosilylation of the corresponding alkyne; 
however, stereo- and regiochemical control of the reaction is difficult, especially 
employing unsymmetrical internal alkynes as substrates.  In response to this problem, 
Alami and co-workers134 have reported a platinum-catalyzed cis-hydrosilylation of 
unsymmetrical internal alkynes which proceeds under ortho-substituent regiocontrol.  
This previously reported ortho-directing effect (ODE)135 causes the silyl group to be 
selectively delivered to the α-carbon of the alkyne moiety, with respect to the aromatic 
ring containing the ortho-substituent.  The results have been rationalized in terms of 
electronic polarization across the alkyne bond induced by the ortho-substituent, 
regardless of the electronic nature of this substituent.  In the example which most pertains 
to the Söderberg cyclization chemistry, reaction of 1-(hept-1-ynyl)-2-nitrobenzene 
(283)134 with PtO2 and triethylsilane, in the absence of solvent, furnished only α-
hydrosilylation isomer 284134 in excellent yield.  The β-isomer was not detected (Scheme 
77). 
Scheme 77: Alami Regioselective Hydrosilylation  
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 It was envisioned that exposure of o-nitrostyrene 284 to typical Söderberg N-
heteroannulation conditions would produce 3-silylindole 285.  Compounds like 285 could 
then be transformed into more complex 3-substituted indole target molecules.136  Upon 
analysis of the crude 1H NMR, it was clear that cyclization had occurred; however, the 
silyl group had been unexpectedly cleaved as well to provide 2-pentylindole (286)137 as 
the sole product in 75% yield (Scheme 78). 
Scheme 78: Exposure of Vinylsilane to Söderberg N-Heteroannulation 
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 This surprising discovery led to a brief investigation into the practicality of this 
methodology for synthesizing 2-substituted indoles.   
4.2 Synthesis of 2-Substituted Indoles via Hydrosilylation 
 There have been very few methods reported for the synthesis of 2-alkylindoles.  
Probably the most commonly used protocol was reported by Katritsky and co-workers.138  
The authors showed that 2-alkyl groups of N-unsubstituted 2-alkylindoles could be 
activated toward proton loss by using carbon dioxide both to protect the N-H position and 
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to enable lithiation at the methyl group.  Subsequent reaction with an electrophile affords 
the corresponding 2-(substituted alkyl)indole-1-carboxylic acid, and loss of CO2 then 
occurs to reform the NH group.  In this way, Katritsky prepared 2-hepylindole (287) from 
2-methylindole (31) in 93% overall yield (Scheme 79).  Although this method is 
effective, it suffers from a procedure which is quite lengthy and cumbersome. 
Scheme 79: Katritsky Synthesis of 2-Alkylindoles   
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 The much more convenient hydrosilyation/N-heteroannulation route to 2-
alkylindoles mentioned above was also attempted on 1-(hex-1-ynyl)-2-nitrobenzene 
(289)139, which was obtained from a routine Sonogashira coupling between 1-iodo-2-
nitrobenzene (226) and 1-hexyne (288) (Scheme 80).  Hydrosilylation of alkyne 289 was 
successful, producing vinylsilane 290 in excellent yield.  Palladium-catalyzed cyclization 
of 290 occurred with concurrent silyl cleavage to produce 2-butylindole (291)140 in 54% 
yield over three steps. 
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Scheme 80: Synthesis of 2-Butylindole 
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 This methodology also proved to be successful in the formation of 2-phenylindole 
(122)141, which was formed in 55% overall yield from 226 (Scheme 81). 
Scheme 81: Synthesis of 2-Phenylindole 
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 The synthesis of indolo[3,2-b]indole (300) was also attempted utilizing this newly 
developed protocol.  In the event, 1-iodo-2-nitrobenzene (226) was coupled to TMS-
acetylene (295), followed by desilylation using TBAF to give alkyne 297142.  Next, a 
second Sonogashira coupling was performed, in this instance between terminal alkyne 
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297 and 226 to furnish symmetrical internal alkyne 298 in good yield.  Alami’s 
hydrosilylation was ineffective when applied to alkyne 298; only possible trace amounts 
of vinylsilane 299 were detected.  It was envisioned that exposure of 299 to the 
Söderberg N-heteroannulation conditions would furnish fused indole 300 after two 
successive cyclizations (Scheme 82). 
Scheme 82: Attempted Synthesis of Indolo[3,2-b]indole via Hydrosilylation 
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4.3 Synthesis of 2,3- and 3-Substituted Indoles via Hydrostannylation 
Alami also reported a palladium-catalyzed route to stannylated stilbene 
derivatives by ortho-substituent directed regioselective addition of tributyltin hydride to 
unsymmetrical diaryl alkynes.143  For example, 2-((E)-1-(tributylstannyl)-2-
phenylvinyl)benzaldehyde (302) was furnished as the sole product from reaction of 
alkyne 301 with Bu3SnH and 1 mol% PdCl2(PPh3)2.  Similar to Alami’s hydrosilylation, 
the β-stannane was not produced (Scheme 83). 
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Scheme 83: Alami Regioselective Hydrostannylation 
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 Although several functional groups were used as ortho-substituents in Alami’s 
hydrostannylation study, the effectiveness of a nitro group in this position was not 
explored.  Since o-nitrostyrenes of this type are typical Söderberg annulation precursors, 
the synthesis of compound 303 was attempted in hopes that a subsequent cyclization 
would occur, affording 3-(tributylstannyl)-2-phenylindole (304) (Scheme 84).  Again, 
metallated indoles of this type could potentially be used as building blocks to form more 
structurally complicated target molecules.  Regioselective hydrostannylation of alkyne 
293 was successful, yielding only α-isomer 303.  The ensuing cyclization, however, was 
ineffective in furnishing indole 304.  Instead, the crude 1H NMR revealed a complex 
mixture of unidentifiable products. 
Scheme 84: Attempted Synthesis of 2-Phenyl-3-stannylindole 
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 An alternate route to 2-phenyl-3-substituted indoles was envisioned by first 
performing a Kosugi-Migita-Stille coupling with stannane 303 and then cyclizing the 
resulting o-nitrostyrene to give the target indole.  This approach was successful, initially 
affording 1,1,2-triarylethylene 306 from the Kosugi-Migita-Stille cross-coupling reaction 
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of stannane 303 and 1-iodo-4-methoxybenzene (305).  Cyclization precursor 306 was 
then transformed into indole 307144 upon exposure to the Söderberg annulation protocol 
(Scheme 85). 
Scheme 85: Successful Synthesis of 2-Phenyl-3-arylindole 
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 The formation of 2-alkyl-3-substituted indoles was also explored using the same 
methodology.  Hence, tributyl((E)-1-(2-nitrophenyl)hex-1-enyl)stannane (308) was 
synthesized from alkyne 289 in good yield using Alami’s protocol (Scheme 86).143  
Scheme 86: Formation of Alkylstannane Using Tributyltinhydride 
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 Subsequent cross-couplings, however, proved to be problematic.  Unlike the 
corresponding phenyl substrate 303, alkylstannane 308 resisted all attempts to undergo 
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couplings with both electron-withdrawing and electron-donating aryl halides.  The results 
are summarized in table 6.  This obstacle prevented the potential formation of any 2-
butyl-3-arylindoles.   
Table 6: Cross-Coupling Attempts with Alkylstannane 
            
NO2
C4H9
SnBu3
X
R
+
NO2
C4H9
R
X
conditions
 
                    308                        309                                                        310 
Entry X R Catalyst System Solvent Temp (oC) Time 
1 Br CN Pd(dba)2, PPh3, CuI DMF 25 3 days 
2 Br CN Pd(OAc)2, XPhos145 DMF 80 42 h 
3 I OMe PdCl2(PPh3)2, PPh3, CuI DMF 25 4 days 
4 I OMe PdCl2(PPh3)2, PPh3, CuI DMF 80 2 days 
5 I OMe Pd(dba)2, PPh3 PhMe reflux 30 h 
 
 Alami and co-workers also extended their ortho-directing effect to terminal 
arylalkynes in order to provide α-styryltributyltin derivatives.146  Again, a wide variety of 
ortho-substituents were used, all giving complete α-regioselectivity in good to excellent 
yield.  Similar to Alami’s previous study143, the effectiveness of a nitro group in this 
position was not explored.  Thus, tributyl(1-(2-nitrophenyl)vinyl)stannane (311) was 
furnished from 1-ethynyl-2-nitrobenzene (297) via the previously described 
regioselective palladium-catalyzed hydrostannylation.  The β-isomer was not detected in 
the crude 1H NMR spectrum (Scheme 87). 
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Scheme 87: Synthesis of Tributyl(1-(2-nitrophenyl)vinyl)stannane 
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 Stannane 311 proved to be a versatile intermediate in the synthesis of some 
unique 3- and 2,3-substituted indoles.  For example, the palladium-catalyzed 
homocoupling of 311 proceeded smoothly in DMF to give dimer 312 in good yield.  
Exposure of dimer 312 to the Söderberg N-heteroannulation protocol resulted in the 
formation of 3,3’-bisindole 313147 (Scheme 88). 
Scheme 88: Synthesis of 3-(1H-Indol-3-yl)-1H-indole 
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 The possibility of synthesizing various 3-arylindoles was also explored by 
coupling stannane 311 with substituted aryl halides.  Kosugi-Migita-Stille cross-coupling 
of stannane 311 and iodide 305 gave the desired o-nitrostyrene 314 as the major product; 
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however, the target alkene 314 was obtained in low yield (31%) as an inseparable 3:1 
mixture (as determined by 1H NMR analysis) with dimer 312 (Scheme 89). 
Scheme 89: Synthesis of 1-(1-(4-Methoxyphenyl)vinyl)-2-nitrobenzene 
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 Nevertheless, cyclization of the 3:1 mixture of 314 and 312 was successful, 
yielding both of the corresponding indole substrates 315148 and 313 in 61% and 75% 
yield, respectively (Scheme 90).  It should be noted that the resulting indole products 315 
and 313 were readily separable by column chromatography. 
Scheme 90: Cyclization of the Inseparable 3:1 Mixture of o-Nitrostyrenes 
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 Finally, the synthesis of indolo[2,3-b]indole (317) was envisioned via 
intermediate stannane 311.  Cross-coupling of 1-iodo-2-nitrobenzene (226) with tin 
derivative 311 afforded cyclization precursor 316 in good yield.  As in previous 
palladium-catalyzed reactions involving stannane 311, dimer 312 was also isolated as a 
minor product in 9% yield.  Palladium-catalyzed N-heteroannulation of 316 gave the 
expected indolo[2,3-b]indole (317) in 42% yield.  Surprisingly, a second product was 
isolated in 24% yield and determined to be quinolinone 318 (Scheme 91).  It seems that 
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an equivalent of carbon monoxide has somehow been inserted into the substrate during 
the cyclization process, giving the carbonyl functionality at C-6 of 318.  Cenini et. al. 
observed a similar CO insertion in a minor product.83  The mechanism of this occurance 
remains unclear.  The structure of 318 was determined by advanced NMR techniques 
along with HRMS (m/z = 235.0867 for C15H11N2O (M+H+)).  In addition, the 
experimental melting point (312-314oC) matched well with a previously reported value 
(314-315oC).149  This marks the first example of a CO insertion into a Söderberg 
cyclization product.  
Scheme 91: Synthesis of Fused Heterocycles 
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4.4 Conclusions 
The hydrosilylation134 and hydrostannylation143,146 procedures developed by 
Alami et. al. have proved to be useful in developing unique o-nitrostyrene intermediates 
suitable for typical Söderberg cyclizations.  Utilizing this N-heteroannulation 
methodology, a variety of 2-and/or 3-substituted indoles were furnished in moderate to 
good yield.                                           
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5.1 Introduction & Background 
In 1997, a variety of specimens were collected off the coast of Cape Town, South 
Africa in order to explore the biomedical potential of South African marine invertebrates.  
During a preliminary cytotoxicity screening, an extract of a mixed collection of sponges 
was selected for investigation.  A bioassay-directed fractionation of the crude extract 
using a brine shrimp lethality assay led to the isolation of a sphingolipid as the active 
metabolite.  The subsequent 1H NMR investigation of the inactive fractions led to the 
structural elucidation of dilemmaones A (319), B (320), and C (321) (Figure 11).150  
These unusual indole alkaloids originally got their names from the dilemma surrounding 
their sponge source.  However, a process of elimination has since suggested that one of 
the sponges in the mixed collection, Ectyonanchora flabellate, is responsible for 
producing these compounds. 
Figure 11: Structures of Dilemmaones A-C 
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 The structures of dilemmaones A-C, although simple, are quite unusual, 
particularly with respect to the methoxymethylene and hydroxymethylene substituents at 
C-2.  Only a few other 6,7-annulated indole natural products have been reported.  The 
trikentrins were isolated by Capon151 from the marine sponge Trikentrion flabelliforme 
and display antibacterial activity.  Members of the trikentrin family include, but are not 
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limited to, cis-trikentrin A (37), trans-trikentrin A (322), cis-trikentrin B (323), and trans-
trikentrin B (324) (Figure 12). 
Figure 12: Structures of the Trikentrins 
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 The structurally similar herbindoles were isolated by Scheuer152 from the 
Australian sponge Axinella sp.  They have been shown to possess both cytotoxic and 
antifeedant properties.  The structures of herbindole A (325), herbindole B (326), and 
herbindole C (327) are shown in figure 13. 
Figure 13: Structures of the Herbindoles 
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 The interesting biological profiles of the trikentrins and herbindoles combined 
with their uncommon structural motifs have made them attractive targets for total 
synthesis.  The significant challenges associated with the construction of these complex 
systems are reflected in the many distinct approaches that have been reported for their 
racemic and enantioselective total syntheses.153,154,155  To date, there has been no reported 
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synthesis for any member of the dilemmaone family, even though their molecular 
skeletons resemble those of the trikentrins and herbindoles.  Hence, a route to 
dilemmaones A-C was envisioned which involves a palladium-catalyzed reductive N-
heteroannulation as the key step. 
5.2 Retrosynthetic Analysis 
 Retrosynthetically, dilemmaone B (320) can be constructed from the palladium-
catalyzed N-heteroannulation of o-nitrostyrene 328.  Compound 328 can arise from a 
Kosugi-Migita-Stille cross-coupling between aryl iodide 329 and vinyl stannane 330.  
Alkene 330 can be formed in one step from a hydrostannylation of propargyl alcohol 
(331).  Iodoindanone 329 could be fashioned through the manipulation of 2,3-dihydro-5-
methylinden-1-one (332), which could be produced by reaction of toluene (334) and 3-
chloropropionyl chloride (333) (Scheme 92). 
Scheme 92: Retrosynthetic Route to Dilemmaone B 
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5.3 Attempted Synthesis of Dilemmaone B 
 The synthesis began via a Friedel-Crafts acylation of toluene (334) with 3-
chloropropionyl chloride (333), resulting in β-chloropropiophenone derivative 335 in 
excellent yield.156  The cyclization precursor 335 was dissolved in CH2Cl2 and refluxed in 
the presence of concentrated H2SO4 and tetrabutylammonium hydrogen sulfate 
(Bu4NHSO4) to give 5-methylindanone (332) (Scheme 93).157 
Scheme 93: Synthesis of 5-Methylindanone 
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 Methylindanone 332 was then subjected to typical aromatic nitration conditions to 
give a 2.4:1 mixture of nitration products 336 and 337, respectively.158  Pure 
nitroindanone 336 could be isolated via chromatography and was subsequently reduced 
to the corresponding aniline 338 by hydrogenation (Scheme 94).158 
Scheme 94: Synthesis of 6-Amino-5-methylindanone 
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 At this stage of the synthesis, an ortho-nitration of aniline 338 was necessary in 
order to install the nitro group present in N-heteroannulation precursor 328.  After 
reviewing the literature, a study reported by Lemaire et. al. was discovered  which 
described the one-step nitration of several free-aniline substrates using 2,3,5,6-
tetrabromo-4-methyl-4-nitrocyclohexa-2,5-dienone (340) as the nitronium ion (NO2+) 
source.159  In one example, 2,4-dibromoaniline (339) was nitrated using 
nitrocyclohexadienone 340 in acetic acid to give o-nitroaniline 341 in excellent yield 
(Scheme 95).  It should be noted that the direct nitration of anilines by classical methods 
is frequently low yielding, due to the susceptibility of anilines to oxidation by the 
nitrating agent. 
Scheme 95: Nitration of 2,4-Dibromoaniline 
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 According to Lemaire and co-workers, the driving force for the reaction is the 
rearomatization of 340, which results in the loss of the nitronium ion, and produces 
compound 342.  Cresol 342 can be easily isolated and recycled to 340 using fuming nitric 
acid (Scheme 96).  This direct C-nitration of substituted anilines must be performed 
under acidic conditions (AcOH) for two reasons.  Firstly, rearomatization of the reagent 
during the course of the reaction is catalyzed by Brønsted acids; secondly, the 
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nucleophilicity of the amine needs to be reduced in order to limit the formation of N-
nitration by-products.159   
Scheme 96: Mechanism of Free-Aniline Nitration 
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 In order to apply this methodology to aniline 338, a synthesis of nitrating agent 
340 was performed using the procedure described by Lemaire.160  Hence, p-cresol (345) 
was tetrabrominated using iron metal as a catalyst to give compound 342.  
Tetrabromocresol 342 was then exposed to fuming nitric acid to afford nitrating agent 
340 in 50% yield over 2 steps (Scheme 97). 
Scheme 97: Synthesis of Cyclohexadienone Nitrating Agent 
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 Utilizing Lemaire’s protocol, aniline 338 was seemingly converted to nitroaniline 
346 in good yield.  This transformation was originally confirmed by detecting the 
absence of a singlet from the aromatic region of the 1H NMR spectrum of 346 when 
 100
compared with aniline 338.   It was assumed that this observation indicated substitution 
of the aromatic ring by a nitro group, most likely ortho to the amino group.  However, 
upon examination of the HRMS of presumed 346, a discrepancy was noticed.  The 
protonated molecular ion (M+H+) of 346 should have an exact mass around m/z 207 (for 
C10H11N2O3).  Instead, the HRMS spectrum surprisingly displayed two high intensity 
peaks at m/z 240 and 242.  After some calculation, it was determined that aniline 338 had 
extracted a bromine atom from compound 340 to give bromoindanone 347 in 59% yield 
(Scheme 98).  The molecular formula for compound 347 (C10H11BrNO, M+H+) 
corresponds almost exactly to the observed m/z values. 
Scheme 98: Unexpected Bromination of Aniline Intermediate 
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 Iranpoor and Firouzabadi have also reported the novel nitration of aromatic 
amines using a Ph3P/Br2/AgNO3 reagent system.161  Interestingly, exposure of aniline 338 
to these conditions also produced the undesired bromoindanone 347 as the sole reaction 
product in comparable yield (Scheme 99). 
Scheme 99: Similar Indanone Bromination using Ph3P/Br2/AgNO3 
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 After the failure of these direct aniline nitration methods, a more traditional route 
to o-nitroaniline 346 was envisioned via application of a protection/nitration/deprotection 
protocol to aniline 338.  To commence this route, aniline 338 was converted to 
acetanilide 348 in good yield using acetyl chloride (AcCl) in the presence of NEt3 
(Scheme 100). 
Scheme 100: Formation of Acetanilide using Acetyl Chloride 
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 Nitration of acetanilide 348 proved to be problematic initially.  However, after 
optimization of the reaction conditions, the most effective and concise procedure was 
shown to involve fuming HNO3 and concentrated H2SO4 at a reaction temperature of       
–20oC for 90 min.  In this way, the target nitroindanone 349 was furnished in 70% yield.  
The results of all attempts to nitrate compound 348 are displayed in table 7. 
Table 7: Attempts to Nitrate Acetanilide Intermediate 
                        
OH
N
O
NO2OH
N
O
conditions
 
                                     348                                                       349 
Entry Reagents Temp (oC) Time (h) Yield (%) 
1 HNO3, glacial AcOH 5 Æ reflux 5 0 
2 KNO3, H2SO4 -5 Æ r.t. 20 0 
3 HNO3, H2SO4  0 Æ r.t. 4 0 
4 HNO3 -40 Æ -20 1 0 
5 HNO3, H2SO4 -20 0.5 45 
6 HNO3, H2SO4 -20 1 50 
7 HNO3, H2SO4 -20 2.5 69 
8 HNO3, H2SO4 -20 1.5 70 
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 Deprotection of acetanilide 349 proceeded smoothly using a procedure reported 
by  Pouli and co-workers162 to give o-nitroaniline 346 in good yield.  Subsequent 
diazotization/iodination of aromatic amine 346 gave a compound tentatively assigned as 
iodoindanone 329.  Seemingly, the corresponding bromide 350 was also synthesized 
from aniline 346 in low yield through a procedure described by Baik et. al.163  While all 
1H and 13C NMR data appear to be in agreement with the proposed structures of 329 and 
350, acceptable m/z values were unable to be located using HRMS (Scheme 101).   
Scheme 101: Formation of 6-Halo-5-methyl-7-nitroindanones 
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 The construction of vinyl stannane 330 was addressed next.  The goal was to 
fashion a suitable coupling partner which could undergo an ensuing Kosugi-Migita-Stille-
type reaction with either aryl iodide 329 or aryl bromide 350, forming cyclization 
precursor 328.  Hydrostannylation of propargyl alcohol (331) in the presence of AIBN at 
80oC164 gave three different tin isomers, as detected by analysis of the crude 1H NMR 
spectrum.  After chromatography using hexanes as the mobile phase, pure trans-stannane 
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330 was isolated in 23% yield, along with an inseparable 6:1 mixture of the cis-stannane 
351 and gem-stannane 205, respectively, in 7% yield (Scheme 102). 
Scheme 102: Construction of (E)-3-(Tributylstannyl)prop-2-en-1-ol 
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 With appropriate coupling pieces in hand, an effort was made to construct o-
nitrostyrene 328 using the conditions reported by Levin126.  Unfortunately, reaction of 
either iodide 329 or bromide 350 with stannane 330 failed to produce the target 
compound 328; only starting materials were returned in all attempts (Scheme 103).  
Subsequent reductive N-heteroannulation of 328 would produce dilemmaone B (320). 
Scheme 103: Attempted Formation of Dilemmaone B Precursor 
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 A possible alternative route to dilemmaone B was envisioned but not attempted to 
date.  This pathway is based largely on Alami’s hydrosilylation chemistry134 discussed in 
chapter 4.  As outlined in scheme 104, either iodide 329 or bromide 350 could undergo a 
Sonogashira coupling with propargyl alcohol (331) to give alkyne 352.  Hydrosilylation 
of alkyne 352 should produce vinylsilane 353 with the denoted stereo- and 
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regiochemistry.  Finally, palladium-catalyzed N-heteroannulation of compound 353 
would produce dilemmaone B (320).   
Scheme 104: Unattempted Hydrosilylation Pathway to Dilemmaone B 
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5.4 Conclusions 
 The synthesis of the marine indole alkaloid, dilemmaone B (320), was envisioned 
utilizing the Söderberg N-heteroannulation as the key step.  Although the target molecule 
was not reached, synthetic progress was achieved by furnishing key halo-intermediates 
329 and 350, along with stannane 330.  More effort involving these important 
intermediates is needed in the future to complete the total syntheses of these unique 
natural products. 
 
 
                   
 
  
 105
Chapter 6 
Synthetic Studies Towards Fistulosin Utilizing Palladium-
Catalyzed Reductive N-Heteroannulation 
6.1 Fistulosin Background        106 
6.2 Synthetic Studies Towards Fistulosin by Clawson et. al.    107 
6.3 Synthetic Studies Towards Fistulosin by Nishida et. al.    115 
6.4 Dimer Synthesis and Analysis via Palladium-Catalyzed N-Heteroannulation 123 
6.5 Conclusions          129 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 106
6.1 Fistulosin Background 
 A novel antifungal compound, fistulosin (354), was isolated in 1999 by Tomita et. 
al. from the roots of the Welsh onion (Allium fistulosum L.) (Figure 14).165  The authors 
proposed the structure of 2-octadecyl-3-indolinone based upon their interpretation of 1H, 
13C, 1H-1H COSY, 1H-13C COSY,  DEPT, and selective INEPT NMR experiments.  
Tomita also reported an absorption at 1684 cm-1 on the IR spectrum and a molecular 
formula of C26H43NO at m/z 385.6337 according to HRMS experiments. 
Figure 14: Tomita’s Proposed Structure of Fistulosin 
                                                           
N
O
C18H37
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 Vegetables among the Allium species are known to be rich in flavonoids and 
alk(en)yl cysteine sulfoxides, which have perceived benefits for human health.166  Since 
the late 1980’s, biologically active products in the Allium species have been investigated 
and the isolation of nematicidal and antibacterial agents has been reported by Tada and 
co-workers.167  Specifically, fistulosin exhibited antifungal activities against the wilt-
producing fungi Fusarium oxysporum.165  Antifungal agents isolated from nature, like 
fistulosin (354), are expected to be useful as a result of their safety to animals, humans, 
and ecosystems.  The proposed fistulosin has a unique structure not found elsewhere in 
nature, although the indolinone core is found in some dimeric alkaloids such as indigo 
(2), peronatin A (355), and peronatin B (356) (Figure 15). 
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Figure 15: Naturally-Occurring Dimeric Indolinone Alkaloids 
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6.2 Synthetic Studies Towards Fistulosin by Clawson et. al. 
 In an effort to synthesize the proposed structure of fistulosin (354), Clawson et. 
al. envisioned a route involving the previously mentioned palladium-catalyzed N-
heteroannulation reaction (Scheme 105).  The synthesis began with the conversion of 
commercially available 1-nonadecanol (357) to 1-iodononadecane (358) using a known 
procedure.168,169  The reaction of 1-lithiononadecane (generated in situ from the reaction 
of 1-iodononadecane (358) with 2.2 equivalents of t-BuLi in diethyl ether at -20oC) with 
chromium hexacarbonyl followed by methylation using trimethyloxonium 
tetraflouroborate  afforded chromium carbene 359 in moderate yield.170  Utilizing 
McDonald’s procedure171 for the formation of α-stannyl ethers from carbenes, tributyl(1-
methoxyicos-1-enyl) stannane (360) was obtained as a 3:1 E/Z mixture in good yield 
from the reaction of carbene 359 with triethylamine and tributyltin triflate.  The 
palladium-catalyzed Kosugi-Migita-Stille coupling of organostannane 360 with o-
iodonitrobenzene (226) afforded the anticipated 1-(1-methoxyicos-1-enyl)-2-
nitrobenzene (361) in excellent yield as 4:1 E/Z mixture of isomers.  Exposing o-
nitrostyrene 361 to slightly altered Söderberg annulation conditions (6 mol% palladium 
acetate and 12 mol % 1,10 phenanthroline) afforded the desired 2-octadecyl-3-
methoxyindole (362) in good yield. 
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Scheme 105: Clawson Attempted Route to Proposed Fistulosin 
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 After many failed attempts to cleave the methyl ether in 362 and arrive at the 
proposed structure of fistulosin (354), an interesting transformation was observed.  
Adhering 362 to silica gel and allowing it to stand open to the air in an effort to cleave 
the methyl ether resulted instead in a ring-opening oxidative cleavage, affording methyl 
2-(nonadecanamido)benzoate (363) in excellent yield (Scheme 106). 
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Scheme 106: Ring-Opening Oxidative Cleavage of Methoxy-Indole 
                                 
N
O
H
C18H37
N
OMe
H
C18H37
SiO2, air
4 h
 
                                           362                                          354 (0%) 
                                  
OMe
O
N
H
O C18H37
SiO2, air
4 h
 
                                       363 (88%) 
 Amide 363 was found to resemble two key natural products; both containing long 
aliphatic chains and both found to have remarkable antifungal properties against 
Fusarium fungi.  N-Arachidylanthranilic acid (364) was isolated from aerial parts of 
Ononis natrix L., a perennial herb found in the Mediterranean region.172  Also, N-
docosanoylanthranilic acid (365) was isolated from the aerial parts of Inula oculus-christi, 
the Eye of Christ flowering plant (Figure 16).173   
Figure 16: Antifungal Natural Products Containing Long Aliphatic Chains 
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 Adding to this new discovery, Lu174 reported that indole (1) undergoes a similar 
oxidative cleavage when exposed to white rot fungus (Pleuotus ostreatus) (Scheme 107).  
Isatoic acid (366) was evidenced as an intermediate (UV-vis, LC/MS) in ultimately 
forming anthranilic acid (367) as the major degradation product. 
Scheme 107: Biodegradation of Indole with White Rot Fungus 
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 With the hypothesis that the true structure of fistulosin (354) was incorrectly 
assigned as 2-octadecyl-3-indolinone, Clawson et. al. carried out a short synthesis175 of 2-
(nonadecanamido)benzoic acid (370) in order to compare its chemical properties to that 
of that compound isolated by Tomita (Scheme 108).  The synthesis began by converting 
carboxylic acid 368 to the corresponding acid chloride 369 in quantitative yield.  Acid 
chloride 369 was then condensed with anthranilic acid (367) in the presence of 
triethylamine to give 2-(nonadecanamido)benzoic acid (370) in good yield.  The structure 
of 370 was confirmed by 1H, 13C, and HMBC NMR experiments.   
Scheme 108: Synthesis of 2-(Nonadecanamido)benzoic acid 
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 Carboxylic acid 370 gives almost identical 1H and 13C chemical shifts when 
compared to Tomita’s proposed fistulosin (354) (2-octadecyl-3-indolinone) (Table 8).  
The only initial difference is the lack of the amide signal in Tomita’s 13C NMR spectral 
data (observed at 172.7 ppm in 370), although the disappearance of amide signals due to 
numerous factors (solution pH, temperature, proximity to a carboxylic acid moiety, etc.) 
has been reported.176  Also, the IR signal reported by Tomita (1684 cm-1) is very close to 
the IR signal of 2-(nonadecanamido)benzoic acid (370) (1673 cm-1).  The larger 
discrepancies at this point for Clawson and co-workers were the melting point difference 
and the HRMS dissimilarity.  Clawson’s proposed fistulosin 370 melted at 94-95oC with 
a m/z of 417.3243 while Tomita’s isolated structure 354 melted at 80-83oC and had a m/z 
of 385.6337.  Nevertheless, the similarities of these two compounds are remarkable.   
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Table 8: Comparison of Tomita’s Fistulosin and Carboxylic Acid 370 
                                       
N
O
C18H37
H
COOH
N
H
C18H37O  
                                          354 (Tomita)a                                  370 (Clawson)b 
mp (oC) 80-83 94-95 
IR (cm-1) 1684 1673 
HRMS (M+) 385.6337 417.3243 
1H NMR 10.8 (br s, 1H) 11.0 (br s, 1H) 
 8.8 (d, 1H) 8.77 (d, 1H) 
 8.1 (d, 1H) 8.13 (dd, 1H) 
 7.6 (t-like, 1H) 7.60 (dt, 1H) 
 7.1 (t-like, 1H) 7.11 (dt, 1H) 
 2.44 (t-like, 1H) 2.47 (t, 2H) 
 1.74 (m, 2H) 1.77 (pent, 2H) 
 1.63 (m, 2H)  
 1.4 (m, 2H) 1.40 (pent, 2H) 
 1.25 (br s, 28H) 1.34-1.24 (m, 28H) 
 0.88 (t-like, 3H) 0.88 (t, 3H) 
13C NMR   172.7 
 171.5 172.1 
 142.5 142.1 
 135.8 135.6 
 131.9 131.7 
 122.7 122.6 
 120.7 120.6 
 113.7 113.9 
 38.9 38.7 
 32.1 31.9 
 29.05-29.92 29.7-29.2 
 25.9 25.5 
 23.4 22.7 
 14.3 14.1 
a In CDCl3 at 500 MHz (125 MHz for 13C) 
b In CDCl3 at 600 MHz (150 MHz for 13C) 
  
 Clawson et. al. noticed a general trend that the melting point increases with 
increased aliphatic carbon chain length in similar compounds.   This trend was observed 
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by comparing N-arachidylanthranilic acid (364) to N-docosanoylanthranilic acid (365) 
(see Figure 16).  Thus, Clawson et. al. proposed that the length of the aliphatic chain may 
be shorter than Tomita’s proposed octadecyl chain.  This adjustment could account for a 
needed decrease in melting point (94-95oCÆ80-83oC).   
 To solve the HRMS discrepancy, the MS fragmentation patterns of the previously 
mentioned N-docosanoylanthranilic acid (365) were examined.  Ziesche173 and co-
workers reported that the molecular ion of (365) (C29H49NO3) of m/z 459.371 was only 
seen in 1%, where the m/z 441.359 peak seen from the loss of H2O was seen in 12%.  
Additionally, Al-Khalil172 reported similar fragmentations for N-arachidylanthranilic acid 
(364).  The molecular ion for C27H45NO3 of m/z 431 was only seen in 2%, where the m/z 
413 peak seen from the loss of H2O was seen in 7%.  Hence, Clawson et. al. proposed 
that Tomita’s reported M+ (100%) of 385 could likely be the more abundant signal 
resulting from the loss of water from a compound with the molecular formula C25H41NO3 
and molecular weight of 403.  With this insight, Clawson and co-workers set out to 
synthesize 2-(octadecanamido)benzoic acid (373) using the same protocol as described 
for the preparation of 2-(nonadecanamido)benzoic acid (370).  This compound contains 
one less carbon in the aliphatic chain attached to the amide and, ironically, has a 
molecular weight of 403.60 g/mol.  Carboxylic acid 371 was transformed into 2-
(octadecanamido)benzoic acid (373) in two steps (Scheme 109). 
Scheme 109:  Synthesis of 2-(Octadecanamido)benzoic acid 
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 The data for compound 373 now matched almost exactly to Tomita’s fistulosin 
(354), except again for the absence of the amide peak in the 13C NMR (Table 9). 
Table 9: Comparison of Tomita’s Fistulosin and Carboxylic Acid 373 
                                       
N
O
C18H37
H
COOH
N
H
C17H35O  
                                         354 (Tomita)a                                   373 (Clawson)b 
mp (oC) 80-83 (white crystals) 81-82 (white powder) 
IR (cm-1) 1684 1673 
HRMS (M+) 385.6337 403.3086 
1H NMR 10.8 (br s, 1H) 10.9 (br s, 1H) 
 8.8 (d, 1H) 8.77 (d, 1H) 
 8.1 (d, 1H) 8.13 (dd, 1H) 
 7.6 (t-like, 1H) 7.60 (dt, 1H) 
 7.1 (t-like, 1H) 7.11 (dt, 1H) 
 2.44 (t-like, 1H) 2.47 (t, 2H) 
 1.74 (m, 2H) 1.77 (m, 2H) 
 1.63 (m, 2H)  
 1.4 (m, 2H) 1.40 (m, 2H) 
 1.25 (br s, 28H) 1.34-1.24 (m, 26H) 
 0.88 (t-like, 3H) 0.88 (t, 3H) 
13C NMR   172.7 
 171.5 172.2 
 142.5 142.2 
 135.8 135.7 
 131.9 131.8 
 122.7 122.6 
 120.7 120.6 
 113.7 113.8 
 38.9 38.7 
 32.1 31.9 
 29.05-29.92 29.7-29.2 
 25.9 25.5 
 23.4 22.7 
 14.3 14.1 
a In CDCl3 at 500 MHz (125 MHz for 13C) 
b In CDCl3 at 600 MHz (150 MHz for 13C) 
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 Most importantly, the melting range for compound 373 was observed at 81-82oC, 
matching the melting range of 80-83oC reported by Tomita.  It seems that Clawson and 
co-workers may have elucidated the true structure of the compound isolated from the 
roots of the Welsh onion; however, other attempts have been made to determine its 
identity. 
6.3 Synthetic Studies Towards Fistulosin by Nishida et. al. 
 Nishida et. al. have published a synthesis of Tomita’s reported structure of 
fistulosin using a ruthenium-catalyzed diene cycloisomerization (Scheme 110).177  The 
synthesis began with the Mitsunobu reaction of readily available aniline 374 with alcohol 
375 to yield α,β-unsaturated ester 376.  Treatment of ester 376 with RuClH(CO)(PPh3)3 
(10 mol%) provided enamide 377 in good yield.  Cycloisomerization of 377 in the 
presence of Grubbs second generation catalyst (10 mol %) and trimethyl(vinyloxy)silane 
gave cyclized product 378 in 87% yield.  Cyclized product 378 was reduced with DIBAL 
to give aldehyde 379, which was treated with an alkyl Grignard reagent to give the 
corresponding secondary alcohol.  Mesylation of the resulting hydroxy group followed by 
reduction of the mesylate with NaBH4 gave indoline 380, which was converted to 3-
indolinone 381 by ozonolysis.  Finally, treatment of 381 with concentrated H2SO4 at 0oC 
gave the deprotected product 354 quantitatively. 
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Scheme 110: Nishida Synthesis of 2-Octadecyl-3-indolinone 
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 Nishida claimed that 3-indoline 354 was pure and stable enough for the structure 
to be characterized; however, further purifications by column chromatography or 
recrystallization were unsuccessful since 354 was gradually tautomerized to the more 
thermodynamically stable 3-hydroxyindole 382 in solution.  Compound 382 provided a 
second candidate for the structure of the natural fistulosin.  Nishida also reported that 
tautomerization of 354 occurred smoothly in an acidic medium, such as aqueous HCl or 
H2SO4, to give the more stable 382 (Scheme 111).  According to the authors, the structure 
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of 3-hydroxyindole 382 was confirmed by 1H-1H COSY, HMBC, and HMQC 2D-NMR 
experiments. 
Scheme 111: Tautomerization of 3-Indolinone 354 in Acidic Medium 
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 Nishida also prepared 3-octadecyl-2-oxindole (384) as a third prospect for 
comparison with Tomita’s isolated product from the roots of the Welsh onion.  Using a 
short procedure developed my Overman and co-workers178, oxindole (5) was condensed 
with octadecanal to give alkene 383 in good yield.  Reduction with zinc afforded the 
desired 3-octadecyl-2-oxindole (384) (Scheme 112). 
Scheme 112: Nishida Synthesis of 3-Octadecyl-2-oxindole 
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 Comparing the spectral data of all three compounds synthesized by Nishida (354, 
382, and 384) to the compound isolated by Tomita (354) clearly shows that none of the 
structures agree with the reported data of the compound isolated from the roots of the 
Welsh onion (Table 10).  Nishida did not comment much further on the true structure of 
fistulosin, only adding that more investigation is necessary in order to determine its 
identity. 
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Table 10: Comparison of Nishida’s Fistulosin Candidates (R=C18H37) 
                       
N
O
H
R
N
OH
H
R
N
O
H
R
N
H
O
R
 
                       354 (Tomita)a         354 (Nishida)b                382b                         384b 
mp (oC) 80-83 100-102 107-108 95-96 
IR (cm-1) 1684 (CO) 1675 (CO) 1674 (OH) 1698 (CO) 
MS (M+) 385 385 385 385 
1H NMR 10.8 (br s, 1H) 7.61 (d, 1H) 7.56 (d, 1H) 8.63 (br s) 
 8.8 (d, 1H) 7.44 (dd, 1H) 7.49 (ddd, 1H) 7.2-7.3 (m,2H) 
 8.1 (d, 1H) 6.88 (d, 1H) 6.95 (d, 1H) 7.02 (dd, 1H) 
 7.6 (t-like, 1H) 6.82 (d, 1H) 6.78 (dd, 1H) 6.91 (m, 1H) 
 7.1 (t-like, 1H) 4.70 (br s, 1H) 6.08 (br s, 1H) 3.47 (m, 1H) 
 2.44 (t-like, 1H) 3.75 (dd, 1H) 1.8-1.9 (m,1H) 1.96 (m, 2H) 
 1.74 (m, 2H) 1.8-2.0 (m, 1H) 0.9-1.3 (m,34H) 1.2-1.4 (m,32H) 
 1.63 (m, 2H) 1.5-1.6 (m, 1H) 0.88 (t, 3H) 0.88 (t, 3H) 
 1.4 (m, 2H) 1.3-1.4 (m, 32 H)   
 1.25 (br s, 28H) 0.88 (t, 3H)   
 0.88 (t-like, 3H)    
13C NMR 171.5 202.7 204.6 180.7 
 142.5 161.3 162.0 141.6 
 135.8 137.0 138.1 129.9 
 131.9 124.5 124.2 127.7 
 122.7 121.5 121.5 124.1 
 120.7 118.9 118.3 122.2 
 113.7 112.6 112.0 109.7 
  64.3 72.5 46.1 
 38.9 32.0 32.0 31.9 
 32.1 31.9 31.9 30.5 
 29.05-29.92 29.3-29.7 29.3-29.8 29.6-29.7 (m) 
 25.9 25.8 23.0 29.3 
 23.4 22.7 22.7 25.8 
 14.3 14.1 14.1 22.7 
    14.1 
a In CDCl3 at 500 MHz (125 MHz for 13C) 
b In CDCl3 at 400 MHz (100 MHz for 13C) 
 
 While Nishida’s proposed structures of 3-indolinone 354 and oxindole 384 are 
believed to be correct, the assigned structure of 2-octadecyl-1H-indol-3-ol (382) raises 
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some doubt.  Nishida claimed to be able to control the tautomerization of 354 to “the 
more thermodynamically stable” compound 382 via acidic media (see Scheme 111).  
This assertion defies literature precedence involving 3-indolinone oxidations to give the 
corresponding dimeric compounds.  The most commonly used method to produce indigo 
(2) involves a transformation of this type.  Indoxyl (386) is prepared from the reaction of 
N-phenylglycine (385) with sodium hydroxide, potassium hydroxide, and sodium 
amide.179  Once the reaction mixture is exposed to atmospheric oxygen, indigo (2) is 
formed via a oxidative dimerization of 3-indolinone 386 (Scheme 113). 
Scheme 113: Formation of Indigo via Oxidative Dimerization 
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 2-Substituted-3-indolinones also undergo a similar dimerization.  Tyrian purple 
(389) is formed from the sulfate ester 387 via tyriverdin (388).  Compound 387 is 
hydrolyzed by a sulfatase to the corresponding 3-hydroxyindole (or 3-indolinone), which 
by oxidative coupling forms the dimeric tyriverdin (388) as a mixture of stereoisomers 
(Scheme 114).180   
Scheme 114: Formation of Tyriverdin via Dimerization   
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 2-Alkyl-3-indolinones also dimerize.  For example, Van Vranken181 reported the 
synthesis of natural products peronatin A (355) and peronatin B (356) using biomimetic 
oxidative coupling methods.  The hydrogen peroxide oxidation of 2,4-dimethylindole 
(390) in the presence of acetic acid produced the intermediate 2,4-dimethylindoxyl (391) 
which immediately dimerized to produce peronatin B (356) (Scheme 115).  Peronatin A 
(355) was formed in the same way from 390 using basic conditions (H2O2, NEt3).  It 
should be noted that Peronatin A (355) slowly isomerizes to the more stable trans-isomer 
Peronatin B (356) in anhydrous chloroform.  Sterner180 has shown that the trans-
conformation is more stable due to an intramolecular H-bonding interaction between the 
N-1 proton and the C’-3 carbonyl oxygen of the dimer. 
Scheme 115: Van Vranken Synthesis of Peronatin B 
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 The fact that both indoxyl (386) and 2,4-dimethylindoxyl (391) undergo oxidative 
coupling reactions to form the corresponding dimers conflicts with Nishida’s proposal 
that 2-octadecyl-3-indolinone (354), when exposed to H2SO4, would give 3-
hydroxyindole 382.  It seems much more likely that 354 dimerizes to give compound 
392, probably with the denoted trans-conformation due to the size of the alkyl chain on 
C-2 (Scheme 116). 
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Scheme 116: Possible Dimerization of 2-Octadecyl-3-indolinone 
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 Comparison of the relevant 1H and 13C NMR signals of Nishida’s 3-
hydroxyindole 382 (now proposed to actually be dimer 392) with the corresponding 
signals belonging to dimeric peronatin B (356) illustrates remarkable similarities (Table 
11).  The only significant difference is the 13C NMR signal at C-4 of Nishida’s compound 
382.  This difference is most likely due to the absence of a methyl group. 
Table 11: Comparison of Nishida’s 3-Hydroxyindole and Peronatin B 
                                               
N
OH
H
C18H37
N
O
H
N
O
H
1
2
33a45
6
7
7a 1
2
3
3a4
5
6
7
7a
 
                                                         382a                                           356b 
1H NMR H-6 7.49 (ddd, 1H) 7.30 (dd, 1H) 
 H-7 6.95 (d, 1H) 6.71 (dd, 1H) 
 H-5 6.78 (dd, 1H) 6.52 (dd, 1H) 
 H-1 6.08 (br s, 1H) 6.12 (bs s, 1H) 
13C NMR C-3 204.6 204.9 
 C-7a 162.0 161.6 
 C-6 138.1 140.1 
 C-4 124.2 137.5 
 C-5 121.5 119.9 
 C-3a 118.3 118.0 
 C-7 112.0 109.4 
 C-2 72.5 68.4 
a In CDCl3 at 400 MHz (100 MHz for 13C) 
b In CDCl3 at 500 MHz (125 MHz for 13C) 
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 The 13C shift for C-3 of Peronatin B (356) at 209.4 ppm matches very nicely with 
the corresponding signal for 382 at 204.6 ppm.  This data further suggests that Nishida 
misassigned dimer 392 as 3-hydroxyindole 382.  13C NMR shifts for quaternary carbons 
of the type reported for 382 at C-3 usually appear much further upfield.  For example, 
Clawson et. al. reported a 13C NMR shift at C-3 of 140.8 ppm for ethoxyindole 393 
(Figure 17).91  Even without the presence of an attached ethyl group, it is difficult to 
justify a chemical shift difference of almost 65 ppm. 
Figure 17: Comparison of 13C NMR Shifts of Heterocycles at C-3 
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 Additional evidence that Nishida may have incorrectly assigned the structure of 
dimeric 392 as 2-octadecyl-3-hydroxyindole (382) can be found by examining the HRMS 
data and fragmentation patterns of the dimeric peronatins.  Sterner has reported that 
peronatin A (355) and peronatin B (356) both showed a very weak molecular ion peak 
when analyzed by HRMS (3-4%).  Both of these compounds were shown to cleave 
symmetrically in the ion source, where one half takes up a hydrogen and gives the base 
peak of (M/2)+1 (the monomer plus a hydrogen) with EI ionization.180  The base peaks 
for both peronatin A and B (exact mass = 320.1525) were found to be m/z 161.0825 (or 
approximately (M/2)+1).  Nishida’s reported molecular ion of m/z 385 for his proposed 
3-hydroxyindole 382 is most likely the (M/2)+1 base peak seen from the symmetrical 
cleavage of dimeric 392 (exact mass = 768.6533).  The molecular ion peak of 392 around 
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m/z 768 may have been overlooked while scanning the small region where an expected 
base peak of m/z 385 would be found. 
6.4 Dimer Synthesis and Analysis via Palladium-Catalyzed N-Heteroannulation 
 In order to confirm that Nishida’s 3-hydroxyindole 382 was indeed the proposed 
dimer 392, an attempt was made to synthesize 392 for further analysis.  Since the 
peroxidation of 2-alkyl indoles is known to give dimers of this type182,183, it was believed 
that 2-octadecylindole  (397) would be a suitable starting material.  Initially, a route was 
envisioned to arrive at (397) that involved a Sonogashira coupling/base-promoted 
heteroannulation strategy.  Specifically, palladium-catalyzed coupling of 2-iodoaniline 
(394) with 1-eicosyne (395) in the presence of copper iodide gave o-alkynylaniline 396 in 
good yield.  Potassium tert-butoxide induced cyclization of 396, as reported by 
Knochel184, failed to produce 2-octadecylindole  (397) (Scheme 117). 
Scheme 117: Failed Route to 2-Octadecylindole 
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 It was then decided to attempt to synthesize 2-octadecylindole (397) via the 
Söderberg annulation route to 2-alkylindoles discussed in chapter 4.  Hence, 1-iodo-2-
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nitrobenzene (226) was coupled to 1-eicosyne (395) in the presence of Pd(PPh3)Cl2 and 
CuI to give nitroalkyne 398 in near quantitative yield.  Platinum-catalyzed regioselective 
addition of triethylsilane to the alkyne moiety in 398 afforded vinyl silane 399 as the only 
product in excellent yield.  Finally, exposure of 399 to typical Söderberg annulation 
conditions caused cleavage of the silyl group and induced cyclization to produce 2-
octadecylindole (397) (Scheme 118). 
Scheme 118: Söderberg N-Heteroannulation Route to 2-Octadecylindole 
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 With indole 397 in hand, dimerization was attempted using the procedures 
reported to synthesize Peronatins A (355) and B (356) from 2,4-dimethylindole (390).181  
Thus, 2-octadecylindole (397) was exposed to both the acidic conditions (H2O2, AcOH, 
r.t.) and basic conditions (H2O2, NEt3, THF, r.t.) described by Van Vranken in an effort to 
arrive at dimer 392.  Unfortunately, no evidence of dimer 392 was detected; only the 
starting indole 397 was returned after several hours (Scheme 119). 
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Scheme 119: Attempted Dimerization Using Van Vranken Conditions 
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 After searching the literature, a study was discovered which described the 
peroxidation of 2-alkylindoles using meta-chloroperoxybenzoic acid (m-CPBA) to give 
both 2,2’-biindolinyl and 3-(3-oxoindolin-2-yl)indole dimers.185  For example, 2-
methylindole (31) was transformed into dimers 400 and 401 in 61% and 20% yield, 
respectively (Scheme 120).  It should be noted that the structures of compounds 400 and 
401 were confirmed by X-ray crystallographic analysis.185 
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Scheme 120: Preparation of Dimers via Oxidation of 2-Methylindole 
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 Since the identification of compounds like 400 and 401, there has been much 
mechanistic controversy; however, agreement has been reached.  Dimers 400 and 401 
have been explained by the intermediate formation of 2-methylindolone (402).  Indolone 
402 could truly be the intermediate in the formation of 401; in fact 401 could arise from 
the nucleophilic attack of indole 31 on indolone 402.  However, the ionic mechanism 
proposed is highly unlikely to explain the formation of 400, which is more likely to arise 
from the dimerization of radical 403 (Scheme 121). 
Scheme 121: Intermediates in Dimer Formations 
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 Reaction of 2-octadecylindole (397) with m-CPBA proceeded in much the same 
manner as reported for 2-methylindole.  Hence, 2-octadecyl-2-(2-octadecyl-3-oxo-2,3-
dihydro-1H-indol-2-yl)-1,2-dihydro-3H-indol-3-one (392) and 2-octadecyl-2-(2-
octadecyl-1H-indol-3-yl)indolin-3-one (404) were furnished in 33% and 36% yield, 
respectively (Scheme 122).  These compounds were confirmed by 1H and 13C NMR, 
along with gHMBC and NOESY 2-D NMR experiments (see Appendix).  In addition, 
HRMS data for dimer 392 showed a peak at m/z 769.6606 (M+H+), albeit in only 3-4%.  
A more intense peak at 386.3422 was also detected, indicating the symmetrical cleavage 
of the dimer ((M/2)+1).  These trends match well with the ones observed in the dimeric 
peronatins.   
Scheme 122: Successful Synthesis of 2,2’-Biindolinyl Dimer 
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 A comparison between confirmed dimer 392 and Nishida’s reported 3-
hydroxyindole 382 clearly indicates that they are the same compound (Table 12).  All 
observed data, including 1H NMR, 13C NMR, mp, and IR, is in almost exact accordance.  
This affirms that Nishida’s “tautomerization” of 2-octadecyl-3-indolinone (354) was 
actually a dimerization yielding compound 392. 
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Table 12: Comparison of Dimer 392 with Nishida’s 3-Hydroxyindole 
                                          
N
O
C18H37
N
O
C18H37
H
H
N
OH
H
C18H37
 
                                                         392a                                                382b 
mp (oC) 105-107 107-108 
IR (cm-1) 1674 (CO) 1674 (OH) 
MS (M+) 768.6527 385 
1H NMR 7.56 (d, 2H) 7.56 (d, 1H) 
 7.48 (t, 2H) 7.49 (ddd, 1H) 
 6.95 (d, 2H) 6.95 (d, 1H) 
 6.78 (t, 2H) 6.78 (dd, 1H) 
 6.02 (s, 2H) 6.08 (br s, 1H) 
 1.85-1.90 (m, 2H) 1.84-1.90 (m,1H) 
 0.94-1.30 (br m, 66H) 0.99-1.31 (m,34H) 
 0.88 (t, 6H) 0.88 (t, 3H) 
13C NMR 204.5 204.6 
 161.9 162.0 
 138.0 138.1 
 124.1 124.2 
 121.6 121.5 
 118.3 118.3 
 112.0 112.0 
 72.5 72.5 
 32.0 32.0 
 31.9 31.9 
 29.3-29.8 (m) 29.3-29.8 (m) 
 22.9 23.0 
 22.7 22.7 
 14.1 14.1 
a In CDCl3 at 600 MHz (150 MHz for 13C) 
b In CDCl3 at 400 MHz (100 MHz for 13C) 
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6.5 Conclusions 
 After much debate, it seems that the true structure of fistulosin is 2-
(octadecanamido)benzoic acid (373) and not 2-octadecyl-3-indolinone (354) as originally 
proposed by Tomita.  Nishida actually synthesized 2-octadecyl-3-indolinone (354) in 
order to verify Tomita’s claim.  Upon comparison, it was clear that fistulosin was not 
(354), nor was it either of Nishida’s other two fistulosin candidates, 3-octadecyl-2-
oxindole (384) or 3-hydroxy-2-octadecylindole (382).  With the structure of Nishida’s 3-
hydroxy-2-octadecylindole (382) in question, a study was carried out verify its identity.  
It was determined that the reported structure of 382 was actually dimer 392 as concluded 
by comparison of the obtained spectral data.  Dimer 392 was obtained from the m-CPBA 
oxidation of 2-octadecylindole (397). 
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7.1 Synthesis of 3-(Halomethyl)benzo[c]isoxazole-N-oxides 
 Originally, a route to 3-bromoindoles was envisioned utilizing the previously 
mentioned Söderberg palladium-catalyzed reductive N-heteroannulation.  These 3-
bromoindoles could be used as synthetic building blocks in constructing more complex 
indole natural products.  Thus, benzaldehyde (405) was converted to the corresponding 
1,1-dibromo-1-alkene 406 using carbon tetrabromide (CBr4) in the presence of PPh3.  
Unfortunately, coupling of dibromide 406 with stannane 208, using a protocol developed 
by Shen et. al. specifically for substrates of this type, was unsuccessful.186  It was 
imagined that compound 407 would have  undergone cyclization to afford 3-bromo-2-
phenylindole (408) (Scheme 123). 
Scheme 123: Attempted Synthesis of 3-Bromo-2-phenylindole 
O
H
CBr4, PPh3, CH2Cl2
H
BrBr
SnBu3
NO2
Pd(dba)2, TFP, toluene
NO2
Br
35%
0%
 
      405                                                     406                      208                              407 
                                                                                                                
N
Br
cyclization
H  
     408 
 After several failed attempts to couple 406 and 208 employing variants of the 
above Kosugi-Migita-Stille coupling, a publication was discovered which described the 
regioselective hydrobromination of 1,2-bis(ethynyl)benzene (409) using aqueous HBr in 
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hot pentanone to give 1,2-bis(1’-bromoethenyl)benzene (410) in near quantitative yield 
(Scheme 124).187 
Scheme 124: Hydrobromination of 1,2-Bis(ethynyl)benzene 
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 It was presumed that this protocol would be equally effective if applied to 1-
ethynyl-2-nitrobenzene (297).  Hence, the synthesis of 297 began with a Sonogashira 
coupling of 1-iodo-2-nitrobenzene (226) and trimethylsilylacetylene to give TMS-alkyne 
296.  Removal of the silyl group in 296 with tetrabutylammonium fluoride (TBAF) led to 
the desired compound 297 in 62% yield over two steps (Scheme 125). 
Scheme 125: Synthesis of 1-Ethynyl-2-nitrobenzene 
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 Nitroalkyne 297 was then exposed to the hydrobromination conditions discussed 
above in hopes that bromoalkene 411 would emerge as the major product.  o-Nitrostyrene 
411 could then undergo a Söderberg cyclization to yield 3-bromoindole.  Surprisingly, 
combining 297 with 48% aqueous HBr in 3-pentanone at 100oC did not yield any of the 
desired product 411; instead, benzisoxazole-N-oxide 412 was produced as the major 
product in 37% yield (Scheme 126).  The structure of 412 was confirmed by gHMBC, 
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1D-NOE, HETCOR, and COSY NMR experiments (see Appendix).  It should be noted 
that this unexpected reaction did not proceed with acetone, toluene or DMF as the 
solvent; only 3-pentanone allowed this transformation to take place. 
Scheme 126: Exposure of 1-Ethynyl-2-nitrobenzene to HBr in 3-Pentanone 
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 There are very few examples of benzisoxazole-N-oxides in the literature.  
Mechanistically, the reaction is believed to proceed by an initial protonation of the alkyne 
moiety in 297.  Attack of the resulting carbocation 413 by an oxygen of the nitro group is 
faster than the corresponding attack by the bromide anion, thus furnishing heterocycle 
414.  Alkene 414 is now attacked by the bromide anion to produce primary alkyl bromide 
412 (Scheme 127). 
Scheme 127: Mechanism of Benzisoxazole-N-oxide Formation 
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 This methodology was also successful in forming the corresponding 
chlorobenzisoxazole-N-oxide when employing 37% aqueous HCl.  Chloride 415 was 
fashioned by heating nitroalkyne 297 with HCl in 3-pentanone (Scheme 128). 
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Scheme 128: Synthesis of 3-(Chloromethyl)benzo[c]isoxazole-N-oxide 
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 It is noteworthy that heteroannulation did not occur with the corresponding 
nitroalkene.  Subjecting 1-nitro-2-vinylbenzene (108) to 48% aqueous HBr in hot 3-
pentanone caused only starting material to be returned (Scheme 129). 
Scheme 129: Reaction of HBr with 1-Nitro-2-vinylbenzene 
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7.2 Incorporation of Additives into N-Heteroannulations 
 In an effort to expand the scope of the Söderberg N-heteroannulation 
methodology, a series of reactions were designed to incorporate double bond moieties 
into the targeted indole core.  Dihydropyran (416) was used as the solvent in a typical 
Söderberg annulation employing o-nitrostyrene 115, in hope that 416 would be included 
in the structure of the final product.  Unfortunately, only a standard cyclization occurred, 
giving indole 417 as the lone isolated species (Scheme 130). 
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Scheme 130: Attempted Incorporation of Dihydropyran into N-heteroannulation 
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 Integrating formaldehyde into Söderberg cyclization products was examined next.  
Reaction of annulation precursor 115 with ten equivalents of paraformaldehyde in the 
presence of palladium(II) acetate and carbon monoxide gave dihydroquinoline 418 in low 
yield (Scheme 131).  It seems that the formaldehyde carbon has been incorporated into 
the C-2 position of 418. 
Scheme 131: Synthesis of Dihydroquinoline 418 
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 The use of hexanal in this reaction was considered next.  It was envisioned that 
419 could be fashioned from hexanal using the conditions described to produce 418.  
Disappointingly, exposure of 115 to these cyclization conditions returned only starting 
material.  The alternate Söderberg conditions were also implemented in order to arrive at 
419; however, only indole 417 was recovered (Scheme 132). 
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Scheme 132: Attempted Incorporation of Hexanal into N-heteroannulation 
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7.3 Conclusions 
 Two novel reactions were developed forming unique nitrogen-containing 
compounds.  A benzisoxazole-N-oxide synthesis was discovered by exposing an o-
alkynylnitrobenzene to aqueous HBr in 3-pentanone.  Also, the Söderberg N-
heteroannulation methodology to produce indoles was expanded by incorporating 
formaldehyde into the final product, giving a dihydroquinoline moiety.  More effort is 
needed in the future to fully determine the scope and limitations of these two novel 
transformations. 
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General Procedures. NMR spectra were determined in CDCl3 at 270 MHz (1H NMR) 
and 67.5 MHz (13C NMR) or at 600 MHz (1H NMR) and 150 MHz (13C NMR), 
respectively.  The chemical shifts are expressed in δ values relative to Me4Si (0.0 ppm, 
1H and 13C) or CDCl3 (77.0 ppm, 13C) internal standards.  1H-1H coupling constants are 
reported as calculated from spectra; thus a slight difference between Ja,b and Jb,a is usually 
obtained.  Tetrahydrofuran (THF) was distilled from sodium benzophenone ketyl prior to 
use.  Hexanes and ethyl acetate were distilled from calcium hydride.  Chemicals prepared 
according to literature procedures have been footnoted first time used; anhydrous 
acetonitrile, benzene, dichloromethane, 1,4-dioxane, diethyl ether, DMF, NMP, and 
toluene and all other reagents were obtained from commercial sources and used as 
received.  All reactions were performed under a nitrogen atmosphere in oven-dried 
glassware unless otherwise stated.  Solvents were removed from reaction mixtures and 
products on a rotary evaporator at water aspirator pressure. Chromatography was 
performed on silica gel 60 (40-63 µm, EMD). Melting points were determined on a 
MelTemp and are uncorrected.   
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8.1 Supporting Information Chapter 3: Tryptophan Derivatives 
 
                        
N
N OMe
MeO
Me3Sn
N
N OMe
MeO
Br
 
                                       198                                                    238 
(2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-2-(2-trimethylstannyl-2-
propen-1-yl)pyrazine (238).  To a solution of (2R,5S)-2-(2-bromo-2-propen-1-yl)-2,5-
dihydro-5-(1-methylethyl)-3,6-dimethoxypyrazine (198) (1.00 g, 3.30 mmol) in benzene 
(25 ml) at ambient temperature and under an atmosphere of nitrogen were added 
diisopropylethylamine (85 mg, 0.66 mmol) and hexamethylditin (2.16 g, 6.60 mmol), 
followed by bis(dibenzylideneacetone)palladium (Pd(dba)2) (95 mg, 0.16 mmol) and 
triphenylphosphine (PPh3) (173 mg, 0.66 mmol).  The solution was heated for 24 h at 80 
oC.  The reaction mixture was quenched by the addition of CuSO4 (sat.-aqueous, 150 
mL). The reaction mixture was extracted with hexane (3 x 100 mL) and the combined 
organic layers were washed with brine (100 mL).  The combined organic phases were 
dried (MgSO4), filtered through Celite, and the solvents were removed under reduced 
pressure.  The resulting residue was purified by chromatography (hexanes/EtOAc, 99:1) 
to afford 238 (1.01 g, 2.61 mmol, 80%) as a colorless oil.  1H NMR δ 0.13 (s, 9H), 0.67 
(d, J=6.6 Hz, 3H), 1.03 (d, J=6.6 Hz, 3H), 2.26 (dsept, J=7.2, 3.6 Hz, 1H), 2.59 (dd, 
J=13.2, 7.2 Hz, 1H), 2.83 (dd, J=13.2, 7.2 Hz, 1H), 3.66 (s, 3H), 3.68 (s, 3H), 3.89 (t, 
J=3.6 Hz, 1H), 4.05 (pent, J=3.6 Hz, 1H), 5.25 (d, J=3.0 Hz, 1H), 5.72 (d, J=3.0 Hz, 1H); 
13C NMR δ -8.8, 16.6, 19.1, 31.7, 44.3, 52.2, 52.4, 56.4, 60.7, 128.4, 151.7, 163.5, 163.7; 
IR (neat) 1220, 1692 cm-1; [α]25D= −12.0 (c=1.2, CH2Cl2); HRMS (ESI) calcd for 
C15H29N2O2Sn (M+H+) 389.1251, found 389.1246. 
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                        238                             236                                           239 
 
(2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-2-(2-(2-nitrophenyl)-2-
propen-1-yl)pyrazine (239).  To a solution of 238 (400 mg, 1.03 mmol) in DMF (10 
mL) was added 2-nitro-1-iodobenzene (236) (214 mg, 0.861 mmol), Pd(dba)2 (25 mg, 
0.043 mmol) and PPh3 (45 mg, 0.17 mmol). CuI (123 mg, 0.646 mmol) was added in one 
portion and the reaction mixture was stirred at ambient temperature for 26 h.  The 
mixture was diluted with Et2O (50 mL), washed with 10% aqueous NH4OH (3 x 50 mL), 
H2O (50 mL), and brine (50 mL).  The organic phase was dried (MgSO4), filtered, and 
the solvents were removed under reduced pressure.  The resulting oil was purified by 
chromatography (hexanes/EtOAc, 97:3) to afford 239 (2R,5S/2S,5S=15:1, 173 mg, 0.500 
mmol, 58%) as a yellow oil.  1H NMR δ 0.61 (d, J=6.6 Hz, 3H), 0.97 (d, J=6.6 Hz, 3H), 
2.15 (dsept, J=6.6, 3.6 Hz, 1H), 2.84 (dd, J=13.8, 6.0 Hz, 1H), 2.92 (dd, J=13.8, 6.0 Hz, 
1H), 3.39 (s, 3H), 3.50 (s, 3H), 3.77 (t, J=3.6 Hz, 1H) Hz, 4.06 (q, J=6.0 Hz, 1H), 5.11 (s, 
1H), 5.26 (s, 1H), 7.22 (d, J=7.2 Hz, 1H), 7.36 (t, J=7.8 Hz, 1H), 7.48 (t, J=7.2 Hz, 1H), 
7.90 (d, J=8.4 Hz, 1H); 13C NMR δ 16.6, 18.9, 31.9, 40.4, 51.9, 52.1, 55.1, 60.9, 118.6, 
124.0, 127.8, 131.9, 132.6, 138.7, 144.2, 147.9, 162.5, 163.2; IR (neat) 1233, 1242, 1350, 
1515, 1693 cm-1; [α]25D =−21.8 (c=1.2, CH2Cl2); HRMS (ESI) calcd for C18H24N3O4 
(M+H+) 346.1767, found 346.1761. 
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                         201                             208                                          209 
 
Alternative method. (2S,5R)-2,5-dihydro-3,6-dimethoxy-5-(1-methylethyl)-2-(2-(2-
nitrophenyl)-2-propen-1-yl)pyrazine (209).  To a solution of (2S,5R)-2-(2-bromo-2-
propen-1-yl))-2,5-dihydro-5-(1-methylethyl)-3,6-dimethoxypyrazine 201 (310 mg, 1.02 
mmol) in N-methylpyrrolidone (3 mL) was added tributyl(2-nitrophenyl)stannane 208 
(506 mg, 1.23 mmol), PdCl2(PhCN)2 (20 mg, 0.051 mmol) and AsPh3 (31 mg, 0.10 
mmol).  CuI (19 mg, 0.10 mmol) was added and the reaction mixture was stirred at 80 oC 
for 3 days.  The mixture was diluted with EtOAc (20 mL), washed with 10% aqueous 
NH4OH (3 x 20 mL), H2O (20 mL), and brine (20 mL).  The organic phase was dried 
(MgSO4), filtered, and the solvents were removed under reduced pressure.  The resulting 
oil was purified by chromatography (hexanes/EtOAc, 95:5) to afford 209 
(2S,5R/2R,5R=10:1, 162 mg, 0.469 mmol, 46%) as a yellow oil.  1H NMR (partial data 
minor isomer) δ 0.72 (d, J=6.9 Hz, 3H), 1.04 (d, J=6.9 Hz, 3H), 3.10 (dd, J=14.4, 4.9 Hz, 
2H), 3.50 (s, 3H), 3.62 (s, 3H), 5.10 (s, 1H), 5.30 (s, 1H). 
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                     238                                      240                                         241 
 
(2R,5S)-2,5-Dihydro-2-(2-(4-methoxy-2-nitrophenyl)-2-propen-1-yl)-5-(1-
methylethyl)-3,6-dimethoxy-pyrazine (241).  Reaction of 1-iodo-4-methoxy-2-
nitrobenzene (240) (240 mg, 0.861 mmol) with 238 (400 mg, 1.03 mmol) in the presence 
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of Pd(dba)2 (25 mg, 0.043 mmol), PPh3 (45 mg, 0.17 mmol), and CuI (123 mg, 0.646 
mmol) in DMF (10 mL), as described for 239 (51 h), gave after extraction and 
chromatography (hexanes/EtOAc, 95:5) 241 (221 mg, 0.589 mmol, 68%) as a yellow oil.  
1H NMR δ 0.62 (d, J=7.2 Hz, 3H), 0.97 (d, J=7.2 Hz, 3H), 2.16 (dsept, J=7.2, 3.6 Hz, 
1H), 2.80 (dd, J=13.8, 6.0 Hz, 1H), 2.89 (dd, J=13.8, 6.0 Hz, 1H), 3.45 (s, 3H), 3.52 (s, 
3H), 3.78 (t, J=3.6 Hz, 1H), 3.85 (s, 3H), 4.04 (dt, J=4.2, 2.4 Hz, 1H), 5.06 (d, J=1.2 Hz, 
1H), 5.21 (s, 1H), 7.03 (dd, J=8.4, 2.4 Hz, 1H), 7.13 (d, J=8.4 Hz, 1H), 7.42 (d, J=3.0 Hz, 
1H); 13C NMR δ 16.6, 18.9, 31.9, 40.5, 52.0, 52.1, 55.0, 55.8, 60.8, 108.7, 118.1, 119.1, 
131.0, 132.8, 143.9, 148.2, 158.9, 162.6, 163.1; IR (neat) 1220, 1528, 1692 cm-1; [α]25D= 
−20.2 (c=1.0, CH2Cl2); HRMS (ESI) calcd for C19H26N3O5 (M+H+) 376.1873, found 
376.1867. 
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                   238                                      242                                           243 
 
(2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(5-methoxy-2-nitrophenyl)-2-propen-1-yl)-
5-(1-methylethyl)pyrazine (243).  Reaction of 3-iodo-4-nitro-1-methoxybenzene (242) 
(240 mg, 0.861 mmol) with 238 (400 mg, 1.03 mmol) in the presence of Pd(dba)2 (25 
mg, 0.043 mmol), PPh3 (45 mg, 0.17 mmol), and CuI (123 mg, 0.646 mmol) in DMF (10 
mL), as described for 239 (43 h), gave after extraction and chromatography 
(hexanes/EtOAc, 95:5) 243 (224 mg, 0.597 mmol, 69%) as a yellow oil.  1H NMR δ 0.63 
(d, J=6.6 Hz, 3H), 0.98 (d, J=6.6 Hz, 3H), 2.18 (dsept, J=6.6, 3.0 Hz, 1H), 2.86 (dd, 
J=14.4, 6.0 Hz, 1H), 2.94 (dd, J=14.4, 6.0 Hz, 1H), 3.45 (s, 3H), 3.52 (s, 3H), 3.79 (t, 
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J=3.6 Hz, 1H), 3.86 (s, 3H), 4.06 (dt, J=4.2, 1.8 Hz, 1H), 5.09 (d, J=1.8 Hz, 1H), 5.23 (d, 
J=1.8 Hz, 1H), 6.65 (d, J=3.0 Hz, 1H), 6.84 (dd, J=9.6, 3.0 Hz, 1H), 8.02 (d, J=9.6 Hz, 
1H); 13C NMR δ 16.5, 18.8, 31.7, 40.3, 51.9, 52.0, 55.0, 55.7, 60.8, 112.9, 116.7, 117.5, 
126.8, 140.6, 141.6, 145.2, 162.5, 162.7, 163.0; IR (neat) 1230, 1336, 1513, 1693 cm-1; 
[α]25D= − 17.5 (c=1.2, CH2Cl2); HRMS (ESI) calcd for C19H26N3O5 (M+H+) 376.1873, 
found 376.1867.   
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                   238                                     244                                            245 
 
(2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(4-fluoro-2-nitrophenyl)-2-propen-1-yl)-5-
(1-methylethyl)pyrazine (245).  Reaction of 4-fluoro-1-iodo-2-nitrobenzene (244) (230 
mg, 0.861 mmol) with 238 (400 mg, 1.03 mmol) in the presence of Pd(PPh3)2Cl2 (30 mg, 
0.043 mmol), PPh3 (23 mg, 0.86 mmol), and CuI (123 mg, 0.646 mmol) in DMF (10 
mL), as described for 239 (72 h), gave after extraction and chromatography (hexanes: 
EtOAc, 95:5) 245 (191 mg, 0.526 mmol, 61%) as a yellow oil. 1H NMR δ 0.62 (d, J=6.6 
Hz, 3H), 0.98 (d, J=6.6 Hz, 3H), 2.17 (dsept, J=6.6, 3.0 Hz, 1H), 2.81 (dd, J=14.4, 6.0 
Hz, 1H), 2.91 (dd, J=14.4, 6.0 Hz, 1H), 3.44 (s, 3H), 3.52 (s, 3H), 3.79 (t, J=4.2 Hz, 1H), 
4.04 (dt, J=4.2, 2.4 Hz, 1H), 5.09 (d, J=1.8 Hz, 1H), 5.27 (d, J=1.8 Hz, 1H), 7.21 (d, 
J=2.4 Hz, 1H), 7.23 (d, J=1.8 Hz, 1H), 7.64 (ddd, J=8.4, 1.8, 0.6 Hz, 1H); 13C NMR δ 
16.6, 18.9, 31.9, 40.4, 52.0, 52.1, 55.0, 60.9, 111.6 (d, J=26.3 Hz), 119.0, 119.8 (d, 
J=20.7 Hz), 133.5 (d, J=7.1 Hz), 134.8 (d, J=3.9 Hz), 143.3, 148.0 (d, J=7.8 Hz), 161.0 
(d, J=249.3 Hz), 162.5, 163.3; IR (neat) 808, 1219, 1234, 1245, 1347, 1550, 1692 cm-1; 
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[α]25D= − 26.5 (c=1.4, CH2Cl2); HRMS (ESI) calcd for C18H23FN3O4 (M+H+) 364.1673, 
found 364.1667. 
 
N
N OMe
MeO
Me3Sn I
NO2
+
N
N OMe
MeONO2MeO2C
MeO2C
 
                    238                                  246                                                 247 
  
Methyl 4-(1-((2R,5S)-2,5-dihydro-5-(1-methylethyl)-3,6-dimethoxypyrazin-2-
yl)prop-2-en-1-yl)-3-nitrobenzoate (247).  Reaction of methyl 4-iodo-3-nitrobenzoate 
(246) (263 mg, 0.861 mmol) with 238 (400 mg, 1.03 mmol) in the presence of Pd(dba)2 
(25 mg, 0.043 mmol), PPh3 (45 mg, 0.17 mmol), and CuI (123 mg, 0.646 mmol) in DMF 
(10 mL), as described for 239 (72 h), gave after extraction and chromatography 
(hexanes/EtOAc, 97:3) 247 (215 mg, 0.533 mmol, 62%) as a yellow oil.  1H NMR δ 0.62 
(d, J=6.6 Hz, 3H), 0.97 (d, J=6.6 Hz, 3H), 2.16 (dsept, J=6.6, 3.0 Hz, 1H), 2.85 (dd, 
J=13.8, 6.0 Hz, 1H), 2.95 (dd, J=13.8, 6.0 Hz, 1H), 3.38 (s, 3H), 3.51 (s, 3H), 3.79 (t, 
J=3.6 Hz, 1H), 3.96 (s, 3H), 4.06 (dt, J=4.2, 2.4 Hz, 1H), 5.17 (s, 1H), 5.34 (s, 1H), 7.33 
(d, J=7.8 Hz, 1H), 8.13 (d, J=7.8 Hz, 1H), 8.54 (s, 1H); 13C NMR δ 16.6, 18.9, 31.9, 
40.2, 52.0, 52.1, 52.6, 55.0, 60.9, 119.6, 125.2, 130.0, 132.2, 133.0, 142.9, 143.5, 147.9, 
162.4, 163.4, 164.9; IR (neat) 1113, 1240, 1283, 1532, 1692, 1729 cm-1; [α]25D= − 8.1 
(c=1.0, CH2Cl2); HRMS (ESI) calcd for C20H26N3O6 (M+H+) 404.1822, found 404.1816. 
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                  238                                    248                                                  249 
 
(2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(2,4-dinitrophenyl)-2-propen-1-yl)-5-(1-
methylethyl)pyrazine (249).  Reaction of 1-bromo-2,4-dinitrobenzene (248) (213 mg, 
0.861 mmol) with 238 (400 mg, 1.03 mmol) in the presence of Pd(dba)2 (25 mg, 0.043 
mmol), PPh3 (45 mg, 0.17 mmol), and CuI (123 mg, 0.646 mmol) in DMF (10 mL), as 
described for 239 (72 h), gave after extraction and chromatography (hexanes/EtOAc, 
95:5) 249 (276 mg, 0.707 mmol, 82%) as a yellow oil.  1H NMR δ 0.62 (d, J=7.2 Hz, 
3H), 0.98 (d, J=7.2 Hz, 3H), 2.16 (dsept, J=6.6, 3.0 Hz, 1H), 2.84 (dd, J=14.4, 6.0 Hz, 
1H), 2.98 (dd, J=14.4, 6.0 Hz, 1H), 3.39 (s, 3H), 3.54 (s, 3H), 3.80 (t, J=4.2 Hz, 1H), 
4.05 (dt, J=4.2, 2.4 Hz, 1H), 5.21 (s, 1H), 5.41 (s, 1H), 7.48 (d, J=8.4 Hz, 1H), 8.34 (dd, 
J=8.4 Hz, 2.4, 1H), 8.75 (d, J=2.4 Hz, 1H); 13C NMR δ 16.6, 18.9, 32.0, 40.3, 52.1, 52.2, 
55.0, 61.0, 119.6, 120.6, 126.5, 133.2, 142.7, 144.9, 146.7, 147.8, 162.3, 163.7; IR (neat) 
1237, 1350, 1529, 1691 cm-1; [α]25D= − 4.3 (c=1.1, CH2Cl2); HRMS (ESI) calcd for 
C18H23N4O6 (M+H+) 391.1618, found 391.1612. 
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                       238                               250                                            251 
 
(2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(3-nitropyridin-2-yl)prop-2-en-1-yl)-5-(1-
methylethyl)pyrazine (251).  Reaction of 2-chloro-3-nitropyridine (250) (136 mg, 0.861 
mmol) with 238 (400 mg, 1.03 mmol) in the presence of Pd(dba)2 (25 mg, 0.043 mmol), 
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PPh3 (45 mg, 0.17 mmol), and CuI (123 mg, 0.646 mmol) in DMF (10 mL), as described 
for 239 (24 h), gave after extraction and chromatography (EtOAc) 251 (180 mg, 0.520 
mmol, 60%) as an orange oil.  1H NMR δ 0.63(d, J=7.2 Hz, 3H), 0.99 (d, J=7.2 Hz, 3H), 
2.16 (dsept, J=6.6, 3.0 Hz, 1H), 2.97 (dd, J=13.8, 6.0 Hz, 1H), 3.17 (dd, J=13.8, 6.0 Hz, 
1H), 3.23 (s, 3H), 3.58 (s, 3H), 3.92 (t, J=3.6 Hz, 1H), 4.19 (dt, J=4.2, 2.4 Hz, 1H), 5.37 
(s, 1H), 5.45 (s, 1H), 7.32 (dd, J=8.4, 4.8 Hz, 1H), 8.06 (d, J=8.4 Hz, 1H), 8.73 (dd, 
J=4.8, 1.2 Hz, 1H); 13C NMR δ 16.7, 18.9, 31.8, 39.3, 51.6, 52.1, 55.5, 60.9, 121.3, 
121.9, 131.7, 142.7, 145.3, 151.6, 155.0, 162.2, 163.7; IR (neat) 732, 785, 1225, 1354, 
1527, 1683 cm-1; [α]25D= + 4.84 (c=1.0, CH2Cl2); HRMS (ESI) calcd for C17H23N4O4 
(M+H+) 347.1719, found 347.1714. 
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                   238                             260                                                 254 
 
Bis-2,3-((2R,5S)-2,5-dihydro-3,6-dimethoxy-5-methylethyl-2-pyrazinylmethyl)-1,4-
butadiene (254).  To a solution of 238 (370 mg, 0.956 mmol) in DMF (10 mL) was 
added 1-iodo-3-methoxy-2-nitrobenzene (260) (133 mg, 0.478 mmol), Pd(dba)2 (14 mg, 
0.024 mmol), PPh3 (25 mg, 0.096 mmol) and CuI (68 mg, 0.36 mmol). The reaction was 
stirred at ambient temperature for 48 h. Et2O (30 mL) was added and the organic phase 
was washed with NH4OH (10%, aq., 3 x 30 mL), H2O (30 mL), and brine (30 mL). The 
organic phase was dried (MgSO4), filtered, and the solvent was removed under reduced 
pressure. The resulting oil was purified by chromatography (hexanes/EtOAc, 95:5) to 
afford 254 (47 mg, 0.10 mmol, 22%) as a yellow oil. 1H NMR δ 0.65 (d, J=6.6 Hz, 6H), 
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1.02 (d, J=6.6 Hz, 6H), 2.23 (dsept, J=7.2, 3.6 Hz, 2H), 2.46 (dd, J=13.8, 7.2 Hz, 2H), 
2.93 (dd, J=13.8, 4.2 Hz, 2H), 3.62 (s, 6H), 3.66 (s, 6H), 3.83 (t, J=3.6 Hz, 2H), 4.15 
(pent, J=3.6 Hz, 2H), 4.85 (s, 2H), 5.13 (d, J=1.8 Hz, 2H); 13C NMR δ 16.5, 19.1, 31.4, 
39.0, 52.0, 52.2, 55.3, 60.6, 115.1, 145.1, 163.0, 163.2; IR (neat) 1011, 1194, 1232, 1693 
cm-1; [a]25D= -50.8 (c=1.2, CH2Cl2); HRMS (ESI) calcd for C24H39N4O4 (M+H+) 
447.2971, found 447.2966. 
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                                             260                                   261 
 
(3-Methoxy-2-nitrophenyl)trimethylstannane (261).  To a solution of 1-iodo-3-
methoxy-2-nitrobenzene (260) (1.57 g, 5.63 mmol) in toluene (25 mL) was added 
hexamethylditin (2.03 g, 6.19 mmol), Pd(PPh3)2Cl2 (39 mg, 0.056 mmol), and PPh3 (30 
mg, 0.11 mmol).  The reaction mixture was heated at 80 oC and stirred for 4 days.  It was 
then diluted with EtOAc (50 mL) and washed with 10% aqueous NH4OH (3 x 50 mL), 
H2O (50 mL), and brine (50 mL).  The organic phase was dried (MgSO4), filtered, and 
the solvents were removed under reduced pressure.  The resulting oil was purified by 
chromatography (hexanes) to afford 261 (1.02 g, 3.23 mmol, 57%) as a yellow oil.  1H 
NMR δ 0.33 (s, 9H), 3.92 (s, 3H), 7.03 (dd, J=8.4, 1.2 Hz, 1H), 7.11 (dd, J=7.2, 1.2 Hz, 
1H), 7.43-7.47 (m, 1H); 13C NMR δ -8.3, 56.3, 113.4, 127.8, 132.4, 139.9, 146.2, 152.4; 
IR (neat) 775, 1269, 1519 cm-1. 
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                      198                               255                                         256 
(2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(2-methoxy-6-nitrophenyl)prop-2-en-1-yl)-
5-(1-methylethyl)pyrazine (256).  Reaction of (6-methoxy-2-
nitrophenyl)trimethylstannane 255 (470 mg, 1.49 mmol) with 198 (225 mg, 0.744 mmol) 
in the presence of Pd(dba)2 (21 mg, 0.037 mmol), PPh3 (39 mg, 0.15 mmol), and CuI 
(106 mg, 0.558 mmol) in DMF (10 mL), as described for 239 (36 h), gave after extraction 
and chromatography (hexanes/EtOAc, 95:5) 256 (151 mg, 0.402 mmol, 54%) as a yellow 
oil.  1H NMR δ 0.68 (d, J=6.6 Hz, 3H), 0.99 (d, J=6.6 Hz, 3H), 2.17 (dsept, J=6.6, 3.0 
Hz, 1H), 2.81 (br s, 1H), 2.97 (d, J=12.0 Hz, 1H), 3.38 (s, 3H), 3.57 (s, 3H), 3.82 (s, 3H), 
3.90 (t, J=3.6 Hz, 1H), 4.17 (t, J=3.6 Hz, 1H), 5.05 (s, 1H), 5.43 (d, J=1.2, 1H), 7.02 (dd, 
J=7.8, 0.6 Hz, 1H), 7.28 (t, J=7.8 Hz, 1H), 7.33 (dd, J=7.8, 0.6 Hz, 1H); 13C NMR δ 16.9, 
18.9, 32.1, 40.6, 52.1, 52.2, 55.0, 56.2, 61.0, 114.0, 115.5, 119.2, 127.2, 127.9, 138.2, 
150.1, 157.4, 163.1, 163.2; IR (neat) 799, 1055, 1230, 1527, 1693 cm-1; [α]25D= -27.2 
(c=1.0, CH2Cl2); HRMS (ESI) calcd for C19H26N3O5 (M+H+) 376.1873, found 376.1867. 
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              198                                261                                                 262 
 
(2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(3-methoxy-2-nitrophenyl)prop-2-en-1-yl)-
5-(1-methylethyl)pyrazine (262).  Reaction of 261 (142 mg, 0.449 mmol) with 198 (113 
mg, 0.374 mmol) in the presence of Pd(dba)2 (11 mg, 0.019 mmol), PPh3 (20 mg, 0.075 
mmol), and CuI (53 mg, 0.28 mmol) in DMF (10 mL), as described for 239 (72 h), gave 
after extraction and chromatography (hexanes/EtOAc, 95:5) 262 (99 mg, 0.26 mmol, 
70%) as a yellow oil.  1H NMR δ 0.65 (d, J=7.2 Hz, 3H), 1.00 (d, J=6.6 Hz, 3H), 2.19 
(dsept, J=7.2, 3.6 Hz, 1H), 2.71 (dd, J=14.4, 7.2 Hz, 1H), 2.94 (dd, J=13.2, 3.6 Hz, 1H), 
3.46 (s, 3H), 3.58 (s, 3H), 3.87 (s, 3H), 3.92 (t, J=3.6 Hz, 1H), 4.08 (dt, J=4.2, 3.6 Hz, 
1H), 5.17 (d, J=1.2 Hz, 1H), 5.24 (d, J=0.6 Hz, 1H), 6.90 (t, J=7.8 Hz, 2H), 7.32 (t, J=7.8 
Hz, 1H); 13C NMR δ 16.7, 18.9, 31.9, 40.7, 52.0, 52.1, 54.8, 56.4, 60.9, 110.9, 119.9, 
121.5, 130.2, 136.8, 140.3, 141.0, 150.6, 162.7, 163.3; IR (neat) 1055, 1250, 1532, 1693 
cm-1; [α]25D= 3.72 (c=1.0, CH2Cl2); HRMS (ESI) calcd for C19H26N3O5 (M+H+) 
376.1873, found 376.1867. 
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                         172                             274                                        275 
 
(2R,5S)-2-(3-Bromo-3-buten-1-yl)-2,5-dihydro-3,6-dimethoxy-5-
methylethylpyrazine (275). BuLi (1.91 mL, 4.77 mmol, 2.5 M in hexane) was added to 
a -78 oC cold solution of (S)-2,5-dihydro-3,6-dimethoxy-2-methylethylpyrazine (172) 
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(800 mg, 4.34 mmol) and N,N'-dimethylethylene urea (0.99 g, 8.7 mmol) in dry THF (40 
mL) under a nitrogen atmosphere.  After 1 h, a solution of 2-bromo-4-iodo-1-butene 
(274) (1.36 g, 5.21 mmol) in dry THF (10 mL) was added over 30 min. The reaction 
mixture was allowed to warm to ambient temperature overnight. The reaction was 
quenched with a 0.1 M phosphate buffer (30 mL) and extracted with Et2O (3 x 30 mL). 
The combined organic phases were dried (MgSO4), filtered, and the solvents were 
removed under reduced pressure. The resulting oil was purified by chromatography 
(hexane/EtOAc 9:1) to afford 275 (419 mg, 1.32 mmol, 31%) as a pale yellow oil. 1H 
NMR δ 0.70 (d, J=7.2 Hz, 3H), 1.04 (d, J=6.6 Hz, 3H), 1.86-1.92 (m, 1H), 2.19-2.17 (m, 
1H), 2.25 (dsept, J=7.2, 3.6 Hz, 1H), 2.42-2.52 (m, 2H), 3.69 (s, 3H), 3.71 (s, 3H), 3.94 
(t, J=3.0 Hz, 1H), 4.02 (dt, J=7.2, 4.2 Hz, 1H), 5.39 (d, J=1.8 Hz, 1H), 5.57 (d, J=1.8 Hz, 
1H); 13C NMR δ 16.7, 19.0, 31.9, 32.6, 37.1, 52.4, 52.5, 54.3, 60.9, 116.5, 134.3, 163.4, 
163.8; IR (neat) 1194, 1234, 1690 cm-1; [α]25D= -2.3 (c=1.2, CH2Cl2);  HRMS (ESI) 
calcd for C13H22BrN2O2 (M+H+) 317.0865, found 317.0859. 
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(2R,5S)-2-(3-Bromo-2-propen-1-yl)-2,5-dihydro-3,6-dimethoxy-5-
methylethylpyrazine (279).  BuLi (2.71 mL, 5.97 mmol, 2.2 M in cyclohexane) was 
added dropwise to a -78 oC cold solution of (S)-2,5-dihydro-3,6-dimethoxy-2-
methylethylpyrazine (172) (1.00 g, 5.43 mmol) in dry THF (15 mL) under a nitrogen 
atmosphere.  After stirring for 30 min, a solution of 1,3-dibromo-1-propene (278) (1.41 g, 
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7.06 mmol, 1:1 E/Z-mixture) in THF (5 mL) was slowly added. After stirring for 90 min, 
the reaction was quenched with water (30 mL) and the mixture was extracted with Et2O 
(3 x 30 mL). The combined organic phases were dried (MgSO4), filtered, and the solvents 
were removed under reduced pressure. The resulting oil was purified by chromatography 
(hexane/EtOAc 95:5) to afford 279 (1.25 g, 4.12 mmol, 76%) as a yellow oil.  Spectral 
data from a 1:1 mixture of Z:E-279: 1H NMR δ 0.68 (d, J=6.6 Hz, 3H), 0.69 (d, J=6.6 
Hz, 3H), 1.04 (d, J=7.2 Hz, 6H), 2.25 (dsept, J=6.6, 3.0 Hz, 2H), 2.46-2.50 (m, 1H), 
2.53-2.57 (m, 1H), 2.62 (dpent, J=6.6, 1.2 Hz, 1H), 2.75-2.79 (m, 1H), 3.68 (s, 3H), 3.67 
(s, 3H), 3.70 (s, 3H), 3.71 (s, 3H), 3.93-3.95 (m, 2H), 4.04-4.07 (m, 1H), 4.12-4.14 (m, 
1H), 6.05-6.09 (m, 3H), 6.22-6.24 (m, 1H); 13C NMR δ 16.6, 19.0, 31.8, 34.8, 37.4, 52.4, 
52.5, 54.5, 54.8, 60.9, 106.7, 109.7, 130.7, 133.4, 162.5, 163.0, 164.1, 164.3 (6 peaks 
overlap); IR (neat) 1010, 1235, 1691 cm-1; [α]25D= -14.4 (c=1.4, CH2Cl2);  HRMS (ESI) 
calcd for C12H20BrN2O2 (M+H+) 303.0708, found 303.0703. 
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                 275                                208                                                276 
 
(2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(3-(2-nitrophenyl)-3-buten-1-yl)-5-(1-
methylethyl)pyrazine (276).  Reaction of tributyl(2-nitrophenyl)stannane 208 (721 mg, 
1.75 mmol) with 275 (370 mg, 1.17 mmol) in the presence of Pd(dba)2 (34 mg, 0.058 
mmol), PPh3 (61 mg, 0.23 mmol), and CuI (167 mg, 0.877 mmol) in DMF (10 mL), as 
described for 239 (18 h), gave after extraction and chromatography (hexanes/EtOAc, 
95:5) 276 (308 mg, 0.857 mmol, 73%) as a yellow oil.  1H NMR δ 0.68 (d, J=6.6 Hz, 
3H), 1.03 (d, J=7.2 Hz, 3H), 1.78-1.84 (m, 1H), 1.96-2.02 (m, 1H), 2.24 (dsept, J=6.6, 
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3.6 Hz, 1H), 2.30-2.39 (m, 2H), 3.65 (s, 3H), 3.67 (s, 3H), 3.92 (t, J=3.6 Hz, 1H), 4.02 
(dt, J=4.2, 3.6 Hz, 1H), 4.99 (s, 1H), 5.19 (d, J=1.2 Hz, 1H), 7.30 (d, J=7.8 Hz, 1H), 7.40 
(t, J=8.4Hz, 1H), 7.53 (t, J=7.2 Hz, 1H), 7.85 (d, J=7.8 Hz, 1H); 13C NMR δ 16.6, 19.0, 
31.8, 31.9, 32.6, 52.3, 52.4, 54.8, 60.8, 114.4, 124.0, 127.9, 131.0, 132.4, 138.5, 146.9, 
148.4, 163.5, 163.7; IR (neat) 1194, 1235, 1525, 1690 cm-1; [α]25D= 4.80 (c=1.0, 
CH2Cl2); HRMS (ESI) calcd for C19H26N3O4 (M+H+) 360.1923, found 360.1918. 
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(2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-((2-nitrophenyl)-2-propen-1-yl))-5-(1-
methylethyl)pyrazine (E/Z) (280).  Reaction of 208 (1.02 g, 2.47 mmol) with 279 (500 
mg, 1.65 mmol) in the presence of Pd(dba)2 (47 mg, 0.083 mmol), PPh3 (86 mg, 0.33 
mmol), and CuI (236 mg, 1.24 mmol) in DMF (10 mL), as described for 239 (48 h), gave 
after extraction and chromatography (hexanes/EtOAc, 9:1) 280 (444 mg, 1.29 mmol, 
78%) as a yellow oil. Spectral data from the E/Z-mixture: 1H NMR (Z-isomer) δ 0.68 (d, 
J=7.2 Hz, 3H), 1.03 (d, J=7.2 Hz, 3H), 2.25 (dsept, J=7.2, 3.6 Hz, 1H), 2.56 (dddd, 
J=15.0, 7.2, 6.0, 1.8 Hz, 1H,), 2.66-2.79 (m, 1H, overlapped by 2H of E-isomer), 3.63 (s, 
3H), 3.65 (s, 3H), 3.97 (t, J=3.6 Hz, 1H), 4.08 (dt, J=4.2, 1.8 Hz, 1H), 5.74 (dt, J=7.8, 4.2 
Hz, 1H), 6.80 (d, J=12.0 Hz, 1H), 7.40 (dt, J=8.4, 1.8, 1H), 7.49-7.52 (m, 1H, overlapped 
by 2H of E-isomer), 7.56 (dt, J=7.8, 1.2 Hz, 1H), 8.01 (dd, J=6.6, 1.2 Hz, 1H).  1H NMR 
(E-isomer) δ 0.69 (d, J=7.2 Hz, 3H), 1.03 (d, J=6.6 Hz, 3H), 2.25 (dsept, J=7.2, 3.6 Hz, 
1H), 2.66-2.79 (m, 2H, overlapped by 1H of Z-isomer), 3.71 (s, 3H), 3.73 (s, 3H), 3.91 (t, 
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J=3.6 Hz, 1H), 4.18 (dt, J=3.6, 1.8 Hz, 1H), 6.08 (dt, J=7.8, 7.2 Hz, 1H), 6.89 (d, J=15.6 
Hz, 1H), 7.33 (ddd, J=8.4, 6.0, 3.0 Hz, 1H), 7.49-7.52 (m, 2H, overlapped by 1H of 1H 
of Z-isomer), 7.86 (d, J=8.4 Hz, 1H); 13C NMR (both isomers) δ 16.5, 16.6, 19.0, 31.8, 
32.8, 37.9, 52.3, 52.4, 52.4, 52.5, 55.0, 55.3, 60.8, 60.9, 124.3, 124.4, 127.6, 127.6, 127.7, 
128.1, 128.6, 129.6, 131.6, 132.0, 132.6, 132.8, 132.8, 133.1, 147.7, 148.1, 162.8, 162.9, 
164.0, 164.2; IR (neat) 738, 1236, 1522, 1691 cm-1; [α]25D= -7.68 (c=1.0, CH2Cl2); 
HRMS (ESI) calcd for C18H24N3O4 (M+H+) 346.1767, found 346.1761. 
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3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)pyrazin-2-yl)methyl)-1H-
indole (263).  239 (140 mg, 0.405 mmol), Pd(dba)2 (14 mg, 0.024 mmol), 1,3-bis-
(diphenylphosphino)propane (dppp) (10 mg, 0.024 mmol), and 1,10-phenanthroline 
(phen) (10 mg, 0.048 mmol) were dissolved in anhydrous DMF (3 mL) in a threaded 
ACE glass pressure tube.  The tube was fitted with a pressure head, and the solution was 
saturated with carbon monoxide (four cycles of 6 atm of CO).  The reaction mixture was 
heated at 120 oC (oil bath temperature) under CO (6 atm) for 18 hours.  Water (10 mL) 
was added and the orange solution was extracted with EtOAc (3 x 30 mL).  The 
combined organic phases were dried (MgSO4), filtered, and the solvent was removed 
under reduced pressure.  The resulting crude product was purified by chromatography 
(hexanes/EtOAc, 8:2 then 1:1) to afford 263 (2R,5S/2S,5S=15:1, 108 mg, 0.345 mmol, 
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85%) as a yellow solid.  mp 99-102 oC; 1H NMR δ 0.62 (d, J=7.2 Hz, 3H), 0.93 (d, J=7.2 
Hz, 3H), 2.14 (dsept, J=7.2, 3.6 Hz, 1H), 3.29 (t, J=3.6 2H), 3.37 (t, J=3.6 Hz, 1H), 3.66 
(s, 3H), 3.68 (s, 3H), 4.36 (q, J=3.6 Hz, 1H), 6.89 (d, J=1.8 Hz, 1H), 7.07 (t, J=7.2 Hz, 
1H), 7.13 (t, J=7.2 Hz, 1H), 7.26 (d, J=7.2, 1H), 7.64 (d, J=7.2 Hz, 1H), 8.03 (br s, 1H); 
13C NMR δ  16.5, 19.0, 29.5, 31.3, 52.1, 52.2, 56.7, 60.4, 110.7, 111.6, 118.9, 119.4, 
121.6, 122.7, 128.4, 135.8, 163.0, 163.7; IR (neat) 725, 1010, 1222, 1236, 1660, 1697 
cm-1; [α]25D= -54.8 (c=1.3, CH2Cl2); HRMS (ESI) calcd for C18H24N3O2 (M+H+) 
314.1869, found 314.1863. Partial data for the minor isomer: 1H NMR δ 0.12 (d, J=6.7 
Hz, 3H), 0.84 (d, J=6.7 Hz, 3H), 3.71 (s, 3H). 
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3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-pyrazin-2-yl)methyl)-6-
methoxy-1H-indole (264).  Reaction of 241 (112 mg, 0.298 mmol) in the presence of 
Pd(dba)2 (10 mg, 0.018 mmol), dppp (7.0 mg, 0.018 mmol), phen (7.0 mg, 0.036 mmol), 
and CO (6 atm) in DMF (3 mL), as described for 263 (26 h), gave after chromatography 
(hexanes/EtOAc, 8:2 then 6:4) 264 (2R,5S/2S,5S=12:1, 71 mg, 0.21 mmol, 70%) as a 
yellow solid.  mp 111-114 oC; 1H NMR δ 0.61 (d, J=6.6 Hz, 3H), 0.92 (d, J=7.2 Hz, 3H), 
2.13 (dsept, J=6.6, 3.0 Hz, 1H), 3.24 (d, J=4.8 Hz, 2H), 3.36 (t, J=3.0 Hz, 1H), 3.65 (s, 
3H), 3.67 (s, 3H), 3.82 (s, 3H), 4.33 (q, J=4.2 Hz, 1H), 6.74 (dd, J=8.4, 1.8 Hz, 1H), 6.76 
(d, J=1.8 Hz, 1H), 6.78 (d, J=1.8 Hz, 1H), 7.49 (d, J=9.0 Hz, 1H), 7.88 (br s, 1H); 13C 
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NMR δ 16.5, 19.0, 29.6, 31.3, 52.1, 52.2, 55.6, 56.8, 60.4, 94.2, 109.0, 111.6, 120.0, 
121.4, 122.9, 136.4, 156.2, 163.0, 163.7; IR (neat) 780, 1027, 1157, 1224, 1693 cm-1; 
[α]25D= -44.6 (c=1.2, CH2Cl2); HRMS (ESI) calcd for C19H26N3O3 (M+H+) 344.1974, 
found 344.1969. Partial data of minor isomer: 1H NMR δ 0.15 (d, J=7.2 Hz, 3H), 0.85 (d, 
J=7.2 Hz, 3H), 3.65 (s, 3H), 3.70 (s, 3H); 13C NMR δ 30.0, 30.9, 52.0, 52.1, 57.2, 60.7, 
108.9, 120.2, 121.6, 122.9. 
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3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-pyrazin-2-yl)methyl)-5-
methoxy-1H-indole (265).  Reaction of 243 (145 mg, 0.386 mmol) in the presence of 
Pd(dba)2 (13 mg, 0.023 mmol), dppp (10 mg, 0.023 mmol), phen (9.0 mg, 0.046 mmol), 
and CO (6 atm) in DMF (3 mL), as described for 263 (22 h), gave after chromatography 
(hexanes/EtOAc, 8:2 then 6:4) 265 (2R,5S/2S,5S=22:1, 112 mg, 0.326 mmol, 85%) as a 
yellow oil.  1H NMR δ 0.63 (d, J=6.6 Hz, 3H), 0.94 (d, J=6.6 Hz, 3H), 2.15 (dsept, J=6.6, 
3.6 Hz, 1H), 3.26 (d, J=4.8 Hz, 2H), 3.40 (t, J=3.6 Hz, 1H), 3.67 (s, 3H), 3.70 (s, 3H), 
3.86 (s, 3H), 4.36 (q, J=4.2 Hz, 1H), 6.80 (dd, J=8.4, 1.8 Hz, 1H), 6.88 (d, J=2.4 Hz, 1H), 
7.10 (d, J=2.4 Hz, 1H), 7.15 (d, J=9.0 Hz, 1H), 7.95 (br s, 1H); 13C NMR δ 16.4, 19.0, 
29.5, 31.2, 52.2, 52.3, 55.9, 56.7, 60.4, 101.3, 111.3, 111.4, 111.9, 123.6, 128.8, 131.0, 
153.7, 163.0, 163.8; IR (neat) 794, 1012, 1232, 1435, 1692 cm-1; [α]25D= -49.5 (c=1.2, 
CH2Cl2); HRMS (ESI) calcd for C19H26N3O3 (M+H+) 344.1974, found 344.1969. Partial 
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data for the minor isomer: 1H NMR δ 0.15 (d, J=6.9 Hz, 3H), 0.85 (d, J=6.7 Hz, 3H), 
3.72 (s, 3H). 
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6-Fluoro-3-(((2R,5S)-2,5-dihydro-3,6-dimethoxy-5-(1-methylethyl)-pyrazin-2-
yl)methyl)-1H-indole (266).  Reaction of 245 (118 mg, 0.325 mmol) in the presence of 
Pd(dba)2 (11 mg, 0.019 mmol), dppp (8.0 mg, 0.019 mmol), phen (8.0 mg, 0.039 mmol), 
and CO (6 atm) in DMF (3 mL), as described for 263 (21 h), gave after chromatography 
(hexanes/EtOAc, 8:2 then 6:4) 266 (2R,5S/2S,5S=4.5:1, 90 mg, 0.27 mmol, 84%) as a 
yellow oil. Spectral data of 2R,5S-266 from the mixture: 1H NMR δ 0.62 (d, J=6.6 Hz, 
3H), 0.93 (d, J=6.6 Hz, 3H), 2.13 (dsept, J=6.6, 3.6 Hz, 1H), 3.25 (d, J=4.2 Hz, 2H), 3.37 
(t, J=3.6 Hz, 1H), 3.65 (s, 3H), 3.67 (s, 3H), 4.34 (q, J=4.2 Hz, 1H), 6.83 (dt, J=9.6, 1.8 
Hz, 1H), 6.86 (d, J=1.8 Hz, 1H), 6.93 (dd, J=9.0, 1.8 Hz, 1H), 7.53 (dd, J=8.4, 5.4 Hz, 
1H), 8.03 (br s, 1H); 13C NMR δ16.5, 19.0, 29.5, 31.3, 52.1, 52.2, 56.7, 60.4, 97.0 (d, 
J=25.6 Hz), 107.7 (d, J=24.6 Hz), 111.8, 120.1 (d, J=6.3 Hz), 122.9 (d, J=3.9 Hz), 125.0, 
135.6 (d, J=12.0 Hz), 159.8 (d, J=235.6 Hz), 162.9, 163.8; IR (neat) 799, 1012, 1140, 
1194, 1220, 1692 cm-1; [α]25D= -41.8 (c=0.9, CH2Cl2); HRMS (ESI) calcd for 
C18H23FN3O2 (M+H+) 332.1774, found 332.1769. Partial data for the minor 2S,5S-266 
isomer: 1H NMR δ 0.10 (d, J=6.6 Hz, 3H), 0.84 (d, J=6.6 Hz, 3H), 1.82 (dsept, J=7.2, 3.6 
Hz, 1H), 3.64 (s, 3H), 3.70 (s, 3H); 13C NMR δ 16.2, 19.4, 29.8, 31.1, 52.0, 52.2, 57.0, 
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60.7, 96.9 (d, J=25.6 Hz), 107.7 (d, J=24.6 Hz), 112.6, 120.3 (d, J=6.3 Hz), 123.1 (d, 
J=4.0 Hz), 125.1, 135.7 (d, J=12.0 Hz), 159.9 (d, J=235.6 Hz), 162.4, 163.2. 
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Methyl 3-(((2R,5S)-2,5-dihydro-3,6-dimethoxy-5-(1-methylethyl)-pyrazin-2-
yl)methyl)-1H-indole-6-carboxylate (267).  Reaction of 247 (87 mg, 0.22 mmol) in the 
presence of Pd(dba)2 (7.0 mg, 0.013 mmol), dppp (5.0 mg, 0.013 mmol), phen (5.0 mg, 
0.026 mmol), and CO (6 atm) in DMF (3 mL), as described for 263 (23 h), gave after 
chromatography (hexanes/EtOAc, 8:2 then 6:4) 267 (2R,5S/2S/5S=10:1, 60 mg, 0.16 
mmol, 73%) as a tan solid.  mp 119–121 oC; 1H NMR δ 0.61 (d, J=6.6 Hz, 3H), 0.91 (d, 
J=7.2 Hz, 3H), 2.12 (dsept, J=7.2, 3.0 Hz Hz, 1H), 3.29 (d, J=4.2 Hz, 2H), 3.34 (t, J=3.6 
Hz, 1H), 3.64 (s, 3H), 3.67 (s, 3H), 3.92 (s, 3H), 4.35 (q, J=4.8 Hz, 1H), 7.08 (d, J=2.4 
Hz, 1H), 7.66 (d, J=8.4 Hz, 1H), 7.76 (dd, J=8.4, 1.2 Hz, 1H), 8.05 (s, 1H), 8.57 (br s, 
1H); 13C NMR δ 16.4, 18.9, 29.4, 31.4, 51.8, 52.2, 52.3, 56.6, 60.4, 112.1, 113.3, 119.0, 
120.0, 123.3, 126.3, 132.0, 135.1, 162.8, 163.8, 168.3; IR (neat) 769, 1086, 1196, 1237, 
1276, 1697, 1710 cm-1; [α]25D= -43.1 (c=1.2, CH2Cl2); HRMS (ESI) calcd for 
C20H26N3O4 (M+H+) 372.1923, found 372.1918. 
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3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-pyrazin-2-yl)methyl)-6-
nitro-1H-indole (268).  Reaction of 249 (165 mg, 0.423 mmol) in the presence of 
Pd(dba)2 (15 mg, 0.025 mmol), dppp (11 mg, 0.025 mmol), phen (10 mg, 0.051 mmol), 
and CO (6 atm) in DMF (3 mL), as described for 263 (18 h), gave after chromatography 
(hexanes/EtOAc, 8:2 then 6:4) 268 (18 mg, 0.050 mmol, 12%) as a yellow oil.  1H NMR 
δ 0.62 (d, J=7.2 Hz, 3H), 0.92 (d, J=6.6 Hz, 3H), 2.13 (dsept, J=6.6, 3.6 Hz, 1H), 3.30 (d, 
J=4.8 Hz, 2H), 3.39 (t, J=3.6 Hz, 1H), 3.65 (s, 3H), 3.68 (s, 3H), 4.35 (q, J=4.2 Hz, 1H), 
7.23 (d, J=1.8 Hz, 1H), 7.70 (d, J=9.0 Hz, 1H), 7.98 (dd, J=8.4, 1.8 Hz, 1H), 8.28 (d, 
J=1.8 Hz, 1H), 8.50 (br s, 1H); 13C NMR δ 16.5, 18.9, 29.2, 31.5, 52.2, 52.3, 56.4, 60.6, 
107.9, 113.2, 114.7, 119.5, 128.7, 133.1, 134.1, 143.2, 162.6, 164.0; IR (neat) 735, 1011, 
1220, 1309, 1504, 1692 cm-1; [α]25D= -36.6 (c=1.3, CH2Cl2); HRMS (ESI) calcd for 
C18H23N4O4 (M+H+) 359.1719, found 359.1714. Partial data for minor isomer: 1H NMR 
δ 0.02 (d, J=6.6 Hz, 3H), 0.81 (d, J=7.2 Hz, 3H), 3.66 (s, 3H), 3.70 (s, 3H), 3.93 (s, 3H), 
7.14 (d, J=1.8 Hz, 1H), 8.03 (s, 1H), 8.50 (br s, 1H). 
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                                    251                                                             269 
 
3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-pyrazin-2-yl)methyl)-1H-
pyrrolo[3,2-b]pyridine (269).  Reaction of 251 (140 mg, 0.404 mmol) in the presence of 
Pd(dba)2 (14 mg, 0.024 mmol), dppp (10 mg, 0.024 mmol), phen (10 mg, 0.049 mmol), 
and CO (6 atm) in DMF (3 mL), as described for 263 (18 h), gave after chromatography 
(hexanes/EtOAc, 8:2 then EtOAc) 269 (2R,5S/2S,5S=11:1, 100 mg, 0.318 mmol, 79%) 
as a tan solid.  mp 148-151 oC; 1H NMR δ 0.64 (d, J=7.2 Hz, 3H), 0.96 (d, J=6.6 Hz, 
3H), 2.18 (dsept, J=6.6, 3.0 Hz, 1H), 3.27 (dd, J=14.4, 6.6 Hz, 1H), 3.53 (m, 2H), 3.63 (s, 
3H), 3.66 (s, 3H), 4.40 (dt, J=3.6, 3.0 Hz, 1H), 7.05 (dd, J=8.4, 4.8 Hz, 1H), 7.28 (d, 
J=1.8 Hz, 1H), 7.60 (dd, J=8.4, 1.2 Hz, 1H), 8.46 (dd, J=4.2, 1.2 Hz, 1H), 8.84 (br s, 1H); 
13C NMR δ 16.6, 19.0, 28.4, 31.5, 52.2, 52.3, 56.4, 60.6, 112.7, 116.5, 118.0, 126.4, 
128.6, 142.6, 145.9, 163.5, 163.6; IR (neat) 765, 1012, 1220, 1695 cm-1; [α]25D= -23.2 
(c=1.1, CH2Cl2); HRMS (ESI) calcd for C17H23N4O2 (M+H+) 315.1821, found 315.1816. 
Partial data for the minor isomer: 1H NMR δ 0.38 (d, J=7.2 Hz, 3H), 0.94 (d, J=7.2 Hz, 
3H), 3.64 (s, 3H), 3.69 (s, 3H). 
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                                          256                                                      270 
 
3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-pyrazin-2-yl)methyl)-4-
methoxy-1H-indole (270).  Reaction of 256 (123 mg, 0.327 mmol) in the presence of 
Pd(dba)2 (11 mg, 0.020 mmol), dppp (8 mg, 0.02 mmol), phen (8 mg, 0.04 mmol), and 
CO (6 atm) in DMF (3 mL), as described for 263 (23 h), gave after chromatography 
(hexanes/EtOAc, 8:2 then 1:1) 270 (99 mg, 0.29 mmol, 88%) as a yellow oil.  1H NMR δ 
0.66 (d, J=7.2 Hz, 3H), 1.00 (d, J=6.6 Hz, 3H), 2.21 (dsept, J=7.2, 3.6 Hz, 1H), 3.18 
(ddd, J=14.4, 7.2, 0.6 Hz, 1H), 3.59 (s, 3H), 3.61 (dd, J=4.2, 0.6 Hz, 1H), 3.63 (t, J=3.6 
Hz, 1H), 3.69 (s, 3H), 3.91 (s, 3H), 4.36 (pent, J=3.6 Hz, 1H), 6.45 (d, J=7.8 Hz, 1H), 
6.83 (d, J=1.8 Hz, 1H), 6.91 (dd, J=7.8, 0.6 Hz, 1H), 7.04 (t, J=8.4 Hz, 1H), 7.98 (br s, 
1H); 13C NMR δ 16.5, 19.1, 31.3, 31.4, 52.2, 52.3, 55.0, 57.1, 60.4, 99.3, 104.3, 112.6, 
118.0, 121.4, 122.4, 137.6, 155.0, 163.5, 164.2; IR (neat) 701, 1086, 1236, 1690 cm-1; 
[α]25D= -22.3 (c=1.0, CH2Cl2); HRMS (ESI) calcd for C19H26N3O3 (M+H+) 344.1974, 
found 344.1969. 
 
 
 161
               
N
N OMe
MeO
NO2 N
N
N
OMe
MeO
H
MeO
OMe  
 
                                      262                                                            271  
  
3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-pyrazin-2-yl)methyl)-7-
methoxy-1H-indole (271).  Reaction of 262 (107 mg, 0.285 mmol) in the presence of 
Pd(dba)2 (10 mg, 0.017 mmol), dppp (7 mg, 0.02 mmol), phen (7 mg, 0.03 mmol), and 
CO (6 atm) in DMF (3 mL), as described for 263 (22 h), gave after chromatography 
(hexanes/EtOAc, 8:2) 271 (2R,5S/2S,5S=6:1, 46.0 mg, 0.134 mmol, 47%) as a yellow 
oil.  1H NMR δ 0.62 (d, J=6.6 Hz, 3H), 0.93 (d, J=7.2 Hz, 3H), 2.13 (dsept, J=6.6, 3.0 
Hz, 1H), 3.26 (d, J=4.8 Hz, 2H), 3.37 (t, J=3.6 Hz, 1H), 3.66 (s, 3H), 3.68 (s, 3H), 3.93 
(s, 3H), 4.35 (q, J=4.2 Hz, 1H), 6.59 (d, J=7.2 Hz, 1H), 6.88 (d, J=2.4 Hz, 1H), 6.98 (t, 
J=7.8 Hz, 1H), 7.24 (d, J=8.4 Hz, 1H), 8.18 (br s, 1H); 13C NMR δ 16.7, 19.2, 29.9, 31.5, 
52.3, 52.5, 55.4, 55.5, 56.9, 60.6, 101.7, 112.5, 119.5, 122.5, 126.5, 130.0, 146.1, 163.2, 
163.9; IR (neat) 729, 1013, 1048, 1225, 1259, 1693 cm-1; [α]25D= -25.2 (c=1.1, CH2Cl2); 
HRMS (ESI) calcd for C19H26N3O3 (M+H+) 344.1974, found 344.1969. 
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                                        276                                                               277 
 
3-(2-((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-pyrazin-2-yl)ethyl)-1H-
indole (277). Reaction of 276 (138 mg, 0.384 mmol) in the presence of Pd(dba)2 (13 mg, 
0.023 mmol), dppp (9.0 mg, 0.02 mmol), phen (9.0 mg, 0.05 mmol), and CO (6 atm) in 
DMF (3 mL), as described for 263 (19 h), gave after chromatography (hexanes/EtOAc, 
9:1) 277 (2R,5S/2S,5S=16:1, 90.0 mg, 0.275 mmol, 72%) as a yellow oil. 1H NMR δ 
0.74 (d, J=6.6 Hz, 3H), 1.08 (d, J=7.2 Hz, 3H), 2.10-2.16 (m, 1H), 2.24-2.33 (m, 2H), 
2.72-2.84 (m, 2H), 3.70 (s, 3H), 3.75 (s, 3H), 4.01 (t, J=3.6 Hz, 1H), 4.14 (dt, J=4.8, 3.6 
Hz, 1H), 6.98 (d, J=1.8 Hz, 1H), 7.12 (dt, J=7.8, 0.6 Hz, 1H), 7.19 (dt, J=7.2, 1.2 Hz, 
1H), 7.34 (d, J=7.8 Hz, 1H), 7.64 (d, J=7.8 Hz, 1H), 7.95 (br s, 1H); 13C NMR δ 16.7, 
19.0, 20.2, 31.8, 34.5, 52.3, 52.4, 55.1, 60.9, 111.0, 116.3, 119.0, 119.1, 121.1, 121.8, 
127.6, 136.4, 163.6, 163.9; IR (neat) 701, 1086, 1236, 1690 cm-1; [α]25D= -2.74 (c=0.8, 
CH2Cl2); HRMS (ESI) calcd for C19H26N3O2 (M+H+) 328.2025, found 328.2020. Partial 
data for minor isomer: 1H NMR δ 0.79 (d, J=6.6 Hz, 3H), 1.10 (d, J=7.2 Hz, 3H), 3.71 (s, 
3H), 3.76 (s, 3H), 7.02 (d, J=1.8 Hz, 1H). 
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             280                                                        281                                           282 
 
2-((2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-pyrazin-2-yl)methyl)-1H-indole 
(281) and 2-(((2R,5S)-2,5-dihydro-3,6-dimethoxy-5-(1-methylethyl)-pyrazin-2-
yl)methyl)-1-hydroxyindole (282).  Reaction of 280 (217 mg, 0.628 mmol) in the 
presence of Pd(dba)2 (22 mg, 0.038 mmol), dppp (16 mg, 0.038 mmol), phen (15 mg, 
0.075 mmol), and CO (6 atm) in DMF (3 mL), as described for 263 (22 h), gave after 
chromatography (hexanes/EtOAc, 95:5 then 9:1) 281 (2R,5S/2S,5S=1.2:1, 68 mg, 0.22 
mmol, 35%) and 282 (22 mg, 0.067 mmol, 11%) both as a yellow oil.  Spectral data for 
281 from the isomer mixture: 1H NMR (minor) δ 0.58 (d, J=7.2 Hz, 3H), 1.05 (d, J=6.6 
Hz, 3H), 2.23 (dsept, J=6.6, 3.0 Hz, 1H), 2.91 (ddd, J=14.4, 9.6, 0.6 Hz, 1H), 3.49 (dd, 
J=14.4, 3.0 Hz, 1H), 3.76 (s, 3H), 3.83 (s, 3H), 4.00 (dd, J=4.8, 3.6, 1H), 4.30 (ddd, 
J=9.6, 4.8, 1.8 Hz, 1H), 6.28 (d, J=9.6 Hz, 1H), 7.06 (t, J=7.8 Hz, 1H), 7.12 (d, J=7.2 Hz, 
1H), 7.29 (d, J=7.8 Hz, 1H), 7.55 (s, 1H); 1H NMR (major) δ 0.73 (d, J=7.2 Hz, 3H), 
1.03 (d, J=6.6 Hz, 3H), 2.23 (dsept, J=6.6, 3.0 Hz, 1H), 3.03 (ddd, J=14.4, 9.6, 0.6 Hz, 
1H), 3.44 (dd, J=14.4, 3.0 Hz, 1H), 3.77 (s, 3H), 3.82 (s, 3H), 3.91 (t, J=3.6 Hz, 1H), 
4.24 (dt, J=3.0, 1.8 Hz, 1H), 6.28 (d, J=9.6 Hz, 1H), 7.06 (t, J=7.8 Hz, 1H), 7.12 (d, 
J=7.2 Hz, 1H), 7.29 (d, J=7.8 Hz, 1H), 7.54 (s, 1H); 13C NMR δ 16.7, 16.9, 19.0, 19.4, 
31.0, 32.1, 32.8, 33.6, 52.4, 52.5, 52.6, 52.7, 55.9, 56.1, 60.7, 61.1, 100.7, 100.9, 110.4, 
110.5, 119.3, 119.4, 119.8, 119.9, 120.9, 121.0, 128.3, 128.4, 135.9, 137.0, 137.1, 161.9, 
162.5, 164.1, 164.7; IR (neat) 732, 1229, 1243, 1688 cm-1; [α]25D=0.35 (c=1.0, CH2Cl2); 
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HRMS (ESI) calcd for C18H24N3O2 (M+H+) 314.1869, found 314.1863. Spectral data for 
282: 1H NMR δ 0.77 (d, J=7.2 Hz, 3H), 0.99 (d, J=6.6 Hz, 3H), 2.14 (dsept, J=6.6, 3.0 
Hz, 1H), 3.24 (dd, J=14.4, 8.4 Hz, 1H), 3.65 (dd, J=15.0, 3.6 Hz, 1H), 3.81 (s, 3H), 3.82 
(s, 3H), 4.01 (t, J=3.6 Hz, 1H), 4.15 (dt, J=3.0, 1.8 Hz, 1H), 6.18 (s, 1H), 7.03 (t, J=7.8 
Hz, 1H), 7.17 (t, J=7.2 Hz, 1H), 7.45 (d, J=8.4 Hz, 1H), 7.52 (d, J=7.8 Hz, 1H), 11.71 (br 
s, 1H); 13C NMR δ 17.6, 19.0, 29.5, 32.9, 53.3, 53.6, 57.8, 62.4, 94.9, 108.1, 118.8, 
120.0, 121.0, 123.1, 132.4, 133.8, 162.2, 168.5; IR (neat) 1008, 1227, 1250, 1670 cm-1; 
[α]25D= -8.50 (c=1.2, CH2Cl2); HRMS (ESI) calcd for C18H24N3O3 (M+H+) 330.1818, 
found 330.1812. 
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8.2 Supporting Information Chapter 4: 2- and/or 3-Substituted Indoles 
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                                                 284                                     286 
 
2-Pentyl-1H-indole (286).  Triethyl((E)-1-(2-nitrophenyl)hept-1-enyl)silane (284) (326 
mg, 0.977 mmol), Pd(dba)2 (34 mg, 0.059 mmol), 1,3-bis-(diphenylphosphino)propane 
(dppp) (24 mg, 0.059 mmol), and 1,10-phenanthroline (phen) (23 mg, 0.117 mmol) were 
dissolved in anhydrous DMF (3 mL) in a threaded ACE glass pressure tube.  The tube 
was fitted with a pressure head, and the solution was saturated with carbon monoxide 
(four cycles of 6 atm of CO).  The reaction mixture was heated at 120oC (oil bath 
temperature) under CO (6 atm) for 20 hours.  Water (20 mL) was added and the orange 
solution was extracted with ethyl acetate (3 x 30 mL).  The combined organic phases 
were dried (MgSO4), filtered, and the solvent was removed under reduced pressure.  The 
resulting crude product was purified by chromatography (hexanes: EtOAc, 95:5) to afford 
286 (136 mg, 0.726 mmol, 75%) as a yellow solid.  All data in accordance with 
previously reported literature values.137 
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                                               289                                       290 
Triethyl((E)-1-(2-nitrophenyl)hex-1-enyl)silane (290).  In a round bottom flask, PtO2 
(45 mg, 0.199 mmol) and 1-(hex-1-ynyl)-2-nitrobenzene 289 (405 mg, 1.99 mmol) were 
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placed under nitrogen atmosphere.  Triethylsilane (462 mg, 3.98 mmol) was introduced 
via syringe and the mixture was stirred at 60oC in an oil bath for 3 hours in the absence of 
solvent.  The residue was then purified directly by flash chromatography (Hexanes: 
EtOAc, 98:2) to give 290 (549 mg, 1.72 mmol, 87%) as a yellow oil.  1H NMR δ 0.53-
0.61 (m, 6H), 0.80 (t, J=7.8 Hz, 3H), 0.89 (t, J=7.8 Hz, 9H), 1.18-1.31 (m, 4H), 1.80-1.85 
(m, 2H), 5.96 (t, J=7.2 Hz, 1H), 7.02 (d, J=7.8 Hz, 1H), 7.32 (t, J=7.8 Hz, 1H), 7.50 (t, 
J=7.2 Hz, 1H), 7.92 (d, J=8.4 Hz, 1H); 13C NMR δ  3.5, 7.2, 13.9, 22.3, 30.5, 31.2, 124.2, 
126.3, 130.5, 132.4, 137.4, 138.9, 143.4, 148.1;  IR (neat) 704, 1039, 1523, 2878, 2954 
cm-1; HRMS (ESI) calcd for C18H29NNaO2Si (M+Na+) 342.1860, found 342.1863. 
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                                               290                                      291 
 
2-Butyl-1H-indole (291).    Reaction of 290 (299 mg, 0.936 mmol) in the presence of 
Pd(dba)2 (32 mg, 0.056 mmol), dppp (23 mg, 0.056 mmol), phen (22 mg, 0.112 mmol), 
and CO (6 atm) in DMF (3 mL), as described for 286 (20 h), gave, after chromatography 
(hexanes:EtOAc, 95:5), 291 (115 mg, 0.664 mmol, 71%) as a yellow solid.  All data in 
accordance with previously reported literature values.140 
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                                                 294                                   122 
 
2-Phenyl-1H-indole (122).  Reaction of 294 (258 mg, 0.760 mmol) in the presence of 
Pd(OAc)2 (10 mg, 0.046 mmol), dppp (19 mg, 0.046 mmol), phen (18 mg, 0.092 mmol), 
and CO (6 atm) in DMF (3 mL), as described for 286 (24 h), gave, after chromatography 
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(hexanes:EtOAc, 95:5), 122 (106 mg, 0.549 mmol, 72%) as a white solid.  All data in 
accordance with previously reported literature values.141 
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                                226                        297                                         298 
1,2-Bis(2-nitrophenyl)ethyne (298).  In a round bottom flask, PdCl2(PPh3)2 (26 mg, 
0.037 mmol) and CuI (7 mg, 0.037 mmol) were suspended in NEt3 (20 mL) under a 
nitrogen atmosphere.  1-Iodo-2-nitrobenzene 226 (184 mg, 0.741 mmol) and 1-ethynyl-2-
nitrobenzene 297 (182 mg, 1.23 mmol) were added in that order and the reaction mixture 
was stirred at ambient temperature for 6 h.  The solvent was removed in vacuo and the 
residue was then purified directly by flash chromatography (Hexanes: EtOAc, 8:2) to 
give 298 (160 mg, 0.596 mmol, 81%) as a brown solid.  mp 175-177 oC; 1H NMR δ 7.54 
(dt, J=7.5, 1.3 Hz, 2H), 7.66 (dt, J=7.6, 1.3 Hz, 2H), 7.83 (dd, J=7.8, 1.2 Hz, 2H), 8.14 
(dd, J=8.3, 1.0 Hz, 2H); 13C NMR δ 91.9, 118.0, 124.8, 129.5, 133.1, 135.2, 149.5; IR 
(neat) 739, 1284, 1335, 1514 cm-1; HRMS (ESI) calcd for C14H8N2NaO4 (M+Na+) 
291.0376, found 291.0377. 
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                                                  293                                    303     
                                 
Tributyl((E)-1-(2-nitrophenyl)-2-phenylvinyl)stannane (303).  Tributyltin hydride 
(2.93 g, 10.08 mmol) was added dropwise at ambient temperature to a solution of 
PdCl2(PPh3)2 (472 mg, 0.672 mmol) and 1-(2-(2-nitrophenyl)ethynyl)benzene 293 (1.50 
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g, 6.72 mmol) in THF (20 mL).  The dark brown reaction mixture was stirred for an 
additional 3 hr and then concentrated in vacuo.  Purification by flash chromatography 
(hexanes) gave 303 (2.93 g, 5.70 mmol, 85%) as an orange oil.   1H NMR δ 0.86 (t, J=7.2 
Hz, 9H), 0.90-0.97 (m, 6H), 1.27 (sext, J=7.2 Hz, 6H), 1.42-1.50 (m, 6H), 6.68 (s, 1H), 
6.88 (d, J=8.4 Hz, 1H), 7.02 (d, J=7.8 Hz, 1H), 7.06-7.09 (m, 3H), 7.28 (t, J=7.8 Hz, 1H), 
7.44 (t, J=7.2 Hz, 1H), 8.10 (d, J=8.4 Hz, 1H); 13C NMR δ  10.9, 13.6, 27.3, 28.8, 124.8, 
126.0, 126.9, 128.1, 128.6, 129.2, 133.8, 137.0, 137.2, 142.8, 146.0, 147.5; IR (neat) 
1017, 1314, 1536, 2901, 2975 cm-1; HRMS (ESI) calcd for C26H38NO2Sn (M+H+) 
516.1919, found 516.1919. 
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                              305                   303                                         306 
 
1-Methoxy-4-((Z)-1-(2-nitrophenyl)-2-phenylvinyl)benzene (306).  To a solution of 
303 (1.50 g, 2.92 mmol) in DMF (10 mL) was added 1-iodo-4-methoxybenzene (305) 
(569 mg, 2.43 mmol), PdCl(PPh3)2 (85 mg, 0.121 mmol) and PPh3 (63 mg, 0.242 mmol). 
CuI (347 mg, 1.82 mmol) was added in one portion and the reaction mixture was stirred 
at ambient temperature for 22 h.  The mixture was diluted with Et2O (50 mL), washed 
with 10% aqueous NH4OH (3 x 50 mL), H2O (50 mL), and brine (50 mL).  The organic 
phase was dried (MgSO4), filtered, and the solvents were removed under reduced 
pressure.  The resulting oil was purified by chromatography (hexanes/EtOAc, 98:2) to 
afford 306 (503 mg, 1.52 mmol, 62%) as an orange oil.  1H NMR δ 3.78 (s, 3H), 6.62 (s, 
1H), 6.74-6.75 (m, 2H), 7.07-7.09 (m, 2H), 7.12-7.18 (m, 5H), 7.42-7.46 (m, 2H), 7.55 
(dt, J=7.8, 1.8 Hz, 1H), 7.78 (dd, J=8.4 Hz, 1.2 Hz, 1H); 13C NMR δ 55.1, 113.6, 124.1, 
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127.1, 128.0, 128.1, 129.3, 129.7, 130.5, 131.4, 132.09, 132.14, 136.8, 138.3, 139.2, 
149.6, 159.1; IR (neat) 693, 1247, 1509, 1523 cm-1; HRMS (ESI) calcd for C21H18NO3 
(M+H+) 332.1281, found 332.1282. 
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                                          306                                             307      
                                 
3-(4-Methoxyphenyl)-2-phenyl-1H-indole (307).  Reaction of 306 (77 mg, 0.232 mmol) 
in the presence of Pd(OAc)2 (3 mg, 0.014 mmol), dppp (6 mg, 0.014 mmol), phen (6 mg, 
0.028 mmol), and CO (6 atm) in DMF (3 mL), as described for 286 (24 h), gave, after 
chromatography (hexanes:EtOAc, 95:5), 307 (45 mg, 0.150 mmol, 65%) as a pale yellow 
solid.  All data in accordance with previously reported literature values.144 
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                                               289                                      308       
                                
Tributyl((E)-1-(2-nitrophenyl)hex-1-enyl)stannane (308).  Tributyltin hydride (4.23g, 
14.56 mmol) was added dropwise at ambient temperature to a solution of PdCl2(PPh3)2 
(102 mg, 0.145 mmol) and 1-(hex-1-ynyl)-2-nitrobenzene 289 (1.48g, 7.28 mmol) in 
THF (10 mL).  The dark brown reaction mixture was stirred for an additional 1 hr and 
then concentrated in vacuo.  Purification by flash chromatography (hexanes) gave 308 
(2.44g, 4.94 mmol, 68%) as a yellow oil.   1H NMR δ 0.79-0.91 (m, 18H), 1.19-1.46 (m, 
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16H), 1.82-1.84 (m, 2H), 5.73 (t, J=6.6 Hz, 1H), 7.02 (d, J=7.8 Hz, 1H), 7.26 (t, J=7.2 
Hz, 1H), 7.48 (t, J=7.8 Hz, 1H), 7.94 (d, J=8.4 Hz, 1H); 13C NMR δ  10.6, 13.6, 13.9, 
22.2, 27.3, 28.8, 30.6, 31.5, 124.3, 125.6, 129.8, 132.6, 141.2, 141.6, 142.4, 146.6;  IR 
(neat) 1340, 1520, 2923, 2955 cm-1; HRMS (ESI) calcd for C24H42NO2Sn (M+H+) 
496.2232, found 496.2232. 
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                                                  297                                 311  
                                   
Tributyl(1-(2-nitrophenyl)vinyl)stannane (311).  Tributyltin hydride (2.74 g, 9.43 
mmol) was added dropwise at ambient temperature to a solution of PdCl2(PPh3)2 (220 
mg, 0.314 mmol) and 1-ethynyl-2-nitrobenzene (297) (925 mg, 6.28 mmol) in THF (20 
mL).  The dark brown reaction mixture was stirred for an additional 24 h and then 
concentrated in vacuo.  Purification by flash chromatography (hexanes) gave 311 (1.61 g, 
3.67 mmol, 59%) as a green oil.  1H NMR δ 0.86 (t, J=7.2 Hz, 9H), 0.91-0.94 (m, 6H), 
1.26 (sext, J=7.8 Hz, 6H), 1.43-1.48 (m, 6H), 5.45 (d, J=2.4 Hz, 1H), 5.74 (d, J=3.0 Hz, 
1H), 7.11 (dd, J=7.8, 1.2 Hz, 1H), 7.31 (dt, J=7.2, 1.2 Hz, 1H), 7.52 (dt, J=7.8, 1.2 Hz, 
1H), 7.99 (dd, J=8.4, 1.2 Hz, 1H); 13C NMR δ  10.9, 13.6, 27.3, 28.8, 124.3, 126.0, 126.3, 
129.7, 133.2, 144.3, 146.0, 154.6; IR (neat) 1038, 1339, 1518, 2922 cm-1; HRMS (ESI) 
calcd for C20H34NO2Sn (M+H+) 440.1606, found 440.1607. 
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                                             311                                               312         
                              
2,3-Bis(2-nitrophenyl)buta-1,3-diene (312).  To a solution of 311 (348 mg, 0.794 
mmol) in DMF (10 mL) was added PdCl2(PPh3)2 (28 mg, 0.040 mmol), PPh3 (21 mg, 
0.080 mmol) and CuI (113 mg, 0.595 mmol). The reaction was stirred at ambient 
temperature for 36 h. Et2O (30 mL) was added and the organic phase was washed with 
NH4OH (10%, aq., 3 x 30 mL), H2O (30 mL), and brine (30 mL). The organic phase was 
dried (MgSO4), filtered, and the solvent was removed under reduced pressure. The 
resulting solid was purified by chromatography (hexanes/EtOAc, 95:5) to afford 312 (78 
mg, 0.263 mmol, 67%) as a dark yellow solid.  mp 122-124 oC; 1H NMR δ 4.92 (s, 2H), 
5.15 (s, 2H), 7.52 (dt, J=7.2, 1.2 Hz, 2H), 7.61 (dd, J=7.8, 1.2 Hz, 2H), 7.66 (dt, J=7.8, 
1.2 Hz, 2H), 7.98 (dd, J=8.4, 1.2 Hz, 2H); 13C NMR δ 118.3, 124.0, 128.7, 132.4, 132.9, 
135.3, 145.2, 149.0; IR (neat) 697, 749, 790, 911, 1332, 1514 cm-1; HRMS (ESI) calcd 
for C16H12N2NaO4 (M+Na+) 319.0689, found 319.0690.  
                                 
NO2
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                                               312                                                  313  
                                  
3-(1H-Indol-3-yl)-1H-indole (313).  Reaction of 312 (68 mg, 0.229 mmol) in the 
presence of Pd(OAc)2 (3 mg, 0.014 mmol), dppp (6 mg, 0.014 mmol), phen (6 mg, 0.028 
mmol), and CO (6 atm) in DMF (3 mL), as described for 286 (39 h), gave, after 
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chromatography (hexanes:EtOAc, 8:2), 313 (36 mg, 0.155 mmol, 68%) as a white solid.  
All data in accordance with previously reported literature values.147   
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          311                       305                                 314                                      312  
                                                                             
1-(1-(4-Methoxyphenyl)vinyl)-2-nitrobenzene (314).  To a solution of 311 (755 mg, 
1.72 mmol) in DMF (8 mL) was added 1-iodo-4-methoxybenzene (305) (336 mg, 1.44 
mmol), PdCl(PPh3)2 (50 mg, 0.072 mmol) and PPh3 (38 mg, 0.144 mmol). CuI (206 mg, 
1.08 mmol) was added in one portion and the reaction mixture was stirred at ambient 
temperature for 30 h.  The mixture was diluted with Et2O (30 mL), washed with 10% 
aqueous NH4OH (3 x 30 mL), H2O (30 mL), and brine (30 mL).  The organic phase was 
dried (MgSO4), filtered, and the solvents were removed under reduced pressure.  The 
resulting solid was purified by chromatography (hexanes/EtOAc, 99:1) to afford an 
inseparable 3:1 mixture of 314 (112 mg, 0.438 mmol, 31%) and 312 (43 mg, 0.146 
mmol, 17%), respectively, as a yellow solid.  Data for 314: 1H NMR δ 3.78 (s, 3H), 5.20 
(s, 1H), 5.64 (s, 1H), 6.80-6.82 (m, 2H), 7.15-7.18 (m, 2H), 7.44 (dd, J=7.8, 1.8 Hz, 1H), 
7.48 (dt, J=7.8, 0.6 Hz, 1H), 7.60-7.62 (m, 1H), 7.90 (dd, J=7.8, 0.6 Hz, 1H); 13C NMR δ 
113.7, 124.2, 127.7. 128.5, 131.8, 132.3, 132.7, 137.2, 145.8, 149.0, 159.6 (1 resonance 
not found); HRMS (ESI) calcd for C15H14NO3 (M+H+) 256.0968, found 256.0969. 
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           314                                     312                                     315                        313    
                                                                                                               
3-(4-Methoxyphenyl)-1H-indole (315).  Reaction of a 3:1 mixture of 314 (50 mg, 0.198 
mmol) and 312 (20 mg, 0.066 mmol), respectively, in the presence of Pd(OAc)2 (4 mg, 
0.014 mmol), dppp (6 mg, 0.014 mmol), phen (6 mg, 0.028 mmol), and CO (6 atm) in 
DMF (3 mL), as described for 286 (24 h), gave, after chromatography (hexanes:EtOAc, 
9:1), 315 (27 mg, 0.121 mmol, 61%) as a light blue solid and 313 (12 mg, 0.052 mmol, 
75%) as a white solid.  All data for 315 in accordance with previously reported literature 
values.148   
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                        226                           311                                       316      
                  
1,1-Bis(2-nitrophenyl)ethene (316).  To a solution of 226 (473 mg, 1.90 mmol) in DMF 
(10 mL) was added tributyl(1-(2-nitrophenyl)vinyl)stannane 311 (1.00 g, 2.28 mmol), 
PdCl2(PPh3)2 (67 mg, 0.095 mmol), PPh3 (50 mg, 0.190 mmol) and CuI (271 mg, 1.43 
mmol). The reaction was stirred at ambient temperature for 24 h. Et2O (30 mL) was 
added and the organic phase was washed with NH4OH (10%, aq., 3 x 30 mL), H2O (30 
mL), and brine (30 mL). The organic phase was dried (MgSO4), filtered, and the solvent 
was removed under reduced pressure. The resulting solid was purified by 
chromatography (hexanes/EtOAc, 9:1) to afford 316 (320 mg, 1.18 mmol, 62%) as a 
white solid.  mp 132-134 oC; 1H NMR δ 5.62 (s, 2H), 7.43-7.46 (m, 2H), 7.58-7.59 (m, 
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4H), 7.71 (dt, J=7.8, 0.6 Hz, 2H); 13C NMR δ 121.3, 123.9, 129.1, 132.4, 133.1, 133.9, 
142.4, 148.7; IR (neat) 716, 774, 1351, 1516 cm-1; HRMS (ESI) calcd for C14H10N2NaO4 
(M+Na+) 293.0533, found 293.0534. 
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                          316                                            317                                     318      
                  
Indolo[2,3-b]indole (317) and 5H-Indolo[2,3-c]quinolin-6(7H)-one (318).  Reaction of 
316 (174 mg, 0.644 mmol) in the presence of Pd(OAc)2 (9 mg, 0.039 mmol), dppp (16 
mg, 0.039 mmol), phen (15 mg, 0.077 mmol), and CO (6 atm) in DMF (3 mL), as 
described for 286 (60 h), gave, after chromatography (hexanes:EtOAc, 4:6), 317 (56 mg, 
0.272 mmol, 42%) as a dark yellow solid and 318 (36 mg, 0.154 mmol, 24%) as a tan 
solid.  Data for 317 - mp 340-343 oC; 1H NMR (DMSO-d6) δ 7.05 (dt, J=8.4, 1.8 Hz, 
2H), 7.10 (dt, J=7.2, 0.6 Hz, 2H), 7.40 (d, J=7.8 Hz, 2H), 7.79 (d, J=7.2 Hz, 2H), 11.34 
(br s, 2H); 13C NMR δ 99.8, 111.4, 117.4, 118.9, 119.2, 121.9, 138.6, 144.6; IR (neat) 
696, 736, 1450, 3363, 3413 cm-1; HRMS (ESI) calcd for C14H11N2 (M+H+) 207.0917, 
found 207.0917.  Data for 318 - mp 312-314 oC; 1H NMR (DMSO-d6) δ 7.32 (t, J=7.2 
Hz, 1H), 7.34 (t, J=7.2 Hz, 1H), 7.41 (t, J=7.2 Hz, 1H), 7.47 (t, J=7.8 Hz, 1H), 7.51 (d, 
J=8.4 Hz, 1H), 7.65 (d, J=7.8 Hz, 1H), 8.44 (d, J=7.2 Hz, 1H), 8.47 (d, J=7.8 Hz, 1H), 
11.85 (br s, 1H), 12.34 (br s, 1H); 13C NMR δ 113.0, 116.1, 118.0, 118.2, 120.7, 122.2, 
122.30, 122.31, 123.0, 125.6, 125.9, 127.6, 134.9, 138.8, 155.7; IR (neat) 729, 1328, 
1620, 1648, 3158, 3316 cm-1; HRMS (ESI) calcd for C15H11N2O (M+H+) 235.0866, 
found 235.0867. 
 175
8.3 Supporting Information Chapter 5: Dilemmaones A-C 
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                                    338                        340                                       347 
 
6-Amino-7-bromo-2,3-dihydro-5-methylinden-1-one (347).  2,3,5,6-tetrabromo-4-
methyl-4-nitrocyclohexa-2,5-dienone 340 (2.13g, 4.55 mmol) was added to a stirred 
solution of 338 (733 mg, 4.55 mmol) in AcOH (5mL).  The resulting solution was 
maintained for 4 hours at ambient temperature and then poured into a 10% NaHCO3 (aq) 
solution (15 mL).  The suspension was extracted with CH2Cl2 (3 x 30 mL) and the combi 
ned organics were washed with H2O (2 x 30 mL), dried over MgSO4, filtered, and 
concentrated in vacuo.  The resulting residue was purified by flash chromatography 
(Hexanes:EtOAc 8:2) to afford 347 (640 mg, 2.66 mmol, 59%) as a brown solid.  Mp 
177-179 oC; 1H NMR δ 2.30 (s, 3H), 2.67-2.72 (m, 2H), 2.93-2.97 (m, 2H), 4.26 (br s, 
2H), 7.11 (s, 1H); 13C NMR δ 19.2, 23.8, 37.4, 103.6, 126.7, 131.2, 132.5, 142.4, 147.4, 
204.2; IR (neat) 871, 1318, 1469, 1621, 1688, 3352, 3378 cm-1; HRMS (ESI) calcd for 
C10H11BrNO (M+H+) 240.0024, found 240.0018.               
 
                                  
O
H2N
OH
N
O  
                                                338                                       348 
                                     
N-(2,3-Dihydro-5-methyl-1-oxo-1H-inden-6-yl)acetamide (348).  To a stirring solution 
of 338 (4.62 g, 28.66 mmol) in 100 mL of CH2Cl2 was added NEt3 (3.19 g, 31.52 mmol) 
at ambient temperature and the solution was allowed to stir for 15 min.  Acetyl chloride 
(2.70 g, 34.39 mmol) was then added dropwise and the reaction mixture was stirred for 
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22 h at ambient temperature.  The crude mixture was washed with water (2 x 100 mL) 
and brine (1 x 100 mL), dried over MgSO4, filtered and concentrated in vacuo.  The 
residue was purified by flash chromatography (EtOAc) to give 348 (4.86 g, 23.91 mmol, 
84%) as a tan solid. Mp 221-223 oC; 1H NMR δ 2.21 (s, 3H), 2.34 (s, 3H), 2.66-2.68 (m, 
2H), 3.05-3.07 (m, 2H), 7.14 (br s, 1H), 7.31 (s, 1H), 7.95 (s, 1H); 13C NMR δ 18.9, 24.0, 
25.3, 36.6, 119.2, 128.4, 135.2, 136.0, 138.8, 152.4, 168.5, 206.0; IR (neat) 864, 1527, 
1656, 1691, 3310 cm-1; HRMS (ESI) calcd for C12H14NO2 (M+H+) 204.1019, found 
204.1019. 
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                                              348                                             349 
 
N-(2,3-Dihydro-5-methyl-7-nitro-1-oxo-1H-inden-6-yl)acetamide (349).  Fuming 
nitric acid (10 mL) was stirred at -20oC for 5 min, then 25 drops of concentrated H2SO4 
was added and the resulting mixture was stirred at -20oC for 20 additional minutes.  This 
mixture was added dropwise to 348 (1.0 g, 4.92 mmol), cooled to -20oC,  and was stirred 
at the same temperature for 2 hrs before quenching with 20 mL of H2O and then 20 mL 
of a sat. NH4Cl soln (aq).  The aqueous mixture was extracted with EtOAc (3 x 50 mL) 
and washed with H2O (3 x 50 mL).  The organic phase was dried over MgSO4, filtered, 
and concentrated in vacuo.  The resulting residue was purified by flash chromatography 
(EtOAc) to afford 349 (860 mg, 3.46 mmol, 70%) as a dark yellow solid. Mp 225-227 oC; 
1H NMR δ 2.18 (s, 3H), 2.39 (s, 3H), 2.77-2.79 (m, 2H), 3.14-3.16 (m, 2H), 7.31 (br s, 
1H), 7.53 (s, 1H); 13C NMR δ 19.5, 23.2, 25.3, 36.8, 126.1, 126.7, 130.7, 142.4, 146.3, 
154.6, 168.9, 200.4; IR (neat) 782, 1536, 1673, 1718, 3347 cm-1; HRMS (ESI) calcd for 
C12H13N2O4 (M+H+) 249.0870, found 249.0871. 
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                                                  349                                          346 
 
6-Amino-2,3-dihydro-5-methyl-7-nitroinden-1-one (346).  A solution of 349 (140 mg, 
0.564 mmol) in EtOH (15 mL) was refluxed with 5N HCl (10 mL) for 18 hours.  The 
organic phase was removed in vacuo and the resulting aqueous solution was made 
alkaline (pH 8-9) with an NaOH solution (aq).  It was then extracted with CH2Cl2 (3 x 20 
mL), dried over MgSO4, filtered, and concentrated in vacuo.  The resulting residue was 
purified by flash chromatography (Hexanes:EtOAc 1:1) to afford 346 (98 mg, 0.475 
mmol, 84%) as a bright yellow solid. Mp 229-231 oC; 1H NMR δ 2.32 (s, 3H), 2.72-2.74 
(m, 2H), 2.97-2.99 (m, 2H), 5.10 (br s, 2H), 7.31 (s, 1H); 13C NMR δ 18.6, 24.6, 37.1, 
129.0, 131.2, 133.6, 139.7, 145.7, 200.6 (1 resonance not found); IR (neat) 887, 1313, 
1518, 1634, 1689, 3362, 3460 cm-1; HRMS (ESI) calcd for C10H11N2O3 (M+H+) 
207.0764, found 207.0764. 
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                                                   346                                 329 
 
2,3-Dihydro-6-iodo-5-methyl-7-nitroinden-1-one (329).  To a stirred solution of 346 
(280 mg, 1.36 mmol) in concentrated HCl (4 mL) and ice at 0oC, a solution of sodium 
nitrite (103 mg, 1.49 mmol) in H2O (3 mL) was added dropwise.  The mixture was stirred 
at 0oC for 30 min before  adding it dropwise  to a stirred solution of KI (676 mg, 4.07 
mmol) in H2O (10 mL) at ambient temperature.  The mixture remained stirring for 16 
hours at ambient temperature and was then extracted with CH2Cl2 (3 x 20 mL).  The 
combined organic extracts were washed with 10% NaOH (aq) (1 x 20 mL), 5% NaHCO3 
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(aq) (1 x 20 mL), and H2O (1 x 20 mL) before being dried over MgSO4, filtered, and 
concentrated in vacuo.  The resulting dark yellow residue was purified by flash 
chromatography (hexanes: EtOAc, 9:1 then 8:2) to afford 329 (187 mg, 0.590 mmol, 
43%) as an off-white solid.  Mp 173-175 oC; 1H NMR δ 2.60 (s, 3H), 2.73-2.75 (m, 2H), 
2.98-3.00 (m, 2H), 7.28 (s, 1H); 13C NMR δ 24.5, 31.1, 36.9, 107.4, 125.8, 131.8, 136.3, 
150.5, 156.8, 201.9; IR (neat) 871, 1149, 1432, 1694, 2923 cm-1; HRMS (ESI) calcd for 
C10H9INO3 (M+H+) 317.9627 (peak not found experimentally). 
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                                                  346                                       350 
 
6-Bromo-2,3-dihydro-5-methyl-7-nitroinden-1-one (350).  A solution of 48% aq. HBr 
(1.50 mL) dissolved in DMSO (10 mL) was added dropwise to a solution of 346 (453 
mg, 2.20 mmol) in a mixture of 10 mL of DMSO and KNO2 (748 mg, 8.79 mmol) at 
35oC with stirring.  The added mixture was stirred at 35oC for 30 min. and then 
transferred to a solution of K2CO3 (2.5 g) in 50 mL of ice water.  The reaction mixture 
was then extracted with EtOAc (3 x 30 mL) and the combined organic extracts were 
washed with H2O (2 x 30 mL) before being dried over MgSO4, filtered, and concentrated 
in vacuo.  The resulting dark orange residue was purified by flash chromatography 
(hexanes: EtOAc, 9:1) to afford 350 (33 mg, 0.122 mmol, 6%) as an off-white solid.  Mp 
159-161 oC; 1H NMR δ 2.57 (s, 3H), 2.74-2.76 (m, 2H), 2.98-3.00 (m, 2H), 7.32 (s, 1H); 
13C NMR δ 24.2, 25.9, 37.2, 122.6, 127.4, 128.7, 134.3, 146.7, 156.0, 202.3; IR (neat) 
862, 1147, 1309, 1440, 1587, 1702 cm-1; HRMS (ESI) calcd for C10H9BrNO3 (M+H+) 
269.9766 (peak not found experimentally).  
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8.4 Supporting Information Chapter 6: Fistulosin 
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                                   394                       395                                       396  
 
2-(Icos-1-ynyl)benzenamine (396).  To a solution of 2-iodobenzenamine (394) (1.00 g, 
4.57 mmol) in NEt3 (10 mL) at ambient temperature was added PdCl2 (41 mg, 0.228 
mmol) and PPh3 (120 mg, 0.457 mmol). The resultant suspension was stirred for 10 min 
followed by addition of 1-eicosyne (395) (2.12 g, 7.62 mmol) and then CuI (44 mg, 0.228 
mmol).  This mixture was then stirred for 24 h under an N2 atmosphere at ambient 
temperature, followed by removal of all volatiles under reduced pressure.  The resulting 
crude product was purified by column chromatography (hexanes: EtOAc, 95:5) to afford 
396 (1.21 g, 3.27 mmol, 72%) as a brown solid.  Mp 39-41oC; 1H NMR δ 0.88 (t, J=7.2 
Hz, 3H), 1.26-1.31 (br m, 28H), 1.45 (pent, J=7.2 Hz, 2H), 1.62 (pent, J=7.2 Hz, 2H), 
2.46 (t, J=7.2 Hz, 2H), 4.15 (br s, 2H), 6.65 (dt, J=7.2, 1.2 Hz, 1H), 6.67 (d, J=8.4 Hz, 
1H), 7.06 (dt, J=7.8, 1.2 Hz, 1H), 7.23 (dd, J=7.2, 1.2 Hz, 1H); 13C NMR δ  14.1, 19.6, 
22.7, 29.0, 29.2, 29.4, 29.5, 29.63, 29.65, 29.66, 29.69, 31.9, 95.8, 109.0, 114.1, 117.8, 
128.8, 132.0, 147.6 (several resonances overlap, 1 resonance missing); IR (neat) 719, 
753, 1467, 1607, 2847, 2915, 3371, 3390, 3467, 3490 cm-1; HRMS (ESI) calcd for 
C26H44N (M+H+) 370.3474, found 370.3475. 
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1-(Icos-1-ynyl)-2-nitrobenzene (398).  To a solution of 1-iodo-2-nitrobenzene (226) 
(2.68 g, 10.75 mmol) in NEt3 (30 mL) at ambient temperature was added Pd(PPh3)2Cl2 
(377 mg, 0.537 mmol). The resultant suspension was stirred for 10 min followed by 
addition of 1-eicosyne (395) (5.0 g, 17.95 mmol) and then CuI (102 mg, 0.537 mmol).  
This mixture was then stirred for 3 h under an N2 atmosphere at ambient temperature, 
followed by removal of all volatiles under reduced pressure.  The resulting crude product 
was purified by column chromatography (hexanes: EtOAc, 97:3) to afford 398 (4.12 g, 
10.31 mmol, 96%) as a brown solid.  Mp 39-42 oC; 1H NMR δ 0.88 (t, J=7.2 Hz, 3H), 
1.22-1.36 (br m, 28H), 1.46 (pent, J=7.2 Hz, 2H), 1.63 (pent, J=7.2 Hz, 2H), 2.47 (t, 
J=7.2 Hz, 2H), 7.38 (dt, J=7.2, 1.2 Hz, 1H), 7.51 (dt, J=7.2, 1.2 Hz, 1H), 7.57 (dd, J=7.8, 
1.2 Hz, 1H), 7.96 (dd, J=8.4, 0.6 Hz, 1H); 13C NMR δ  14.1, 19.8, 22.7, 28.3, 28.9, 29.1, 
29.3, 29.5, 29.6, 29.7, 31.9, 75.9, 99.5, 119.4, 124.3, 127.7, 132.4, 134.7, 150.1 (7 peaks 
overlap); IR (neat) 1339, 1514, 2848, 2917 cm-1; HRMS (ESI) calcd for C26H41NNaO2 
(M+Na+) 422.3035, found 422.3030. 
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Triethyl((E)-1-(2-nitrophenyl)icos-1-enyl)silane (399).  In a rb flask, PtO2 (278 mg, 
1.23 mmol) and 1-(icos-1-ynyl)-2-nitrobenzene (398) (4.90 g, 12.26 mmol) were placed 
 181
under a N2 atmosphere.  Triethylsilane (2.85 g, 24.52 mmol) was introduced via syringe 
and the mixture was stirred at 60oC in an oil bath for 3 hours in the absence of solvent.  
The resulting crude product was purified by chromatography (hexanes: EtOAc, 98:2) to 
afford 399 (5.37 g, 10.41 mmol, 85%) as a yellow oil.  1H NMR δ 0.50-0.61 (m, 6H), 
0.84-0.90 (m, 12H), 1.12-1.32 (br m, 32H), 1.74-1.85 (m, 2H), 5.95 (t, J=7.2 Hz, 1H), 
7.01(dd, J=7.8, 1.2 Hz, 1H), 7.30 (dt, J=7.8, 1.8 Hz, 1H), 7.48 (dt, J=7.8, 1.2 Hz, 1H), 
7.90 (dd, J=8.4, 1.2 Hz, 1H); 13C NMR δ  3.4, 7.2, 14.1, 22.7, 29.0, 29.1, 29.4, 29.5, 29.6, 
29.7, 30.8, 31.9, 124.2, 126.3, 130.5, 132.3, 137.3, 138.9, 143.5, 148.1 (8 peaks overlap); 
IR (neat) 705, 718, 1347, 1525, 2852, 2921 cm-1; HRMS (ESI) calcd for C32H57NNaO2Si 
(M+Na+) 538.4056, found 538.4050. 
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2-Octadecyl-1H-indole (397).   Triethyl((E)-1-(2-nitrophenyl)icos-1-enyl)silane (399) 
(2.03 g, 3.93 mmol), Pd(dba)2 (135 mg, 0.236 mmol), 1,3-bis-
(diphenylphosphino)propane (dppp) (97 mg, 0.236 mmol), and 1,10-phenanthroline 
(phen) (94 mg, 0.472 mmol) were dissolved in anhydrous DMF (8 mL) in a threaded 
ACE glass pressure tube.  The tube was fitted with a pressure head, and the solution was 
saturated with carbon monoxide (four cycles of 6 atm of CO).  The reaction mixture was 
heated at 120oC (oil bath temperature) under CO (6 atm) for 16 hours.  Water (30 mL) 
was added and the orange solution was extracted with ethyl acetate (3 x 30 mL).  The 
combined organic phases were dried (MgSO4), filtered, and the solvent was removed 
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under reduced pressure.  The resulting crude product was purified by chromatography 
(hexanes: EtOAc, 98:2) to afford 397 (1.01 g, 2.73 mmol, 70%) as a tan solid.  Mp 73-
74oC; 1H NMR δ 0.88 (t, J=7.2 Hz, 3H), 1.18-1.35 (br m, 28H), 1.36-1.42 (m, 2H), 1.71 
(pent, J=7.2 Hz, 2H), 2.74 (t, J=7.8 Hz, 2H), 6.23 (d, J=2.4 Hz, 1H), 7.06 (dt, J=7.2, 1.2 
Hz, 1H), 7.10 (dt, J=7.2, 1.2 Hz, 1H), 7.28 (d, J=7.2 Hz, 1H), 7.51 (d, J=7.2 Hz, 1H), 
7.82 (br s, 1H); 13C NMR δ  14.1, 22.7, 28.3, 29.2, 29.3, 29.4, 29.5, 29.6, 29.7, 31.9, 99.5, 
110.2, 119.6, 119.7, 120.9, 128.9, 135.8, 140.0 (8 peaks overlap); IR (neat) 746, 1456, 
1471, 2849, 2915, 3375 cm-1; HRMS (ESI) calcd for C26H44N (M+H+) 370.3474, found 
370.3470. 
N
H
C18H37 N
O
C18H37
N
O
+ N
O
NC18H37
C18H37
C18H37
H
HH
H
 
         397                                                         392                                                404 
 
2-octadecyl-2-(2-octadecyl-3-oxo-2,3-dihydro-1H-indol-2-yl)-1,2-dihydro-3H-indol-
3-one (392) and 2-octadecyl-2-(2-octadecyl-1H-indol-3-yl)indolin-3-one (404).  A 
solution of m-chloroperoxybenzoic acid (248 mg, 1.01 mmol) in dichloromethane (5 mL) 
was added dropwise at ambient temperature to a stirred solution of 2-octadecyl-1H-indole 
(397) (310 mg, 0.838 mmol) in the same solvent (2 mL). The mixture was stirred for 1 h, 
then poured into 5% NH4Cl (15 mL) and extracted with CH2Cl2 (3 x 25mL).  The 
combined organic phases were dried (MgSO4), filtered, and the solvent was removed 
under reduced pressure.  The resulting crude product was purified by chromatography 
(hexanes, then hexanes:EtOAc 98:2) to afford 392 (107 mg, 0.139 mmol, 33 %) as a 
bright yellow solid and 404 (113 mg, .150 mmol, 36%) as a dark yellow solid.  Data for 
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392 - Mp 105-107 oC; 1H NMR δ 0.88 (t, J=6.6 Hz, 6H), 0.94-1.30 (br m, 66H), 1.85-
1.90 (m, 2H), 6.02 (s, 2H), 6.78 (t, J=6.6 Hz, 2H), 6.95 (d, J=8.4 Hz, 2H), 7.48 (t, J=8.4 
Hz, 2H), 7.56 (d, J=7.8 Hz, 2H); 13C NMR δ 14.1, 22.7, 22.9, 29.31, 29.35, 29.41, 29.44, 
29.54, 29.62, 29.64, 29.66, 29.67, 29.68, 29.76, 72.5, 111.9, 118.3, 121.6, 124.1, 138.0, 
162.0, 204.5 (4 signals overlap); IR (neat) 741, 1613, 1674, 2849, 2916, 3358 cm-1; 
HRMS (ESI) calcd for C52H85N2O2 (M+H+) 769.6606, found 769.6613.  Data for 404 - 
Mp 49-52 oC; 1H NMR δ 0.88 (t, J=6.6 Hz, 6H), 1.21-1.31 (br m, 60H), 1.52-1.56 (m, 
4H), 2.23 (dt, J=12.0, 4.2 Hz, 1H), 2.48 (dt, J=12.6, 3.6 Hz, 1H), 2.79-2.82 (m, 2H), 5.03 
(br s, 1H), 6.82 (t, J=7.2, 1H), 6.87 (d, J=8.4 Hz, 1H), 7.03 (t, J=7.8 Hz, 1H), 7.09 (t, 
J=7.2 Hz, 1H), 7.24 (d, J=8.4 Hz, 1H), 7.46 (t, J=8.4 Hz, 1H), 7.63 (d, J=7.8 Hz, 1H), 
7.77 (d, J=8.4 Hz, 1H), 7.81 (br s, 1H); 13C NMR δ 14.1, 22.7, 23.9, 28.4, 29.36, 29.41, 
29.47, 29.56, 29.61, 29.64, 29.65, 29.66, 29.68, 29.70, 29.71, 29.72, 29.9, 30.8, 31.9, 
38.1, 70.9, 108.9, 110.4, 112.1, 118.8, 119.6, 120.6, 121.2, 125.0, 127.3, 128.4, 133.5, 
135.2, 136.8, 137.1, 160.1, 203.3 (15 signals overlap); IR (neat) 718, 741, 1486, 1611, 
2850, 2917 cm-1; HRMS (ESI) calcd for C52H85N2O (M+H+) 753.6656, found 753.6652. 
 184
8.5 Supporting Information Chapter 7: Miscellaneous Reactions 
NO2
N
O
Br
O  
                                                 297                               412 
3-(Bromomethyl)benzo[c]isoxazole-N-oxide (412).  To a 3-pentanone solution (4 mL) 
of 1-ethynyl-2-nitrobenzene (297) (294 mg, 1.99 mmol) was added aqueous HBr (48 wt 
%, 1.0 mL), and the mixture was heated at 100oC for 3 h.  The solution was concentrated, 
extracted with ether (3 x 20 mL), and washed with water (1 x 20 mL).  The ether extract 
was dried over MgSO4, and eluted through a silica column (using 95:5 hexanes: EtOAc 
as the mobile phase) to give 412 (167 mg, 0.732 mmol, 37%) as a brown solid.  Mp 52-
54oC; 1H NMR δ 4.90 (s, 2H), 7.08 (d, J=8.9 Hz, 1H), 7.32 (dd, J=6.3, 4.8 Hz, 1H), 7.53-
7.61 (m, 2H); 13C NMR δ 17.9, 115.8, 116.2, 118.8, 124.8, 131.0, 157.4, 162.2.    
 
NO2
N
O
Cl
O  
 
                                                 297                                415 
 
3-(Chloromethyl)benzo[c]isoxazole-N-oxide (415).  To a 3-pentanone solution (2 mL) 
of 1-ethynyl-2-nitrobenzene (297) (147 mg, 1.00 mmol) was added aqueous HCl (37 wt 
%, 0.5 mL), and the mixture was heated at 100oC for 3 h.  The solution was concentrated, 
extracted with ether (3 x 20 mL), and washed with water (1 x 20 mL).  The ether extract 
was dried over MgSO4, and eluted through a silica column (using 95:5 hexanes: EtOAc 
as the mobile phase) to give 415 (97 mg, 0.528 mmol, 53%) as a brown oil.  1H NMR δ 
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5.03 (s, 2H), 7.06 (dd, J=8.7, 6.1 Hz, 1H), 7.32 (dd, J=9.3, 6.5 Hz, 1H), 7.56-7.61 (m, 
2H). 
 
                                        
NO2
CO2Me
N
CO2Me
H  
 
                                             115                                         418 
 
Methyl 1,2-dihydroquinoline-5-carboxylate (418).   Methyl 3-nitro-2-vinylbenzoate 
(115) (500 mg, 2.41 mmol), Pd(OAc)2 (33 mg, 0.145 mmol), triphenylphosphine (PPh3) 
(152 mg, 0.579 mmol), and paraformaldehyde (723 mg, 24.10 mmol) were dissolved in 
anhydrous MeCN (7 mL) in a threaded ACE glass pressure tube.  The tube was fitted 
with a pressure head, and the solution was saturated with carbon monoxide (four cycles 
of 4 atm of CO).  The reaction mixture was heated at 90oC (oil bath temperature) under 
CO (4 atm) for 17 hours.  Water (20 mL) was added and the orange solution was 
extracted with ethyl acetate (3 x 20 mL).  The combined organic phases were dried 
(MgSO4), filtered, and the solvent was removed under reduced pressure.  The resulting 
crude product was purified by chromatography (hexanes: EtOAc, 9:1) to afford 418 (100 
mg, 0.528 mmol, 22%) as a yellow solid.  1H NMR δ 3.13 (br t, J=5.9 Hz, 1H), 3.95 (s, 
3H), 5.61 (d, J=6.3 Hz, 2H), 7.11 (d, J=3.2 Hz, 1H), 7.22-7.28 (m, 2H), 7.66 (d, J=8.3 
Hz, 1H), 7.90 (d, J=7.5 Hz, 1H). 
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1H and 13C NMR for Chapter 3: Tryptophan Derivatives 
 
Figure 18: 1H NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-2-(2-
trimethylstannyl-2-propen-1-yl)pyrazine (238) 
 201
 
Figure 19: 13C NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-2-(2-
trimethylstannyl-2-propen-1-yl)pyrazine (238) 
 202
 
Figure 20: 1H NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-2-(2-(2-
nitrophenyl)-2-propen-1-yl)pyrazine (239) 
 203
 
Figure 21: 13C NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-2-(2-(2-
nitrophenyl)-2-propen-1-yl)pyrazine (239) 
 204
 
Figure 22: 1H NMR of (2R,5S)-2,5-Dihydro-2-(2-(4-methoxy-2-nitrophenyl)-2-propen-1-
yl)-5-(1-methylethyl)-3,6-dimethoxy-pyrazine (241) 
 205
 
Figure 23: 13C NMR of (2R,5S)-2,5-Dihydro-2-(2-(4-methoxy-2-nitrophenyl)-2-propen-
1-yl)-5-(1-methylethyl)-3,6-dimethoxy-pyrazine (241) 
 206
 
Figure 24: 1H NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(5-methoxy-2-
nitrophenyl)-2-propen-1-yl)-5-(1-methylethyl)pyrazine (243) 
 207
 
Figure 25: 13C NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(5-methoxy-2-
nitrophenyl)-2-propen-1-yl)-5-(1-methylethyl)pyrazine (243) 
 208
 
Figure 26: 1H NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(4-fluoro-2-
nitrophenyl)-2-propen-1-yl)-5-(1-methylethyl)pyrazine (245) 
 209
 
Figure 27: 13C NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(4-fluoro-2-
nitrophenyl)-2-propen-1-yl)-5-(1-methylethyl)pyrazine (245) 
 210
 
Figure 28: 1H NMR of Methyl 4-(1-((2R,5S)-2,5-dihydro-5-(1-methylethyl)-3,6-
dimethoxypyrazin-2-yl)prop-2-en-1-yl)-3-nitrobenzoate (247) 
 211
 
Figure 29: 13C NMR of Methyl 4-(1-((2R,5S)-2,5-dihydro-5-(1-methylethyl)-3,6-
dimethoxypyrazin-2-yl)prop-2-en-1-yl)-3-nitrobenzoate (247) 
 212
 
Figure 30: 1H NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(2,4-dinitrophenyl)-2-
propen-1-yl)-5-(1-methylethyl)pyrazine (249) 
 213
 
Figure 31: 13C NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(2,4-dinitrophenyl)-2-
propen-1-yl)-5-(1-methylethyl)pyrazine (249) 
 214
 
Figure 32: 1H NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(3-nitropyridin-2-
yl)prop-2-en-1-yl)-5-(1-methylethyl)pyrazine (251) 
 215
 
Figure 33: 13C NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(3-nitropyridin-2-
yl)prop-2-en-1-yl)-5-(1-methylethyl)pyrazine (251) 
 216
 
Figure 34: 1H NMR of Bis-2,3-((2R,5S)-2,5-dihydro-3,6-dimethoxy-5-methylethyl-2-
pyrazinylmethyl)-1,4-butadiene (254) 
 217
 
Figure 35: 13C NMR of Bis-2,3-((2R,5S)-2,5-dihydro-3,6-dimethoxy-5-methylethyl-2-
pyrazinylmethyl)-1,4-butadiene (254) 
 218
 
Figure 36: 1H NMR of (3-Methoxy-2-nitrophenyl)trimethylstannane (261) 
 219
 
Figure 37: 13C NMR of (3-Methoxy-2-nitrophenyl)trimethylstannane (261) 
 
 220
 
Figure 38: 1H NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(2-methoxy-6-
nitrophenyl)prop-2-en-1-yl)-5-(1-methylethyl)pyrazine (256) 
 221
 
Figure 39: 13C NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(2-methoxy-6-
nitrophenyl)prop-2-en-1-yl)-5-(1-methylethyl)pyrazine (256) 
 222
 
Figure 40: 1H NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(3-methoxy-2-
nitrophenyl)prop-2-en-1-yl)-5-(1-methylethyl)pyrazine (262) 
 223
 
 
Figure 41: 13C NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(2-(3-methoxy-2-
nitrophenyl)prop-2-en-1-yl)-5-(1-methylethyl)pyrazine (262) 
 224
 
Figure 42: 1H NMR of (2R,5S)-2-(3-Bromo-3-buten-1-yl)-2,5-dihydro-3,6-dimethoxy-5-
methylethylpyrazine (275) 
 225
 
Figure 43: 13C NMR of (2R,5S)-2-(3-Bromo-3-buten-1-yl)-2,5-dihydro-3,6-dimethoxy-5-
methylethylpyrazine (275) 
 226
 
Figure 44: 1H NMR of (2R,5S)-2-(3-Bromo-2-propen-1-yl)-2,5-dihydro-3,6-dimethoxy-
5-methylethylpyrazine (279) 
 227
 
Figure 45: 13C NMR of (2R,5S)-2-(3-Bromo-2-propen-1-yl)-2,5-dihydro-3,6-dimethoxy-
5-methylethylpyrazine (279) 
 228
 
Figure 46: 1H NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(3-(2-nitrophenyl)-3-
buten-1-yl)-5-(1-methylethyl)pyrazine (276) 
 229
 
Figure 47: 13C NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-(3-(2-nitrophenyl)-3-
buten-1-yl)-5-(1-methylethyl)pyrazine (276) 
 230
 
Figure 48: 1H NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-((2-nitrophenyl)-2-propen-
1-yl))-5-(1-methylethyl)pyrazine (E/Z) (280) 
 231
 
Figure 49: 13C NMR of (2R,5S)-2,5-Dihydro-3,6-dimethoxy-2-((2-nitrophenyl)-2-
propen-1-yl))-5-(1-methylethyl)pyrazine (E/Z) (280) 
 232
 
Figure 50: 1H NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-
methylethyl)pyrazin-2-yl)methyl)-1H-indole (263) 
 233
 
Figure 51: 13C NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-
methylethyl)pyrazin-2-yl)methyl)-1H-indole (263) 
 234
 
Figure 52: 1H NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-6-methoxy-1H-indole (264) 
 235
 
Figure 53: 13C NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-6-methoxy-1H-indole (264) 
 236
 
Figure 54: 1H NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-5-methoxy-1H-indole (265) 
 
 237
 
Figure 55: 13C NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-5-methoxy-1H-indole (265) 
 238
 
Figure 56: 1H NMR of 6-Fluoro-3-(((2R,5S)-2,5-dihydro-3,6-dimethoxy-5-(1-
methylethyl)-pyrazin-2-yl)methyl)-1H-indole (266) 
 239
 
Figure 57: 13C NMR of 6-Fluoro-3-(((2R,5S)-2,5-dihydro-3,6-dimethoxy-5-(1-
methylethyl)-pyrazin-2-yl)methyl)-1H-indole (266) 
 240
 
Figure 58: 1H NMR of Methyl 3-(((2R,5S)-2,5-dihydro-3,6-dimethoxy-5-(1-
methylethyl)-pyrazin-2-yl)methyl)-1H-indole-6-carboxylate (267) 
 241
 
Figure 59: 13C NMR of Methyl 3-(((2R,5S)-2,5-dihydro-3,6-dimethoxy-5-(1-
methylethyl)-pyrazin-2-yl)methyl)-1H-indole-6-carboxylate (267) 
 242
 
Figure 60: 1H NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-6-nitro-1H-indole (268) 
 243
 
Figure 61: 13C NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-6-nitro-1H-indole (268) 
 244
 
Figure 62: 1H NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-1H-pyrrolo[3,2-b]pyridine (269) 
 245
 
Figure 63: 13C NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-1H-pyrrolo[3,2-b]pyridine (269) 
 246
 
Figure 64: 1H NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-4-methoxy-1H-indole (270) 
 247
 
Figure 65: 13C NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-4-methoxy-1H-indole (270) 
 248
 
Figure 66: 1H NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-7-methoxy-1H-indole (271) 
 249
 
Figure 67: 13C NMR of 3-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-7-methoxy-1H-indole (271) 
 250
 
Figure 68: 1H NMR of 3-(2-((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)ethyl)-1H-indole (277) 
 251
 
Figure 69: 13C NMR of 3-(2-((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)ethyl)-1H-indole (277) 
 252
 
Figure 70: 1H NMR of 2-((2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-pyrazin-2-
yl)methyl)-1H-indole (281) 
 253
 
Figure 71: 13C NMR of 2-((2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-pyrazin-2-
yl)methyl)-1H-indole (281) 
 254
 
Figure 72: 1H NMR of 2-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-1-hydroxyindole (282) 
 255
 
Figure 73: 13C NMR of 2-(((2R,5S)-2,5-Dihydro-3,6-dimethoxy-5-(1-methylethyl)-
pyrazin-2-yl)methyl)-1-hydroxyindole (282) 
 256
1H and 13C NMR for Chapter 4: 2- and/or 3-Substituted Indoles 
 
Figure 74: 1H NMR of Triethyl((E)-1-(2-nitrophenyl)hex-1-enyl)silane (290) 
 257
 
Figure 75: 13C NMR of Triethyl((E)-1-(2-nitrophenyl)hex-1-enyl)silane (290) 
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Figure 76: 1H NMR of 1,2-Bis(2-nitrophenyl)ethyne (298) 
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Figure 77: 13C NMR of 1,2-Bis(2-nitrophenyl)ethyne (298) 
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Figure 78: 1H NMR of Tributyl((E)-1-(2-nitrophenyl)-2-phenylvinyl)stannane (303) 
 
 261
 
Figure 79: 13C NMR of Tributyl((E)-1-(2-nitrophenyl)-2-phenylvinyl)stannane (303) 
 262
 
Figure 80: 1H NMR of 1-Methoxy-4-((Z)-1-(2-nitrophenyl)-2-phenylvinyl)benzene (306) 
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Figure 81: 13C NMR of 1-Methoxy-4-((Z)-1-(2-nitrophenyl)-2-phenylvinyl)benzene 
(306) 
 264
 
Figure 82: 1H NMR of Tributyl((E)-1-(2-nitrophenyl)hex-1-enyl)stannane (308) 
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Figure 83: 13C NMR of Tributyl((E)-1-(2-nitrophenyl)hex-1-enyl)stannane (308) 
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Figure 84: 1H NMR of Tributyl(1-(2-nitrophenyl)vinyl)stannane (311) 
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Figure 85: 13C NMR of Tributyl(1-(2-nitrophenyl)vinyl)stannane (311) 
 268
 
Figure 86: 1H NMR of 2,3-Bis(2-nitrophenyl)buta-1,3-diene (312) 
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Figure 87: 13C NMR of 2,3-Bis(2-nitrophenyl)buta-1,3-diene (312) 
 270
 
Figure 88: 1H NMR of 1-(1-(4-Methoxyphenyl)vinyl)-2-nitrobenzene (314) and 2,3-
Bis(2-nitrophenyl)buta-1,3-diene (312).   
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Figure 89: 13C NMR of 1-(1-(4-Methoxyphenyl)vinyl)-2-nitrobenzene (314) and 2,3-
Bis(2-nitrophenyl)buta-1,3-diene (312).   
 272
 
Figure 90: 1H NMR of 1,1-Bis(2-nitrophenyl)ethene (316) 
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Figure 91: 13C NMR of 1,1-Bis(2-nitrophenyl)ethene (316) 
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Figure 92: 1H NMR of Indolo[2,3-b]indole (317) 
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Figure 93: 13C NMR of Indolo[2,3-b]indole (317) 
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Figure 94: 1H NMR of 5H-Indolo[2,3-c]quinolin-6(7H)-one (318) 
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Figure 95: 13C NMR of 5H-Indolo[2,3-c]quinolin-6(7H)-one (318) 
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Figure 96: 13C NMR APT and DEPT-90 of 5H-Indolo[2,3-c]quinolin-6(7H)-one (318) 
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1H and 13C NMR for Chapter 5: Dilemmaones A-C 
 
Figure 97: 1H NMR of 6-Amino-7-bromo-2,3-dihydro-5-methylinden-1-one (347) 
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Figure 98: 13C NMR of 6-Amino-7-bromo-2,3-dihydro-5-methylinden-1-one (347) 
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Figure 99: 1H NMR of N-(2,3-Dihydro-5-methyl-1-oxo-1H-inden-6-yl)acetamide (348) 
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Figure 100: 13C NMR of N-(2,3-Dihydro-5-methyl-1-oxo-1H-inden-6-yl)acetamide (348) 
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Figure 101: 1H NMR of N-(2,3-Dihydro-5-methyl-7-nitro-1-oxo-1H-inden-6-
yl)acetamide (349) 
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Figure 102: 13C NMR of N-(2,3-Dihydro-5-methyl-7-nitro-1-oxo-1H-inden-6-
yl)acetamide (349) 
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Figure 103: 1H NMR of 6-Amino-2,3-dihydro-5-methyl-7-nitroinden-1-one (346) 
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Figure 104: 13C NMR of 6-Amino-2,3-dihydro-5-methyl-7-nitroinden-1-one (346) 
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Figure 105: 1H NMR of 2,3-Dihydro-6-iodo-5-methyl-7-nitroinden-1-one (329) 
 
 288
 
Figure 106: 13C NMR of 2,3-Dihydro-6-iodo-5-methyl-7-nitroinden-1-one (329) 
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Figure 107: 1H NMR of 6-Bromo-2,3-dihydro-5-methyl-7-nitroinden-1-one (350) 
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Figure 108: 13C NMR of 6-Bromo-2,3-dihydro-5-methyl-7-nitroinden-1-one (350) 
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1H and 13C NMR for Chapter 6: Fistulosin 
 
Figure 109: 1H NMR of 2-(Icos-1-ynyl)benzenamine (396) 
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Figure 110: 13C NMR of 2-(Icos-1-ynyl)benzenamine (396) 
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Figure 111: 1H NMR of 1-(Icos-1-ynyl)-2-nitrobenzene (398) 
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Figure 112: 13C NMR of 1-(Icos-1-ynyl)-2-nitrobenzene (398) 
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Figure 113: 1H NMR of Triethyl((E)-1-(2-nitrophenyl)icos-1-enyl)silane (399) 
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Figure 114: 13C NMR of Triethyl((E)-1-(2-nitrophenyl)icos-1-enyl)silane (399) 
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Figure 115: 1H NMR of 2-Octadecyl-1H-indole (397) 
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Figure 116: 13C NMR of 2-Octadecyl-1H-indole (397) 
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Figure 117: 1H NMR of 2-Octadecyl-2-(2-octadecyl-3-oxo-2,3-dihydro-1H-indol-2-yl)-
1,2-dihydro-3H-indol-3-one (392) 
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Figure 118: 13C NMR of 2-Octadecyl-2-(2-octadecyl-3-oxo-2,3-dihydro-1H-indol-2-yl)-
1,2-dihydro-3H-indol-3-one (392) 
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Figure 119: 1H NMR Expansion of 2-Octadecyl-2-(2-octadecyl-3-oxo-2,3-dihydro-1H-
indol-2-yl)-1,2-dihydro-3H-indol-3-one (392) 
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Figure 120: 13C NMR Expansion of 2-Octadecyl-2-(2-octadecyl-3-oxo-2,3-dihydro-1H-
indol-2-yl)-1,2-dihydro-3H-indol-3-one (392) 
 303
 
 
Figure 121: gHMBC of 2-Octadecyl-2-(2-octadecyl-3-oxo-2,3-dihydro-1H-indol-2-yl)-
1,2-dihydro-3H-indol-3-one (392) 
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Figure 122: gHMBC Expansion (aliphatic region) of 2-Octadecyl-2-(2-octadecyl-3-oxo-
2,3-dihydro-1H-indol-2-yl)-1,2-dihydro-3H-indol-3-one (392) 
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Figure 123: gHMBC Expansion (aromatic region) of 2-Octadecyl-2-(2-octadecyl-3-oxo-
2,3-dihydro-1H-indol-2-yl)-1,2-dihydro-3H-indol-3-one (392) 
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Figure 124: 1H NMR of 2-Octadecyl-2-(2-octadecyl-1H-indol-3-yl)indolin-3-one (404) 
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Figure 125: 13C NMR of 2-Octadecyl-2-(2-octadecyl-1H-indol-3-yl)indolin-3-one (404) 
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Figure 126: 1H NMR Expansion of 2-Octadecyl-2-(2-octadecyl-1H-indol-3-yl)indolin-3-
one (404) 
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Figure 127: 13C NMR Expansion (aliphatic region) of 2-Octadecyl-2-(2-octadecyl-1H-
indol-3-yl)indolin-3-one (404) 
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Figure 128: 13C NMR Expansion (aromatic region) of 2-Octadecyl-2-(2-octadecyl-1H-
indol-3-yl)indolin-3-one (404) 
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Figure 129: gHMBC Expansion (ring linkage) of 2-Octadecyl-2-(2-octadecyl-1H-indol-
3-yl)indolin-3-one (404) 
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Figure 130: gHMBC Expansion (diastereotopic protons) of 2-Octadecyl-2-(2-octadecyl-
1H-indol-3-yl)indolin-3-one (404) 
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Figure 131: gHMBC Expansion (aromatics) of 2-Octadecyl-2-(2-octadecyl-1H-indol-3-
yl)indolin-3-one (404) 
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Figure 132: gHMBC Expansion (carbonyl) of 2-Octadecyl-2-(2-octadecyl-1H-indol-3-
yl)indolin-3-one (404) 
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Figure 133: 2D NOESY (full) of 2-Octadecyl-2-(2-octadecyl-1H-indol-3-yl)indolin-3-
one (404) 
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Figure 134: 2D NOESY Expansion (aromatic region) of 2-Octadecyl-2-(2-octadecyl-1H-
indol-3-yl)indolin-3-one (404) 
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1H and 13C NMR for Chapter 7: Miscellaneous Reactions 
 
Figure 135: 1H NMR of 3-(Bromomethyl)benzo[c]isoxazole-N-oxide (412) 
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Figure 136: 13C NMR of 3-(Bromomethyl)benzo[c]isoxazole-N-oxide (412) 
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Figure 137: gHMBC of 3-(Bromomethyl)benzo[c]isoxazole-N-oxide (412) 
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Figure 138: 1D NOE of 3-(Bromomethyl)benzo[c]isoxazole-N-oxide (412) 
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Figure 139: HETCOR of 3-(Bromomethyl)benzo[c]isoxazole-N-oxide (412) 
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Figure 140: COSY of 3-(Bromomethyl)benzo[c]isoxazole-N-oxide (412) 
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Figure 141: 1H NMR of 3-(Chloromethyl)benzo[c]isoxazole-N-oxide (415) 
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Figure 142: 1H NMR of Methyl 1,2-dihydroquinoline-5-carboxylate (418) 
 
